fileName;bpmnModeler;modelType;isEnglish;nTaskNoneLoopNoneCompensateNoneCallNone;nTaskNoneLoopNoneCompensateNoneCall;nTaskNoneLoopNoneCompensateCallNone;nTaskNoneLoopNoneCompensateCall;nTaskNoneLoopStandardCompensateNoneCallNone;nTaskNoneLoopStandardCompensateNoneCall;nTaskNoneLoopStandardCompensateCallNone;nTaskNoneLoopStandardCompensateCall;nTaskNoneLoopMIParallelCompensateNoneCallNone;nTaskNoneLoopMIParallelCompensateNoneCall;nTaskNoneLoopMIParallelCompensateCallNone;nTaskNoneLoopMIParallelCompensateCall;nTaskNoneLoopMISequentialCompensateNoneCallNone;nTaskNoneLoopMISequentialCompensateNoneCall;nTaskNoneLoopMISequentialCompensateCallNone;nTaskNoneLoopMISequentialCompensateCall;nTaskSendLoopNoneCompensateNone;nTaskSendLoopNoneCompensate;nTaskSendLoopStandardCompensateNone;nTaskSendLoopStandardCompensate;nTaskSendLoopMIParallelCompensateNone;nTaskSendLoopMIParallelCompensate;nTaskSendLoopMISequentialCompensateNone;nTaskSendLoopMISequentialCompensate;nTaskReceiveLoopNoneCompensateNone;nTaskReceiveLoopNoneCompensate;nTaskReceiveLoopStandardCompensateNone;nTaskReceiveLoopStandardCompensate;nTaskReceiveLoopMIParallelCompensateNone;nTaskReceiveLoopMIParallelCompensate;nTaskReceiveLoopMISequentialCompensateNone;nTaskReceiveLoopMISequentialCompensate;nTaskUserLoopNoneCompensateNone;nTaskUserLoopNoneCompensate;nTaskUserLoopStandardCompensateNone;nTaskUserLoopStandardCompensate;nTaskUserLoopMIParallelCompensateNone;nTaskUserLoopMIParallelCompensate;nTaskUserLoopMISequentialCompensateNone;nTaskUserLoopMISequentialCompensate;nTaskManualLoopNoneCompensateNone;nTaskManualLoopNoneCompensate;nTaskManualLoopStandardCompensateNone;nTaskManualLoopStandardCompensate;nTaskManualLoopMIParallelCompensateNone;nTaskManualLoopMIParallelCompensate;nTaskManualLoopMISequentialCompensateNone;nTaskManualLoopMISequentialCompensate;nTaskBusinessRuleLoopNoneCompensateNone;nTaskBusinessRuleLoopNoneCompensate;nTaskBusinessRuleLoopStandardCompensateNone;nTaskBusinessRuleLoopStandardCompensate;nTaskBusinessRuleLoopMIParallelCompensateNone;nTaskBusinessRuleLoopMIParallelCompensate;nTaskBusinessRuleLoopMISequentialCompensateNone;nTaskBusinessRuleLoopMISequentialCompensate;nTaskServiceLoopNoneCompensateNone;nTaskServiceLoopNoneCompensate;nTaskServiceLoopStandardCompensateNone;nTaskServiceLoopStandardCompensate;nTaskServiceLoopMIParallelCompensateNone;nTaskServiceLoopMIParallelCompensate;nTaskServiceLoopMISequentialCompensateNone;nTaskServiceLoopMISequentialCompensate;nTaskScriptLoopNoneCompensateNone;nTaskScriptLoopNoneCompensate;nTaskScriptLoopStandardCompensateNone;nTaskScriptLoopStandardCompensate;nTaskScriptLoopMIParallelCompensateNone;nTaskScriptLoopMIParallelCompensate;nTaskScriptLoopMISequentialCompensateNone;nTaskScriptLoopMISequentialCompensate;nSubProcessExtendedEventNoneAdHocNoneTransactionNoneLoopNoneCompensateNone;nSubProcessExtendedEventNoneAdHocNoneTransactionNoneLoopNoneCompensate;nSubProcessExtendedEventNoneAdHocNoneTransactionNoneLoopStandardCompensateNone;nSubProcessExtendedEventNoneAdHocNoneTransactionNoneLoopStandardCompensate;nSubProcessExtendedEventNoneAdHocNoneTransactionNoneLoopMIParallelCompensateNone;nSubProcessExtendedEventNoneAdHocNoneTransactionNoneLoopMIParallelCompensate;nSubProcessExtendedEventNoneAdHocNoneTransactionNoneLoopMISequentialCompensateNone;nSubProcessExtendedEventNoneAdHocNoneTransactionNoneLoopMISequentialCompensate;nSubProcessExtendedEventNoneAdHocLoopNoneCompensateNone;nSubProcessExtendedEventNoneAdHocLoopNoneCompensate;nSubProcessExtendedEventNoneAdHocLoopStandardCompensateNone;nSubProcessExtendedEventNoneAdHocLoopStandardCompensate;nSubProcessExtendedEventNoneAdHocLoopMIParallelCompensateNone;nSubProcessExtendedEventNoneAdHocLoopMIParallelCompensate;nSubProcessExtendedEventNoneAdHocLoopMISequentialCompensateNone;nSubProcessExtendedEventNoneAdHocLoopMISequentialCompensate;nSubProcessExtendedEventNoneTransactionLoopNoneCompensateNone;nSubProcessExtendedEventNoneTransactionLoopNoneCompensate;nSubProcessExtendedEventNoneTransactionLoopStandardCompensateNone;nSubProcessExtendedEventNoneTransactionLoopStandardCompensate;nSubProcessExtendedEventNoneTransactionLoopMIParallelCompensateNone;nSubProcessExtendedEventNoneTransactionLoopMIParallelCompensate;nSubProcessExtendedEventNoneTransactionLoopMISequentialCompensateNone;nSubProcessExtendedEventNoneTransactionLoopMISequentialCompensate;nSubProcessExtendedEventLoopNoneCompensateNone;nSubProcessExtendedEventLoopNoneCompensate;nSubProcessExtendedEventLoopStandardCompensateNone;nSubProcessExtendedEventLoopStandardCompensate;nSubProcessExtendedEventLoopMIParallelCompensateNone;nSubProcessExtendedEventLoopMIParallelCompensate;nSubProcessExtendedEventLoopMISequentialCompensateNone;nSubProcessExtendedEventLoopMISequentialCompensate;nSubProcessExtendedEventAdHocLoopNoneCompensateNone;nSubProcessExtendedEventAdHocLoopNoneCompensate;nSubProcessExtendedEventAdHocLoopStandardCompensateNone;nSubProcessExtendedEventAdHocLoopStandardCompensate;nSubProcessExtendedEventAdHocLoopMIParallelCompensateNone;nSubProcessExtendedEventAdHocLoopMIParallelCompensate;nSubProcessExtendedEventAdHocLoopMISequentialCompensateNone;nSubProcessExtendedEventAdHocLoopMISequentialCompensate;nSubProcessCollapsedEventNoneAdHocNoneTransactionNoneLoopNoneCompensateNone;nSubProcessCollapsedEventNoneAdHocNoneTransactionNoneLoopNoneCompensate;nSubProcessCollapsedEventNoneAdHocNoneTransactionNoneLoopStandardCompensateNone;nSubProcessCollapsedEventNoneAdHocNoneTransactionNoneLoopStandardCompensate;nSubProcessCollapsedEventNoneAdHocNoneTransactionNoneLoopMIParallelCompensateNone;nSubProcessCollapsedEventNoneAdHocNoneTransactionNoneLoopMIParallelCompensate;nSubProcessCollapsedEventNoneAdHocNoneTransactionNoneLoopMISequentialCompensateNone;nSubProcessCollapsedEventNoneAdHocNoneTransactionNoneLoopMISequentialCompensate;nSubProcessCollapsedEventNoneAdHocLoopNoneCompensateNone;nSubProcessCollapsedEventNoneAdHocLoopNoneCompensate;nSubProcessCollapsedEventNoneAdHocLoopStandardCompensateNone;nSubProcessCollapsedEventNoneAdHocLoopStandardCompensate;nSubProcessCollapsedEventNoneAdHocLoopMIParallelCompensateNone;nSubProcessCollapsedEventNoneAdHocLoopMIParallelCompensate;nSubProcessCollapsedEventNoneAdHocLoopMISequentialCompensateNone;nSubProcessCollapsedEventNoneAdHocLoopMISequentialCompensate;nSubProcessCollapsedEventNoneTransactionLoopNoneCompensateNone;nSubProcessCollapsedEventNoneTransactionLoopNoneCompensate;nSubProcessCollapsedEventNoneTransactionLoopStandardCompensateNone;nSubProcessCollapsedEventNoneTransactionLoopStandardCompensate;nSubProcessCollapsedEventNoneTransactionLoopMIParallelCompensateNone;nSubProcessCollapsedEventNoneTransactionLoopMIParallelCompensate;nSubProcessCollapsedEventNoneTransactionLoopMISequentialCompensateNone;nSubProcessCollapsedEventNoneTransactionLoopMISequentialCompensate;nSubProcessCollapsedEventLoopNoneCompensateNone;nSubProcessCollapsedEventLoopNoneCompensate;nSubProcessCollapsedEventLoopStandardCompensateNone;nSubProcessCollapsedEventLoopStandardCompensate;nSubProcessCollapsedEventLoopMIParallelCompensateNone;nSubProcessCollapsedEventLoopMIParallelCompensate;nSubProcessCollapsedEventLoopMISequentialCompensateNone;nSubProcessCollapsedEventLoopMISequentialCompensate;nSubProcessCollapsedEventAdHocLoopNoneCompensateNone;nSubProcessCollapsedEventAdHocLoopNoneCompensate;nSubProcessCollapsedEventAdHocLoopStandardCompensateNone;nSubProcessCollapsedEventAdHocLoopStandardCompensate;nSubProcessCollapsedEventAdHocLoopMIParallelCompensateNone;nSubProcessCollapsedEventAdHocLoopMIParallelCompensate;nSubProcessCollapsedEventAdHocLoopMISequentialCompensateNone;nSubProcessCollapsedEventAdHocLoopMISequentialCompensate;nDataObject;nDataObjectCollection;nDataStore;nDataInput;nDataOutput;nExclusiveGatewayNoMarker;nExclusiveGatewayMarker;nParallelGateway;nInclusiveGateway;nEventBasedGateway;nEventBasedGatewayExclusiveInstantiation;nEventBasedGatewayParallelInstantiation;nComplexGateway;nStartMultipleParallelEventDefinition;nStartMultipleEventDefinition;nStartNoneEventDefinition;nStartSignalEventDefinition;nStartConditionalEventDefinition;nStartTimerEventDefinition;nStartMessageEventDefinition;nStartMessageEventSubProcessInterruptingDefinition;nStartTimerEventSubProcessInterruptingDefinition;nStartEscalationEventSubProcessInterruptingDefinition;nStartConditionalEventSubProcessInterruptingDefinition;nStartErrorEventSubProcessInterruptingDefinition;nStartCompensateEventSubProcessInterruptingDefinition;nStartSignalEventSubProcessInterruptingDefinition;nStartMultipleEventSubProcessInterruptingDefinition;nStartMultipleParallelEventSubProcessInterruptingDefinition;nStartMessageEventSubProcessNonInterruptingDefinition;nStartTimerEventSubProcessNonInterruptingDefinition;nStartEscalationEventSubProcessNonInterruptingDefinition;nStartConditionalEventSubProcessNonInterruptingDefinition;nStartSignalEventSubProcessNonInterruptingDefinition;nStartMultipleParallelEventSubProcessNonInterruptingDefinition;nStartMultipleEventSubProcessNonInterruptingDefinition;nEndNoneEventDefinition;nEndMultipleEventDefinition;nEndEscalationEventDefinition;nEndErrorEventDefinition;nEndSignalEventDefinition;nEndCompensateEventDefinition;nEndCancelEventDefinition;nEndMessageEventDefinition;nEndTerminateEventDefinition;nIntermediateCatchMultipleEventDefinition;nIntermediateCatchMultipleParallelEventDefinition;nIntermediateCatchMessageEventDefinition;nIntermediateCatchTimerEventDefinition;nIntermediateCatchConditionalEventDefinition;nIntermediateCatchLinkEventDefinition;nIntermediateCatchSignalEventDefinition;nIntermediateThrowNoneEventDefinition;nIntermediateThrowMessageEventDefinition;nIntermediateThrowEscalationEventDefinition;nIntermediateThrowLinkEventDefinition;nIntermediateThrowSignalEventDefinition;nIntermediateThrowCompensateEventDefinition;nIntermediateThrowMultipleEventDefinition;nIntermediateBoundaryMessageEvent;nIntermediateBoundaryTimerEvent;nIntermediateBoundaryCancelEvent;nIntermediateBoundaryConditionalEvent;nIntermediateBoundaryEscalationEvent;nIntermediateBoundaryErrorEvent;nIntermediateBoundarySignalEvent;nIntermediateBoundaryCompensateEvent;nIntermediateBoundaryMultipleEvent;nIntermediateBoundaryMultipleParallelEvent;nIntermediateBoundaryTimerEventNonInterrupting;nIntermediateBoundaryEscalationEventNonInterrupting;nIntermediateBoundaryConditionalEventNonInterrupting;nIntermediateBoundaryMessageEventNonInterrupting;nIntermediateBoundarySignalEventNonInterrupting;nIntermediateBoundaryMultipleEventNonInterrupting;nIntermediateBoundaryMultipleParallelEventNonInterrupting;nMessageFlow;nSequenceFlow;nDefaultFlow;nConditionalFlow;nLane;nPoolCollapsedMultiplicityNone;nPoolCollapsedMultiplicity;nPoolExpandedMultiplicityNone;nPoolExpandedMultiplicity;nChoreographyTask;nChoreographyMessage;nChoreographyTaskSequentialMultipleInstance;nChoreographyTaskParallelMultipleInstance;nChoreographyTaskLoop;nChoreographySubprocessCollapsed;nChoreographySubprocessCollapsedParallelMultipleInstance;nChoreographySubprocessCollapsedSequentialMultipleInstance;nChoreographySubprocessCollapsedLoop;nChoreographySubprocessCollapsedCall;nChoreographySubprocessCollapsedCallSequentialMultipleInstance;nChoreographySubprocessCollapsedCallParallelMultipleInstance;nChoreographySubprocessCollapsedCallLoop;nChoreographySubprocessExpanded;nChoreographySubprocessExpandedSequentialMultipleInstance;nChoreographySubprocessExpandedParallelMultipleInstance;nChoreographySubprocessExpandedLoop;nChoreographyParticipant;nChoreographyParticipantMultiple;nConversationNone;nConversationSubProcess;nConversationCall;nConversationLink;nAssociationUndirected;nAssociationUnidirectional;nAssociationBidirectional;nAssociationDataOutput;nAssociationDataInput;nGroup;nTextAnnotation;Model's Execution Time;TotalElements;Practical Complexity;File Size (Kb);Duplicate String;Labels Separated by (^^^);Concatenated Labels;Total number of words;Total number of characters;average;median;mode;
c2984a6c-87a8-42ec-914c-92cd253d8b29.bpmn;BPMN2;Process;false;312;133;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;84;262;0;0;0;0;0;0;30;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;21;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;1805;0;0;54;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;416;0;0;0;0;0;193;1439.0;3310;10;1078746;31213300000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000008426200000030000000000000000000002100000000000000000000000000000000000000001805005400000000000000000000000000041600000193107874612.9cm12.9cm13positiveaxillarynodes13positiveaxillarynodes13positiveaxillarynodes13positiveaxillarynodes21geneRTPCRassay21geneRTPCRassay<1cm<1cmAbdominalandpelvicdiagnosticCTAbdominalandpelvicdiagnosticCTAbdominalandpelvicdiagnosticCTAbdominalandpelvicdiagnosticCTAbdominalandpelvicdiagnosticCTAbdominalandpelvicdiagnosticCTAbdominalandpelvicdiagnosticCTAbdominalandpelvicdiagnosticCTAbdominalandpelvicdiagnosticMRIAbdominalandpelvicdiagnosticMRIAbdominalandpelvicdiagnosticMRIAbdominalandpelvicdiagnosticMRIAbdominalandpelvicdiagnosticMRIAbdominalandpelvicdiagnosticMRIAbdominalandpelvicdiagnosticMRIAbdominalandpelvicdiagnosticMRIAbdominalCTAbdominalCTAbdominalCTAbdominalCTAbdominalCTAbdominalCTAbdominalCTAbdominalCTAbdominalCTAbdominalCTAbdominalMRIAbdominalMRIAbdominalMRIAbdominalMRIAbdominalMRIAbdominalMRIAbdominalMRIAbdominalMRIAbdominalMRIAbdominalMRIAbdominalorpelvicdiagnosticCTAbdominalorpelvicdiagnosticCTAbdominalorpelvicdiagnosticMRIAbdominalorpelvicdiagnosticMRIAbdominalsymptomsAbdominalsymptomsAbnormalliverfunctiontestsAbnormalliverfunctiontestsAbnormallongandweightbearingbonesfoundAbnormallongandweightbearingbonesfoundAbnormalphysicalexaminationoftheabdomenAbnormalphysicalexaminationoftheabdomenAbnormalphysicalexaminationofthepelvisAbnormalphysicalexaminationofthepelvisAC(doxorubicin/cyclophosphamide)AC(doxorubicin/cyclophosphamide)AC(doxorubicin/cyclophosphamide)every3weeksAC(doxorubicin/cyclophosphamide)every3weeksAC(doxorubicin/cyclophosphamide)every3weeksAC(doxorubicin/cyclophosphamide)every3weeksACfollowedbydocetaxel+trastuzumab±pertuzumabACfollowedbydocetaxel+trastuzumab±pertuzumabACfollowedbydocetaxel+trastuzumab±pertuzumabACfollowedbydocetaxel+trastuzumab±pertuzumabACfollowedbydocetaxelevery3weeksACfollowedbydocetaxelevery3weeksACfollowedbydocetaxelevery3weeksACfollowedbydocetaxelevery3weeksACfollowedbyT+trastuzumab±pertuzumab(doxorubicin/cyclophosphamidefollowedbypaclitaxelplustrastuzumab± pertuzumabvariousschedules)ACfollowedbyT+trastuzumab±pertuzumab(doxorubicin/cyclophosphamidefollowedbypaclitaxelplustrastuzumab± pertuzumabvariousschedules)ACfollowedbyT+trastuzumab±pertuzumab(doxorubicin/cyclophosphamidefollowedbypaclitaxelplustrastuzumab± pertuzumabvariousschedules)ACfollowedbyT+trastuzumab±pertuzumab(doxorubicin/cyclophosphamidefollowedbypaclitaxelplustrastuzumab± pertuzumabvariousschedules)ACfollowedbyweeklypaclitaxelACfollowedbyweeklypaclitaxelACfollowedbyweeklypaclitaxelACfollowedbyweeklypaclitaxelAcuteLymphoblasticLeukemiaAcuteLymphoblasticLeukemiaAcuteLymphoblasticLeukemiatestAcuteLymphoblasticLeukemiatestAdditionallineofendocrinetherapyAdditionallineofendocrinetherapyAdditionallineofendocrinetherapyAdditionallineofendocrinetherapyAdditionallineofendocrinetherapyAdditionallineofendocrinetherapyAdditionallineofendocrinetherapyAdditionallineofendocrinetherapyAdditionalsystemicchemotherapyHER2+AdditionalsystemicchemotherapyHER2+AdditionalsystemicchemotherapyHER2negativeAdditionalsystemicchemotherapyHER2negativeADDITIONALTESTINGADDITIONALTESTINGadjuvantchemotherapyAdjuvantchemotherapyAdjuvantchemotherapyAdjuvantchemotherapyAdjuvantchemotherapyAdjuvantchemotherapyAdjuvantchemotherapyadjuvantchemotherapyAdjuvantchemotherapyAdjuvantchemotherapyAdjuvantchemotherapyAdjuvantchemotherapyAdjuvantchemotherapyAdjuvantchemotherapyAdjuvantEndocrineTherapyAdjuvantendocrinetherapyAdjuvantendocrinetherapyAdjuvantendocrinetherapyAdjuvantendocrinetherapyAdjuvantendocrinetherapyAdjuvantendocrinetherapyAdjuvantendocrinetherapyAdjuvantendocrinetherapyAdjuvantendocrinetherapyAdjuvantendocrinetherapyAdjuvantendocrinetherapyAdjuvantendocrinetherapyAdjuvantendocrinetherapyAdjuvantendocrinetherapyAdjuvantendocrinetherapyAdjuvantEndocrineTherapyAdjuvantendocrinetherapyAdjuvantendocrinetherapyAdjuvantendocrinetherapyAdjuvantendocrinetherapyAdjuvantEndocrineTherapyAdjuvantendocrinetherapyAdjuvantendocrinetherapyAdjuvantendocrinetherapyAdjuvantendocrinetherapyAdjuvantendocrinetherapyAdjuvantendocrinetherapyAdjuvantendocrinetherapyAdjuvantendocrinetherapyAdjuvantendocrinetherapyAdjuvantendocrinetherapyAdjuvantendocrinetherapyAdjuvantendocrinetherapyAdjuvantendocrinetherapyAdjuvantendocrinetherapyAdjuvantendocrinetherapyAdjuvantEndocrineTherapyAdjuvantendocrinetherapyAdjuvantendocrinetherapyAdjuvantendocrinetherapyAdjuvantendocrinetherapyAdjuvantendocrinetherapyforriskreductionAdjuvantendocrinetherapyforriskreductionAdjuvantEndocrineTherapy3.2014AdjuvantEndocrineTherapy3.2014AdjuvantsettingAdjuvantsettingAdjuvantsettingNodenegativeTumor≥1cm AdjuvantsettingNodenegativeTumor≥1cm AdjuvantsettingNodepositiveAdjuvantsettingNodepositiveADJUVANTTREATMENTADJUVANTTREATMENTADJUVANTTREATMENTADJUVANTTREATMENTADJUVANTTREATMENTADJUVANTTREATMENTADJUVANTTREATMENTADJUVANTTREATMENTADJUVANTTREATMENTADJUVANTTREATMENTADJUVANTTREATMENTADJUVANTTREATMENTADJUVANTTREATMENTADJUVANTTREATMENTADJUVANTTREATMENTADJUVANTTREATMENTADJUVANTTREATMENTADJUVANTTREATMENTADJUVANTTREATMENTADJUVANTTREATMENTAdjuvant chemotherapyAdjuvant chemotherapyAdotrastuzumabemtansine(TDM1)Adotrastuzumabemtansine(TDM1)Adotrastuzumabemtansine(TDM1)Adotrastuzumabemtansine(TDM1)AlbuminboundpaclitaxelAlbuminboundpaclitaxelAnnualgynecologicassessmentevery12monthsAnnualgynecologicassessmentevery12monthsAromataseinhibitorAromataseinhibitorAromataseinhibitorfor23yAromataseinhibitorfor23yAromataseinhibitorfor5yAromataseinhibitorfor5yAromataseinhibitorfor5yAromataseinhibitorfor5yAromataseinhibitorfor5yAromataseinhibitorfor5yAromataseinhibitorfor5yAromataseinhibitorfor5yAromataseinhibitortocomplete5yofendocrinetherapyAromataseinhibitortocomplete5yofendocrinetherapyASSAYASSAYAssaynotdoneAssaynotdoneAssessandencourageadherencetoadjuvantendocrinetherapyAssessandencourageadherencetoadjuvantendocrinetherapyAssessfordistressAssessfordistressAssessfordistressAssessfordistressAssessfordistressAssessfordistressAsymptomaticvisceralAsymptomaticvisceralAsymptomaticvisceralAsymptomaticvisceralAverageHER2copynumber<4.0signals/cellAverageHER2copynumber<4.0signals/cellAverageHER2copynumber<4.0signals/cellAverageHER2copynumber<4.0signals/cellAverageHER2copynumber<4.0signals/cellAverageHER2copynumber<4.0signals/cellAverageHER2copynumber≥4.0and<6.0signals/cellAverageHER2copynumber≥4.0and<6.0signals/cellAverageHER2copynumber≥4.0and<6.0signals/cellAverageHER2copynumber≥4.0and<6.0signals/cellAverageHER2copynumber≥4.0signals/cellAverageHER2copynumber≥4.0signals/cellAverageHER2copynumber≥6.0signals/cellAverageHER2copynumber≥6.0signals/cellAverageHER2copynumber≥6.0signals/cellAverageHER2copynumber≥6.0signals/cellAxillarydissectionlevelI/IIAxillarydissectionlevelI/IIAxillarydissectionlevelI/IIAxillarydissectionlevelI/IIAxillaryimagingwithultrasoundAxillaryimagingwithultrasoundAxillarylymphnodedissectionAxillarylymphnodedissectionAxillarylymphnodedissectionAxillarylymphnodedissectionAxillarylymphnodedissectionAxillarylymphnodedissectionAxillarylymphnodedissectionAxillarylymphnodedissectionAxillarylymphnodestagingAxillarylymphnodestagingAxillaryradiationforregionalcontrolofdiseaseAxillaryradiationforregionalcontrolofdiseaseAxillaryrecurrenceAxillaryrecurrenceBiopsyoffirstrecurrenceofdiseaseBiopsyoffirstrecurrenceofdiseaseBonediseasenotpresentBonediseasenotpresentBonediseasepresentBonediseasepresentBoneonlyBoneonlyBoneonlyBoneonlyBonescanBonescanBonescanBonescanBonescanBonescanBonescanBonescanBonescanBonescanBonescan forsystemicstagingBonescan forsystemicstagingBonescan forsystemicstagingBonescan forsystemicstagingBrainMRIBrainMRIBreastMRIBreastMRIBreastMRIBreastMRIBreastMRIBreastMRIBreastreconstructionBreastreconstructionCAF/FAC(cyclophosphamide/doxorubicin/fluorouracil)CAF/FAC(cyclophosphamide/doxorubicin/fluorouracil)CapecitabineCapecitabineCarboplatinCarboplatinCBCCBCCBCCBCCBCCBCCBCCBCCBCCBCChemoindicatedChemoindicatedChemoindicatedChemoindicatedChemoindicatedChemoindicatedChemoindicatedChemoindicatedChemoindicatedChemoindicatedChemoindicatedChemoindicatedChemoindicatedChemoindicatedChemoindicatedPostmastectomyradiationtobedoneChemoindicatedPostmastectomyradiationtobedoneChemotherapyChemotherapyChemotherapyforRecurrentorMetastaticBreastCancerChemotherapyforRecurrentorMetastaticBreastCancerChemotherapyforRecurrentorMetastaticBreastCancer:HER2positiveChemotherapyforRecurrentorMetastaticBreastCancer:HER2positiveChemotherapyforrecurrent/metastaticdiseaseChemotherapyforrecurrent/metastaticdiseaseChemotherapy:Recurrent/MetastaticChemotherapy:Recurrent/MetastaticChemotherapy:Recurrent/MetastaticHER2+Chemotherapy:Recurrent/MetastaticHER2+Chemotherapy:Recurrent/MetastaticHER2+3.2014Chemotherapy:Recurrent/MetastaticHER2+3.2014Chemotherapy:Recurrent/Metastatic3.2014Chemotherapy:Recurrent/Metastatic3.2014ChestdiagnosticCTChestdiagnosticCTChestdiagnosticCTChestdiagnosticCTChestdiagnosticCTChestdiagnosticCTChest diagnosticCTChest diagnosticCTChest diagnosticCTChest diagnosticCTCisplatinCisplatinCLINICALPRESENTATIONCLINICALPRESENTATIONCLINICALPRESENTATIONCLINICALPRESENTATIONCLINICALPRESENTATIONCLINICALPRESENTATIONCLINICALPRESENTATIONCLINICALPRESENTATIONCLINICALPRESENTATIONCLINICALPRESENTATIONCLINICALPRESENTATIONCLINICALPRESENTATIONCLINICALPRESENTATIONCLINICALPRESENTATIONCLINICALPRESENTATIONCLINICALPRESENTATIONCLINICALPRESENTATIONCLINICALPRESENTATIONCLINICALPRESENTATIONCLINICALPRESENTATIONCLINICALPRESENTATIONCLINICALPRESENTATIONCLINICALPRESENTATIONCLINICALPRESENTATIONCLINICALPRESENTATIONCLINICALPRESENTATIONClinicalStageIIAT0N1M0T1N1M0T2N0M0ClinicalStageIIAT0N1M0T1N1M0T2N0M0ClinicalStageIIAT0N1M0T1N1M0T2N0M0ClinicalStageIIAT0N1M0T1N1M0T2N0M0ClinicalStageIIBT2N1M0T3N0M0ClinicalStageIIBT2N1M0T3N0M0ClinicalStageIIBT2N1M0T3N0M0ClinicalStageIIBT2N1M0T3N0M0ClinicalStageIIIAT3N1M0ClinicalStageIIIAT3N1M0ClinicalStageIIIAT3N1M0ClinicalStageIIIAT3N1M0ClinicalStageIT1N0M0ClinicalStageIT1N0M0ClinicalStageIT1N0M0ClinicalStageIT1N0M0ClinicallynegativeaxillaeUndergoingmastectomyRTisplannedClinicallynegativeaxillaeUndergoingmastectomyRTisplannedClinicallynegativeipsilateralaxillarylymphnode(s)Clinicallynegativeipsilateralaxillarylymphnode(s)Clinicallynegativeipsilateralaxillarylymphnodes(duringinitialworkup)andipsilaterialaxillarylymphnodeFNAorcorebiopsypositive(priortopreoperativesystemictherapy)Clinicallynegativeipsilateralaxillarylymphnodes(duringinitialworkup)andipsilaterialaxillarylymphnodeFNAorcorebiopsypositive(priortopreoperativesystemictherapy)Clinicallynegativeipsilateralaxillarylymphnodes(duringinitialworkup)andipsilaterialaxillarylymphnodeFNAorcorebiopsypositive (priortopreoperativesystemictherapy)Clinicallynegativeipsilateralaxillarylymphnodes(duringinitialworkup)andipsilaterialaxillarylymphnodeFNAorcorebiopsypositive (priortopreoperativesystemictherapy)ClinicallynodenegativeattimeofdiagnosisClinicallynodenegativeattimeofdiagnosisClinicallynodepositiveattimeofdiagnosisClinicallynodepositiveattimeofdiagnosisClinicallypositiveipsilateralaxillarylymphnode(s)Clinicallypositiveipsilateralaxillarylymphnode(s)Clinicallypositiveipsilateralaxillarylymphnodes(duringinitialworkup)andipsilaterialaxillarylymphnodeFNAorcorebiopsypositive (priortopreoperativesystemictherapy)Clinicallypositiveipsilateralaxillarylymphnodes(duringinitialworkup)andipsilaterialaxillarylymphnodeFNAorcorebiopsypositive (priortopreoperativesystemictherapy)Clinicallypositiveipsilateralaxillarylymphnodes(duringinitialworkup)andipsilaterialaxillarylymphnodeFNAorcorebiopsypositive (priortopreoperativesystemictherapy)Clinicallypositiveipsilateralaxillarylymphnodes(duringinitialworkup)andipsilaterialaxillarylymphnodeFNAorcorebiopsypositive (priortopreoperativesystemictherapy)CMF(cyclophosphamide/methotrexate/fluorouracil)CMF(cyclophosphamide/methotrexate/fluorouracil)CMF(cyclophosphamide/methotrexate/fluorouracil)CMF(cyclophosphamide/methotrexate/fluorouracil)CMF(cyclophosphamide/methotrexate/fluorouracil)CMF(cyclophosphamide/methotrexate/fluorouracil)CompleteresponseCompleteresponseCompleteuptooneyearoftrastuzumabcontainingchemotherapyCompleteuptooneyearoftrastuzumabcontainingchemotherapyConfirmedprogressivediseaseatanytimeConfirmedprogressivediseaseatanytimeContinueendocrinetherapyuntildevelopmentofunacceptabletoxicityContinueendocrinetherapyuntildevelopmentofunacceptabletoxicityContinueendocrinetherapyuntildiseaseprogressionorunacceptabletoxicityContinueendocrinetherapyuntildiseaseprogressionorunacceptabletoxicityContinueendocrinetherapyuntilprogressionContinueendocrinetherapyuntilprogressionContinueHER2targetedtherapyContinueHER2targetedtherapyContraindicationtoaromataseinhibitorsContraindicationtoaromataseinhibitorsCorebiopsyofbreastwithimagedetectablemarker(s)Corebiopsyofbreastwithimagedetectablemarker(s)CorebiopsyoflymphnodenegativeCorebiopsyoflymphnodenegativeCorebiopsyoflymphnodepositiveCorebiopsyoflymphnodepositiveCorebiopsyoflymphnodepositiveCorebiopsyoflymphnodepositiveCorebiospypositiveCorebiospypositiveCorebiospy negativeCorebiospy negativeCounselingforfertilityconcernsCounselingforfertilityconcernsCyclophosphamideCyclophosphamideDenovostageIVDenovostageIVDecline aromataseinhibitorsDecline aromataseinhibitorsDenosumabDenosumabDeterminationofER/PRstatusDeterminationofER/PRstatusDeterminationofER/PRstatusDeterminationofER/PRstatusDeterminationofER/PRstatusonmetastaticsiteDeterminationofER/PRstatusonmetastaticsiteDeterminationofHER2statusDeterminationofHER2statusDeterminationofHER2statusDeterminationofHER2statusDeterminationofHER2statusonmetastaticsiteDeterminationofHER2statusonmetastaticsiteDeterminationofHER2 statusDeterminationofHER2 statusDeterminationoftumorestrogen/progesteronereceptor(ER/PR)statusDeterminationoftumorestrogen/progesteronereceptor(ER/PR)statusDiagnosticbilateralmammogramDiagnosticbilateralmammogramDiagnosticbilateralmammogramDiagnosticbilateralmammogramDiagnosticbilateralmammogramDiagnosticbilateralmammogramDiagnosticCTforsystemicstagingDiagnosticCTforsystemicstagingDiagnosticCTforsystemicstagingDiagnosticCTforsystemicstagingDocetaxelDocetaxelDocetaxel+cyclophosphamide+trastuzumabDocetaxel+cyclophosphamide+trastuzumabDocetaxel+cyclophosphamide+trastuzumabDocetaxel+cyclophosphamide+trastuzumabDocetaxel/capecitabineDocetaxel/capecitabineDoesNOTmeetallofthefollowing:T1orT2tumor1or2positivesentinellymphnodesBreastconservingtherapyWholebreastRTplannedNopreoperativechemotherapyDoesNOTmeetallofthefollowing:T1orT2tumor1or2positivesentinellymphnodesBreastconservingtherapyWholebreastRTplannedNopreoperativechemotherapyDosedenseAC(doxorubicin/cyclophosphamide)DosedenseAC(doxorubicin/cyclophosphamide)DosedenseAC(doxorubicin/cyclophosphamide)DosedenseAC(doxorubicin/cyclophosphamide)DosedenseAC(doxorubicin/cyclophosphamide)followedby paclitaxelevery2weeksDosedenseAC(doxorubicin/cyclophosphamide)followedby paclitaxelevery2weeksDosedenseAC(doxorubicin/cyclophosphamide)followedby paclitaxelevery2weeksDosedenseAC(doxorubicin/cyclophosphamide)followedby paclitaxelevery2weeksDosedenseAC(doxorubicin/cyclophosphamide)followedby weeklypaclitaxelDosedenseAC(doxorubicin/cyclophosphamide)followedby weeklypaclitaxelDosedenseAC(doxorubicin/cyclophosphamide)followedby weeklypaclitaxelDosedenseAC(doxorubicin/cyclophosphamide)followedby weeklypaclitaxelDoxorubicinDoxorubicinDuctalDuctalDuctalDuctalDuctalDuctalDuctalDuctalDuctalDuctalEC(epirubicin/cyclophosphamide)EC(epirubicin/cyclophosphamide)EC(epirubicin/cyclophosphamide)EC(epirubicin/cyclophosphamide)EC(epirubicin/cyclophosphamide)EC(epirubicin/cyclophosphamide)ECOGperformancestatus≥3ECOGperformancestatus≥3EducatemonitorandreferforlymphedemamanagementEducatemonitorandreferforlymphedemamanagementEducationandcounselingregardinganactivelifestylehealthydietlimitedalcoholintakeandachievingandmaintinganidealbodyweight(2025BMI)Educationandcounselingregardinganactivelifestylehealthydietlimitedalcoholintakeandachievingandmaintinganidealbodyweight(2025BMI)ElevatedalkalinephosphataseElevatedalkalinephosphataseElevatedalkalinephosphataseElevatedalkalinephosphataseEndocrinetherapyEndocrinetherapyEndocrinetherapyaloneEndocrinetherapyaloneEndocrinetherapyaloneEndocrinetherapyaloneEndocrinetherapyaloneEndocrinetherapyaloneEndocrinetherapyaloneEndocrinetherapyaloneEndocrinetherapyasforpostmenopausalEndocrinetherapyasforpostmenopausalEndocrinetherapyasforpostmenopausalEndocrinetherapyasforpostmenopausalEndocrinetreatmentEndocrinetreatmentEpirubicinEpirubicinEquivocalresultEquivocalresultEquivocalresultEquivocalresultEquivocalresultEquivocalresultERnegativePRnegativeERnegativePRnegativeERpositiveERpositiveERnegativePRnegativeERnegativePRnegativeERnegativePRnegativeERnegativePRnegativeERpositiveERpositiveERpositiveERpositiveEribulinEribulinFACfollowedbyT (fluorouracil/doxorubicin/cyclophosphamidefollowedbyweeklypaclitaxel)FACfollowedbyT (fluorouracil/doxorubicin/cyclophosphamidefollowedbyweeklypaclitaxel)FACfollowedbyT (fluorouracil/doxorubicin/cyclophosphamidefollowedbyweeklypaclitaxel)FACfollowedbyT (fluorouracil/doxorubicin/cyclophosphamidefollowedbyweeklypaclitaxel)FDGPET/CTFDGPET/CTFDGPET/CTFDGPET/CTFDGPET/CTFDGPET/CTFDGPET/CTFDGPET/CTFDGPET/CTFDGPET/CTFDGPET/CTFDGPET/CTFEC(fluorouracil/epirubicin/cyclophosphamide)FEC(fluorouracil/epirubicin/cyclophosphamide)FECfollowedbydocetaxel+trastuzumab+pertuzumabFECfollowedbydocetaxel+trastuzumab+pertuzumabFECfollowedbydocetaxel+trastuzumab+pertuzumabFECfollowedbydocetaxel+trastuzumab+pertuzumabFECfollowedbypaclitaxel+trastuzumab+pertuzumabFECfollowedbypaclitaxel+trastuzumab+pertuzumabFECfollowedbypaclitaxel+trastuzumab+pertuzumabFECfollowedbypaclitaxel+trastuzumab+pertuzumabFEC/CEFfollowedbyT(fluorouracil/epirubicin/cyclophosphamidefollowedbydocetaxel)FEC/CEFfollowedbyT(fluorouracil/epirubicin/cyclophosphamidefollowedbydocetaxel)FEC/CEFfollowedbyT(fluorouracil/epirubicin/cyclophosphamidefollowedbydocetaxel)FEC/CEFfollowedbyT(fluorouracil/epirubicin/cyclophosphamidefollowedbydocetaxel)FEC/CEFfollowedbyT(fluorouracil/epirubicin/cyclophosphamidefollowedbyweeklypaclitaxel)FEC/CEFfollowedbyT(fluorouracil/epirubicin/cyclophosphamidefollowedbyweeklypaclitaxel)FEC/CEFfollowedbyT(fluorouracil/epirubicin/cyclophosphamidefollowedbyweeklypaclitaxel)FEC/CEFfollowedbyT(fluorouracil/epirubicin/cyclophosphamidefollowedbyweeklypaclitaxel)FertilitycounselingFertilitycounselingFertilitycounselingFertilitycounselingFINDINGSFINDINGSFINDINGSFINDINGSFinishFinishFinishFinishFinishFinishFinishFinishFinishFinishFinishFinishFinishFinishFinishFinishFinishFinishFinishFinishFinishFinishFinishFinishFinishFinishFinishFinishFinishFinishFinishFinishFinishFinishFinishFinishFinishFinishFinishFinishFinishFinishFirst5yearsaftertreatmentFirst5yearsaftertreatmentFNAnegativeFNAnegativeFNApositiveFNApositiveFulfillscriteriaforbreastconservingsurgeryexceptfortumorsizeFulfillscriteriaforbreastconservingsurgeryexceptfortumorsizeGemcitabineGemcitabineGemcitabine/carboplatinGemcitabine/carboplatinGeneticcounselingGeneticcounselingGeneticcounselingGeneticcounselingGeneticcounselingGeneticcounselingGeneticcounselingGeneticcounselingGT(gemcitabine/paclitaxel)GT(gemcitabine/paclitaxel)H&PH&PH&PH&PH&PH&PH&P14timesperyearasclinicallyappropriateH&P14timesperyearasclinicallyappropriateH&P annuallyH&P annuallyHER2negativeHER2negativeHER2negativeadjuvant chemotherapyHER2negativeadjuvant chemotherapyHER2negativeadjuvant chemotherapyHER2negativeadjuvant chemotherapyHER2negativepreoperativechemotherapyHER2negativepreoperativechemotherapyHER2negativepreoperativechemotherapyHER2negativepreoperativechemotherapyHER2negativepreoperativechemotherapyHER2negativepreoperativechemotherapyHER2negativepreoperativechemotherapyHER2negativepreoperativechemotherapyHER2negativepreoperativechemotherapyHER2negativepreoperativechemotherapyHER2negativepreoperativechemotherapyHER2negativepreoperativechemotherapyHER2negativepreoperativechemotherapyHER2negativepreoperativechemotherapyHER2negativepreoperativechemotherapyHER2negativepreoperativechemotherapyHER2negativepreoperativechemotherapyHER2negativepreoperativechemotherapyHER2negativepreoperativechemotherapyHER2negativepreoperativechemotherapyHER2positiveHER2positiveHER2positiveadjuvant chemotherapyHER2positiveadjuvant chemotherapyHER2positivepreoperativechemowithtrastuzumabHER2positivepreoperativechemowithtrastuzumabHER2positivepreoperativechemotherapyHER2positivepreoperativechemotherapyHER2positivepreoperativechemotherapyHER2positivepreoperativechemotherapyHER2positivepreoperativechemotherapyHER2positivepreoperativechemotherapyHER2positivepreoperativechemotherapyHER2positivepreoperativechemotherapyHER2positivepreoperativechemotherapyHER2positivepreoperativechemotherapyHER2positivepreoperativechemotherapyHER2positivepreoperativechemotherapyHER2positivepreoperativechemotherapyHER2positivepreoperativechemotherapyHER2positivepreoperativechemotherapyHER2positivepreoperativechemotherapyHER2positivepreoperativechemotherapywithtrastuzumabHER2positivepreoperativechemotherapywithtrastuzumabHER2testingHER2testingHER2testing3.2014HER2testing3.2014HER2+HER2+HER2+HER2+HER2HER2HER2negativeHER2negativeHER2negativeHER2negativeHER2negativediseaseHER2negativediseaseHER2positiveHER2positiveHER2positiveHER2positiveHER2positiveHER2positiveHER2positivediseaseHER2positivediseaseHER2targetedchemotherapyHER2targetedchemotherapyHER2/CEP17ratio<2.0HER2/CEP17ratio<2.0HER2/CEP17ratio≥2.0HER2/CEP17ratio≥2.0Highrecurrencescore(≥31)Highrecurrencescore(≥31)HISTOLOGYHISTOLOGYHISTOLOGYHISTOLOGYHISTOLOGYHISTOLOGYHISTOLOGYHISTOLOGYHISTOLOGYHISTOLOGYHistory&physicalHistory&physicalHRnegativeHER2negativeHRnegativeHER2negativeHRnegativeHER2negativeHRnegativeHER2negativeHRnegativeHER2positiveHRnegativeHER2positiveHRpositiveHRpositiveHRpositiveendocrinerefractoryHER2negativeHRpositiveendocrinerefractoryHER2negativeHRpositiveendocrinerefractoryHER2negativeHRpositiveendocrinerefractoryHER2negativeHRpositiveendocrinerefractoryHER2positiveHRpositiveendocrinerefractoryHER2positiveHRpositiveendocrinerefractoryHER2positiveHRpositiveendocrinerefractoryHER2positiveHRpositiveHER2negativeHRpositiveHER2negativeHRpositiveHER2+HRpositiveHER2+HRpositiveHER2negativeHRpositiveHER2negativeHRpositiveHER2positiveHRpositiveHER2positiveIHC01+IHC01+IHC2+IHC2+IHC3+IHC3+ImagingstudiesformetastasesscreeningImagingstudiesformetastasesscreeningIndicationsforradiationtherapyIndicationsforradiationtherapyIndicationsforradiationtherapyIndicationsforradiationtherapyIndividualizedtreatmentIndividualizedtreatmentInitialtreatmentwithlumpectomyRadiationtherapyInitialtreatmentwithlumpectomyRadiationtherapyInitialtreatmentwithmastectomyLevelI/IIaxillarydissectionPriorradiationtherapyInitialtreatmentwithmastectomyLevelI/IIaxillarydissectionPriorradiationtherapyInitialtreatmentwith mastectomyNopriorradiationtherapyInitialtreatmentwith mastectomyNopriorradiationtherapyInoperable/LocallyAdvanced(StageIII)Inoperable/LocallyAdvanced(StageIII)Inoperable/LocallyAdvanced(StageIII)3.2014Inoperable/LocallyAdvanced(StageIII)3.2014Intermediaterecurrencescore(1830)Intermediaterecurrencescore(1830)InternalmammarynoderecurrenceInternalmammarynoderecurrenceIntolerantofaromataseinhibitorsIntolerantofaromataseinhibitorsInvasiveBreastCancerInvasiveBreastCancerInvasiveBreastCancer2.2016InvasiveBreastCancer2.2016IpsilateralaxillarylymphnodeFNAnegativeIpsilateralaxillarylymphnodeFNAnegativeIpsilateralaxillarylymphnodeFNApositiveIpsilateralaxillarylymphnodeFNApositiveIpsilateralaxillarylymphnodeFNApositiveIpsilateralaxillarylymphnodeFNApositiveISHnegativeISHnegativeISHnegativeISHnegativeISHpositiveISHpositiveISHpositiveISHpositiveISHpositiveISHpositiveISHpositiveISHpositiveIxabepiloneIxabepiloneLaboratorystudiesformetastasesscreeningLaboratorystudiesformetastasesscreeningLapatinib+capecitabineLapatinib+capecitabineLevelI/IIaxillarydissectionLevelI/IIaxillarydissectionLevelI/IIaxillarydissectionLevelI/IIaxillarydissectionLevelI/IIaxillarydissectionLevelI/IIaxillarydissectionLevelI/IIaxillarydissectionnotpreviouslydoneLevelI/IIaxillarydissectionnotpreviouslydoneLiverfunctiontestsalkalinephosphataseLiverfunctiontestsalkalinephosphataseLiverfunctiontestsalkalinephosphataseLiverfunctiontestsalkalinephosphataseLiverfunctiontestsalkalinephosphataseLiverfunctiontestsalkalinephosphataseLiverfunctiontestsalkalinephosphataseLiverfunctiontestsalkalinephosphataseLiverfunctiontestsalkalinephosphataseLiverfunctiontestsalkalinephosphataseLobularLobularLobularLobularLobularLobularLobularLobularLobularLobularLocalandregionalrecurrenceLocalandregionalrecurrenceLocalonlyrecurrenceLocalonlyrecurrenceLocalizedbonepainLocalizedbonepainLOCOREGIONALTREATMENTLOCOREGIONALTREATMENTLocoregionalTreatment:IIIAIIBIIIA(T3N1M0only)LocoregionalTreatment:IIIAIIBIIIA(T3N1M0only)LocoregionalTreatment:IIIAIIBIIIA(T3N1M0only)3.2014LocoregionalTreatment:IIIAIIBIIIA(T3N1M0only)3.2014Lowrecurrencescore(<18)Lowrecurrencescore(<18)LowriskstageILowriskstageILowriskstageILowriskstageILumpectomyLumpectomyLumpectomyLumpectomyLumpectomyLumpectomyLumpectomy(omitaxillarystaging)Lumpectomy(omitaxillarystaging)LumpectomywithsurgicalaxillarystagingLumpectomywithsurgicalaxillarystagingLymphnodestatusattimeofdiagnosisLymphnodestatusattimeofdiagnosisMammographyevery12monthsMammographyevery12monthsMarginspositiveMarginspositiveMastectomy(omitaxillarystaging)+/reconstructionMastectomy(omitaxillarystaging)+/reconstructionMastectomy+/reconstructionMastectomy+/reconstructionMastectomy+/reconstructionMastectomy+/reconstructionMetaplasticMetaplasticMetaplasticMetaplasticMetaplasticMetaplasticMetaplasticMetaplasticMetaplasticMetaplasticMetastaticbreastcancerMetastaticbreastcancerMetastatic HER2positivediseaseMetastatic HER2positivediseaseMicroinvasiveMicroinvasiveMicroinvasiveMicroinvasiveMicroinvasiveMicroinvasiveMicroinvasiveMicroinvasiveMixedMixedMixedMixedMixedMixedMixedMixedMixedMixedMonitoringofbonehealthwithabonemineraldensitydeterminationatbaselineandperiodicallythereafterMonitoringofbonehealthwithabonemineraldensitydeterminationatbaselineandperiodicallythereafterMucinousMucinousMucinousMucinousNegative axillarynodesNegative axillarynodesNegative axillarynodesTumor>5cmNegative axillarynodesTumor>5cmNegative axillarynodesTumor≤5cmMargins≥1mmNegative axillarynodesTumor≤5cmMargins≥1mmNegative axillarynodesTumor≤5cmNegativemarginsbut<1mmNegative axillarynodesTumor≤5cmNegativemarginsbut<1mmNewspecimenavailableNewspecimenavailableNewspecimenavailableNewspecimenavailableNewspecimenavailableNewspecimenavailableNoadjuvanttherapyNoadjuvanttherapyNobenefitafter3sequentiallinesofchemotherapyNobenefitafter3sequentiallinesofchemotherapyNoclinicalbenefitafter3sequentialendocrinetherapiesNoclinicalbenefitafter3sequentialendocrinetherapiesNoclinicalsignsorsymptomssuggestiveofrecurrentdiseaseNoclinicalsignsorsymptomssuggestiveofrecurrentdiseaseNofurtheraxillarysurgeryNofurtheraxillarysurgeryNofurtheraxillarysurgeryNofurtheraxillarysurgeryNofurthercytotoxictherapyNofurthercytotoxictherapyNofurtherendocrinetherapyNofurtherendocrinetherapyNopriorendocrinetherapywithin1yearNopriorendocrinetherapywithin1yearNoradiationtherapyNoradiationtherapyNoresponseNoresponseNoresponseNoresponseNosymptomaticvisceraldiseaseNosymptomaticvisceraldiseaseNosymptomaticvisceraldiseaseNosymptomaticvisceraldiseaseNodepositive(oneormoremetastases>2mmtooneormoreipsilateralaxillarylymphnodes)Nodepositive(oneormoremetastases>2mmtooneormoreipsilateralaxillarylymphnodes)Nodepositive(oneormoremetastases>2mmtooneormoreipsilateralaxillarylymphnodes)Nodepositive(oneormoremetastases>2mmtooneormoreipsilateralaxillarylymphnodes)Nodepositive(oneormoremetastases>2mmtooneormoreipsilateralaxillarylymphnodes)Nodepositive(oneormoremetastases>2mmtooneormoreipsilateralaxillarylymphnodes)Nodepositive(oneormoremetastases>2mmtooneormoreipsilateralaxillarylymphnodes)Nodepositive(oneormoremetastases>2mmtooneormoreipsilateralaxillarylymphnodes)Nodepositive(oneormoremetastases>2mmtooneormoreipsilateralaxillarylymphnodes)Nodepositive(oneormoremetastases>2mmtooneormoreipsilateralaxillarylymphnodes)NotcompletedpreoperativelyNotcompletedpreoperativelyNoteligibleforotherstandardadjuvantregimensduetocomorbiditiesNoteligibleforotherstandardadjuvantregimensduetocomorbiditiesNoteligibleforotherstandardadjuvantregimensduetocomorbiditiesNoteligibleforotherstandardadjuvantregimensduetocomorbiditiesNotendocrinerefractoryNotendocrinerefractoryNotendocrinerefractoryNotendocrinerefractoryOrdernewtestwithIHCOrdernewtestwithIHCOrdernewtestwithIHCOrdernewtestwithIHCOrdernewtestwithIHCOrdernewtestwithIHCOrdernewtestwithISHOrdernewtestwithISHOrdernewtestwithISHOrdernewtestwithISHOrdernewtestwithISHOrdernewtestwithISHOvarianablationOvarianablationOvarianablationOvarianablationOvarianfailuresecondarytotreatmentOvarianfailuresecondarytotreatmentOvariansuppressionorablationOvariansuppressionorablationOvariansuppressionorablationOvariansuppressionorablationOvarian suppressionOvarian suppressionOvarian suppressionOvarian suppressionPaclitaxelPaclitaxelPaclitaxel+trastuzumabPaclitaxel+trastuzumabPaclitaxel+trastuzumabPaclitaxel+trastuzumabPaclitaxel/bevacizumabPaclitaxel/bevacizumabPamidronatePamidronatePartialbreastirradiationinselectedpatientsPartialbreastirradiationinselectedpatientsPartialresponseLumpectomynotpossiblePartialresponseLumpectomynotpossiblePartialresponseLumpectomypossiblePartialresponseLumpectomypossiblePathologyreviewPathologyreviewPathologyreviewPathologyreviewPathologyreviewPathologyreviewPatientdoesnothavemultiplehighriskrecurrencefactorsPatientdoesnothavemultiplehighriskrecurrencefactorsPatienthasmultiplehighriskrecurrencefactorsPatienthasmultiplehighriskrecurrencefactorsPatientishighriskforhereditarybreastcancerPatientishighriskforhereditarybreastcancerPatientishighriskforhereditarybreastcancerPatientishighriskforhereditarybreastcancerPatientishighriskforhereditarybreastcancerPatientishighriskforhereditarybreastcancerPatientishighriskforhereditarybreastcancerPatientishighriskforhereditarybreastcancerPatientisontamoxifenUterusispresentPatientisontamoxifenUterusispresentPatienttakingaromataseinhibitorPatienttakingaromataseinhibitorPegylatedliposomaldoxorubicinPegylatedliposomaldoxorubicinPeriodicscreeningforchangesinfamilyhistoryPeriodicscreeningforchangesinfamilyhistoryPertuzumab+trastuzumab+docetaxelPertuzumab+trastuzumab+docetaxelPertuzumab+trastuzumab+docetaxelfollowedbyFECPertuzumab+trastuzumab+docetaxelfollowedbyFECPertuzumab+trastuzumab+docetaxelfollowedbyFECPertuzumab+trastuzumab+docetaxelfollowedbyFECPertuzumab+trastuzumab+paclitaxelPertuzumab+trastuzumab+paclitaxelPertuzumab+trastuzumab+paclitaxelfollowedbyFECPertuzumab+trastuzumab+paclitaxelfollowedbyFECPertuzumab+trastuzumab+paclitaxelfollowedbyFECPertuzumab+trastuzumab+paclitaxelfollowedbyFECPertuzumab/trastuzumab/taxanePertuzumab/trastuzumab/taxanePlannedadjuvantsystemictherapy basedonhormoneandHER2receptorstatusPlannedadjuvantsystemictherapy basedonhormoneandHER2receptorstatusPlannedadjuvantsystemictherapy basedonhormoneandHER2receptorstatusPlannedadjuvantsystemictherapy basedonhormoneandHER2receptorstatuspN0pN0pN0pN0pN0pN0pN0pN0pN1mipN1mipN1mipN1mipN1mipN1mipN1mipN1miPostmastectomyradiationtherapyPostmastectomyradiationtherapyPostmenopausalPostmenopausalPostmenopausalPostmenopausalPostmenopausalPostmenopausalPostmenopausalatdiagnosisPostmenopausalatdiagnosisPRpositivePRpositivePRpositivePRpositivePRpositivePRpositivePremenopausalPremenopausalPremenopausalPremenopausalPremenopausalPremenopausalPremenopausalPremenopausalPremenopausalPremenopausalPremenopausalPremenopausalPremenopausalatdiagnosisPremenopausalatdiagnosisPreoperativeAxillaryEvaluation/SystemicTherapyPreoperativeAxillaryEvaluation/SystemicTherapyPreoperativeAxillaryEvaluation/SystemicTherapy3.2014PreoperativeAxillaryEvaluation/SystemicTherapy3.2014PreoperativeradiationPreoperativeradiationPreoperativesettingPreoperativesettingPreoperativeSystemicTherapyPREOPERATIVESYSTEMICTHERAPYPreoperativeSystemicTherapyPREOPERATIVESYSTEMICTHERAPYPreoperativesystemictherapybasedonhormoneandHER2receptorstatusPreoperativesystemictherapybasedonhormoneandHER2receptorstatusPreoperativesystemictherapybasedonhormoneandHER2receptorstatusPreoperativesystemictherapybasedonhormoneandHER2receptorstatusPreoperativesystemictherapynotcompletedpreoperativelyPreoperativesystemictherapynotcompletedpreoperativelyPreoperativeWorkupPreoperativeWorkupPreoperativeWorkup3.2014PreoperativeWorkup3.2014Preoperative/AdjuvantChemotherapy:HER2negativePreoperative/AdjuvantChemotherapy:HER2negativePreoperative/AdjuvantChemotherapy:HER2positivePreoperative/AdjuvantChemotherapy:HER2positivePreoperative/AdjuvantChemotherapy:HER2positivePreoperative/AdjuvantChemotherapy:HER2positivePreoperative/AdjuvantChemotherapy:HER2positive3.2014Preoperative/AdjuvantChemotherapy:HER2positive3.2014Preoperative/AdjuvantChemotherapy:HER2negativePreoperative/AdjuvantChemotherapy:HER2negativePreoperative/AdjuvantChemotherapy:HER2negative3.2014Preoperative/AdjuvantChemotherapy:HER2negative3.2014PRIMARYTREATMENTPRIMARYTREATMENTPRIMARYTREATMENTPRIMARYTREATMENTPRIMARYTREATMENTPRIMARYTREATMENTPRIMARYTREATMENTPRIMARYTREATMENTPRIMARYTREATMENTPRIMARYTREATMENTPRIMARYTREATMENTPRIMARYTREATMENTPRIMARYTREATMENTPRIMARYTREATMENTPriorendocrinetherapywithin1yearPriorendocrinetherapywithin1yearpT1pT2orpT3andpN0orpN1mi(≤2mmaxillarynodemetastasis)pT1pT2orpT3andpN0orpN1mi(≤2mmaxillarynodemetastasis)pT1pT2orpT3andpN0orpN1mi(≤2mmaxillarynodemetastasis)pT1pT2orpT3andpN0orpN1mi(≤2mmaxillarynodemetastasis)pT1pT2orpT3andpN0orpN1mi(≤2mmaxillarynodemetastasis)pT1pT2orpT3andpN0orpN1mi(≤2mmaxillarynodemetastasis)pT1pT2orpT3andpN0orpN1mi(≤2mmaxillarynodemetastasis)pT1pT2orpT3andpN0orpN1mi(≤2mmaxillarynodemetastasis)pT1pT2orpT3andpN0orpN1mi(≤2mmaxillarynodemetastasis)pT1pT2orpT3andpN0orpN1mi(≤2mmaxillarynodemetastasis)Pulmonary symptomspresentPulmonary symptomspresentRadiationRadiationRadiationRadiationRadiationRadiationRadiationRadiationRadiationRadiationRadiationRadiationRadiationindicatedandnotpreviouslyadministeredRadiationindicatedandnotpreviouslyadministeredRadiationindicatedandnotpreviouslyadministeredRadiationindicatedandnotpreviouslyadministeredRadiationindicatedandnotpreviouslyadministeredRadiationindicatedandnotpreviouslyadministeredRadiationindicatedandnotpreviouslyadministeredRadiationindicatedandnotpreviouslyadministeredRadiationindicatedandnotpreviouslyadministeredRadiationindicatedandnotpreviouslyadministeredRadiationpreviouslydoneornotindicatedRadiationpreviouslydoneornotindicatedRadiationpreviouslydoneornotindicatedRadiationpreviouslydoneornotindicatedRadiationpreviouslydoneornotindicatedRadiationpreviouslydoneornotindicatedRadiationpreviouslydoneornotindicatedRadiationpreviouslydoneornotindicatedRadiationpreviouslydoneornotindicatedRadiationpreviouslydoneornotindicatedRadiationtherapyRadiationtherapyRadiationtherapyRadiationtherapyRadiationtherapyRadiationtherapyRadiationtherapybasedontumorsizeandaxillarylymphnodestatusatdiagnosisRadiationtherapybasedontumorsizeandaxillarylymphnodestatusatdiagnosisRadiationtherapytochestwallRadiationtherapytochestwallRadiationtherapytochestwall±infraclavicularregion±supraclaviculararea±internalmammarynodesandanypartoftheaxillarybedatriskRadiationtherapytochestwall±infraclavicularregion±supraclaviculararea±internalmammarynodesandanypartoftheaxillarybedatriskRadiationtherapytochestwallinfraclavicularregionsupraclavicularareainternalmammarynodesandanypartoftheaxillarybedatriskRadiationtherapytochestwallinfraclavicularregionsupraclavicularareainternalmammarynodesandanypartoftheaxillarybedatriskRadiationtherapytochestwallinfraclavicularregionsupraclavicularareainternalmammarynodesandanypartoftheaxillarybedatriskRadiationtherapytochestwallinfraclavicularregionsupraclavicularareainternalmammarynodesandanypartoftheaxillarybedatriskRadiationtherapytochestwallinfraclavicularregionsupraclavicularareainternalmammarynodesandanypartoftheaxillarybedatriskRadiationtherapytochestwallinfraclavicularregionsupraclavicularareainternalmammarynodesandanypartoftheaxillarybedatriskRadiationtherapytochestwallinfraclavicularregionsupraclavicularareainternalmammarynodesandanypartoftheaxillarybedatriskRadiationtherapytochestwallinfraclavicularregionsupraclavicularareainternalmammarynodesandanypartoftheaxillarybedatriskRadiationtherapytochestwallinfraclavicularregionsupraclavicularareainternalmammarynodesandanypartoftheaxillarybedatriskRadiationtherapytochestwallinfraclavicularregionsupraclavicularareainternalmammarynodesandanypartoftheaxillarybedatriskRadiationtherapytoinfraclavicularregionsupraclavicularareainternalmammarynodesandanypartoftheaxillarybedatriskRadiationtherapytoinfraclavicularregionsupraclavicularareainternalmammarynodesandanypartoftheaxillarybedatriskRadiationtherapytoinfraclavicularregionsupraclavicularareainternalmammarynodesandanypartoftheaxillarybedatriskRadiationtherapytoinfraclavicularregionsupraclavicularareainternalmammarynodesandanypartoftheaxillarybedatriskRadiationtherapytowholebreastwithboosttotumorbedRadiationtherapytowholebreastwithboosttotumorbedRadiationtherapytowholebreastwithboosttotumorbedRadiationtherapytowholebreastwithboosttotumorbedRadiationtherapytowholebreastwithboosttotumorbed+ infraclavicularregionsupraclavicularareainternalmammarynodesandanypartoftheaxillarybedatriskRadiationtherapytowholebreastwithboosttotumorbed+ infraclavicularregionsupraclavicularareainternalmammarynodesandanypartoftheaxillarybedatriskRadiationtherapytowholebreastwithoutboosttotumorbedRadiationtherapytowholebreastwithoutboosttotumorbedRadiationtherapytowholebreastwithoutboosttotumorbedRadiationtherapytowholebreastwithoutboosttotumorbedRadiationtherapytowholebreastwithoutboosttotumorbed+ infraclavicularregionsupraclavicularareainternalmammarynodesandanypartoftheaxillarybedatriskRadiationtherapytowholebreastwithoutboosttotumorbed+ infraclavicularregionsupraclavicularareainternalmammarynodesandanypartoftheaxillarybedatriskReconstructionReconstructionRecurrence/StageIV:InitialTreatmentRecurrence/StageIV:InitialTreatmentRecurrence/StageIV:InitialTreatment3.2014Recurrence/StageIV:InitialTreatment3.2014Recurrence/StageIV:SystemicTreatmentRecurrence/StageIV:SystemicTreatmentRecurrence/StageIV:SystemicTreatment3.2014Recurrence/StageIV:SystemicTreatment3.2014RecurrentbreastcancerRecurrentbreastcancerRecurrentdiseaseRecurrentdiseaseRecurrentHER2positivediseaseRecurrentHER2positivediseaseReferraltogeneticcounselingReferraltogeneticcounselingReflextestwithdualprobeISHReflextestwithdualprobeISHReflextestwithIHCReflextestwithIHCReflextestwithIHCReflextestwithIHCReflextestwithISHReflextestwithISHRegionalonlyRegionalonlyRepeatdeterminationofER/PRstatusRepeatdeterminationofER/PRstatusResponseResponseResponseResponseReviewHRandHER2receptorstatusReviewHRandHER2receptorstatusRoutineimagingofreconstructedbreastRoutineimagingofreconstructedbreastSamespecimenSamespecimenSamespecimenSamespecimenSamespecimenSamespecimenSamplebycorebiopsyoflymphnodepriortopreoperativesystemictherapySamplebycorebiopsyoflymphnodepriortopreoperativesystemictherapySamplebycorebiopsyoflymphnodepriortopreoperativesystemictherapySamplebycorebiopsyoflymphnodepriortopreoperativesystemictherapySamplebyFNApriortopreoperativesystemictherapySamplebyFNApriortopreoperativesystemictherapySamplebyFNApriortopreoperativesystemictherapySamplebyFNApriortopreoperativesystemictherapySeeappropriatepathwaySeeappropriatepathwaySeeASCO/CAPHER2GuidelineDataSupplement2EformoreinformationontheserarescenariosSeeASCO/CAPHER2GuidelineDataSupplement2EformoreinformationontheserarescenariosSeeFollowupSeeFollowupSeeFollowupSeeFollowupSeeFollowupSeeFollowupSeeFollowupSeeFollowupSeeFollowupSeeFollowupSeeLocoregionalTreatmentSeeLocoregionalTreatmentSeeNCCNGuidelinesforDistressManagementSeeNCCNGuidelinesforDistressManagementSeeNCCNGuidelinesforGenetic/FamilialHighRiskAssessment:BreastandOvarianSeeNCCNGuidelinesforGenetic/FamilialHighRiskAssessment:BreastandOvarianSeeNCCNGuidelinesforGenetic/FamilialHighRiskAssessment:BreastandOvarianSeeNCCNGuidelinesforGenetic/FamilialHighRiskAssessment:BreastandOvarianSeeNCCNGuidelinesforGenetic/FamilialHighRiskAssessment:BreastandOvarianSeeNCCNGuidelinesforGenetic/FamilialHighRiskAssessment:BreastandOvarianSeeNCCNGuidelinesforGenetic/FamilialHighRiskAssessment:BreastandOvarianSeeNCCNGuidelinesforGenetic/FamilialHighRiskAssessment:BreastandOvarianSeeNCCNGuidelinesforPalliative CareSeeNCCNGuidelinesforPalliative CareSeeNCCNGuidelinesforSupportiveCareSeeNCCNGuidelinesforSupportiveCareSeeNCCNGuidelinesforSurvivorshipSeeNCCNGuidelinesforSurvivorshipSeeNCCNGuidelinesfor DistressManagementSeeNCCNGuidelinesfor DistressManagementSeeNCCNGuidelinesfor DistressManagementSeeNCCNGuidelinesfor DistressManagementSeePreoperativeSystemicTherapySeePreoperativeSystemicTherapySeeRecurrentDiseaseSeeRecurrentDiseaseSeeSurveillance/FollowupSeeSurveillance/FollowupSeeSystemicAdjuvantTreatment:HR+HER2+SeeSystemicAdjuvantTreatment:HR+HER2+SeeSystemicAdjuvantTreatment:HR+HER2SeeSystemicAdjuvantTreatment:HR+HER2SeeSystemicAdjuvantTreatment:HRHER2+SeeSystemicAdjuvantTreatment:HRHER2+SeeSystemicAdjuvantTreatment:HRHER2SeeSystemicAdjuvantTreatment:HRHER2SeeSystemicAdjuvantTreatment: FavorableHistologiesSeeSystemicAdjuvantTreatment: FavorableHistologiesSeesystemictreatmentfor recurrent/metastaticdiseaseSeesystemictreatmentfor recurrent/metastaticdiseaseSeesystemictreatmentfor recurrent/metastaticdiseaseHER2+Seesystemictreatmentfor recurrent/metastaticdiseaseHER2+SeeSystemictreatmentHRnegativeorHR+andendocrinerefractoryHER2negativeSeeSystemictreatmentHRnegativeorHR+andendocrinerefractoryHER2negativeSeeSystemictreatmentHRnegativeorHR+andendocrinerefractoryHER2+SeeSystemictreatmentHRnegativeorHR+andendocrinerefractoryHER2+SeeSystemictreatment HR+HER2negativeorpositiveSeeSystemictreatment HR+HER2negativeorpositiveSelectiveERmodulatorsSelectiveERmodulatorsSelectiveERmodulatorsSelectiveERmodulatorsSelectiveER downregulatorSelectiveER downregulatorSentinellymphnodebiopsySentinellymphnodebiopsySentinellymphnodebiopsySentinellymphnodebiopsySentinelnodemappingandexcisionSentinelnodemappingandexcisionSentinelnodenegativeSentinelnodenegativeSentinelnodenotidentifiedSentinelnodenotidentifiedSentinelnodepositiveSentinelnodepositiveSignsandsymptomspresentSignsandsymptomspresentSLNBperformedduringaxillaryevaluationandnegativefindingsSLNBperformedduringaxillaryevaluationandnegativefindingsSLNBperformedduringaxillaryevaluationandnegativefindingsSLNBperformedduringaxillaryevaluationandnegativefindingsSodiumFluoridePET/CTSodiumfluoridePET/CTSodiumfluoridePET/CTSodiumfluoridePET/CTSodiumFluoridePET/CTSodiumfluoridePET/CTSodiumfluoridePET/CTSodiumfluoridePET/CTSofttissueonlySofttissueonlySofttissueonlySofttissueonlySomeclinicalbenefitswithin3sequentialendocrinetherapiesSomeclinicalbenefitswithin3sequentialendocrinetherapiesStageIStageIStageIIAStageIIAStageIIA(T2N0M0)Fulfillscriteriaforbreastconservingsurgeryexceptfortumorsize)StageIIA(T2N0M0)Fulfillscriteriaforbreastconservingsurgeryexceptfortumorsize)StageIIAT2N0M0StageIIAT2N0M0StageIIBStageIIBStageIIB(T2N1M0)Fulfillscriteriaforbreastconservingsurgeryexceptfortumorsize)StageIIB(T2N1M0)Fulfillscriteriaforbreastconservingsurgeryexceptfortumorsize)StageIIB(T3N0M0)Fulfillscriteriaforbreastconservingsurgeryexceptfortumorsize)StageIIB(T3N0M0)Fulfillscriteriaforbreastconservingsurgeryexceptfortumorsize)StageIIBT2N1M0T3N0M0StageIIBT2N1M0T3N0M0StageIIIA(T3N1M0)StageIIIA(T3N1M0)StageIIIA(T3N1M0)StageIIIA(T3N1M0)StageIIIA(T3N1M0)Fulfillscriteriaforbreastconservingsurgeryexceptfortumorsize)StageIIIA(T3N1M0)Fulfillscriteriaforbreastconservingsurgeryexceptfortumorsize)StageIIIAT0N2M0T1N2M0T2N2M0T3N2M0StageIIIAT0N2M0T1N2M0T2N2M0T3N2M0StageIIIAT2N1M0StageIIIAT2N1M0StageIIIBT4N0M0T4N1M0T4N2M0StageIIIBT4N0M0T4N1M0T4N2M0StageIIICAnyTN3M0StageIIICAnyTN3M0StageIVdiseaseStageIVdiseaseSTAGINGSTAGINGStartStartStartStartStartStartStartStartStartStartStartStartStartStartStartStartStartStartStartStartStartStartStartStartStartStartStartStartStartStartStartStartStartStartStartStartStartStartStartStartStartStartStartStartStartfromRecurrence/StageIV:InitialTreatment3.2014StartfromRecurrence/StageIV:InitialTreatment3.2014StartfromRecurrence/StageIV:InitialTreatment3.2014(2)StartfromRecurrence/StageIV:InitialTreatment3.2014(2)StartfromRecurrence/StageIV:InitialTreatment3.2014(3)StartfromRecurrence/StageIV:InitialTreatment3.2014(3)StartfromSystemicAdjTherapy:FavorableHistologies3.2014StartfromSystemicAdjTherapy:FavorableHistologies3.2014StartfromSystemicAdjTherapy:HR+HER2+3.2014StartfromSystemicAdjTherapy:HR+HER2+3.2014StartfromSystemicAdjTherapy:HR+HER23.2014StartfromSystemicAdjTherapy:HR+HER23.2014StartfromSystemicAdjTherapy:HRHER2+3.2014StartfromSystemicAdjTherapy:HRHER2+3.2014StartfromSystemicAdjTherapy:HRHER23.2014StartfromSystemicAdjTherapy:HRHER23.2014SupraclavicularrecurrenceSupraclavicularrecurrenceSurgicalAxillaryStagingSurgicalAxillaryStagingSurgicalAxillaryStaging3.2014SurgicalAxillaryStaging3.2014SurgicalresectionSurgicalresectionSurgicalresectionSurgicalresectionSurgicalresectionSurgicalresectionSURGICALTREATMENTSURGICALTREATMENTSURGICALTREATMENTSURGICALTREATMENTSurgicaltreatment+/surgicalaxillarystaging+/reconstructionSurgicaltreatment+/surgicalaxillarystaging+/reconstructionSurgical/AdjuvantTreatmentSurgical/AdjuvantTreatmentSurgical/AdjuvantTreatment3.2014Surgical/AdjuvantTreatment3.2014SurveillanceSURVEILLANCESurveillanceSurveillanceSURVEILLANCESurveillanceSurveillance3.2014Surveillance3.2014Surveillance/FollowupSurveillance/FollowupSuspiciousCNSsymptomsSuspiciousCNSsymptomsSuspiciousnodesSuspiciousnodesSymptomaticvisceralSymptomaticvisceralSymptomaticvisceralSymptomaticvisceralSymptomaticvisceralSymptomaticvisceralSymptomaticvisceraldiseaseSymptomaticvisceraldiseaseSystemicAdjTherapy:FavorableHistologiesSystemicAdjTherapy:FavorableHistologiesSystemicAdjTherapy:FavorableHistologies3.2014SystemicAdjTherapy:FavorableHistologies3.2014SystemicAdjTherapy:HR+HER2+SystemicAdjTherapy:HR+HER2+SystemicAdjTherapy:HR+HER2+3.2014SystemicAdjTherapy:HR+HER2+3.2014SystemicAdjTherapy:HR+HER2SystemicAdjTherapy:HR+HER2SystemicAdjTherapy:HR+HER23.2014SystemicAdjTherapy:HR+HER23.2014SystemicAdjTherapy:HRHER2+SystemicAdjTherapy:HRHER2+SystemicAdjTherapy:HRHER2+3.2014SystemicAdjTherapy:HRHER2+3.2014SystemicAdjTherapy:HRHER2SystemicAdjTherapy:HRHER2SystemicAdjTherapy:HRHER23.2014SystemicAdjTherapy:HRHER23.2014SystemicdiseaseSystemicdiseaseSystemictherapySystemictherapySystemictherapytobestresponseHER2negativeSystemictherapytobestresponseHER2negativeSystemictherapytobestresponseHER2negativeSystemictherapytobestresponseHER2negativeSystemictherapytobestresponseHER2positiveSystemictherapytobestresponseHER2positiveSystemictherapytobestresponseHER2positiveSystemictherapytobestresponseHER2positiveSYSTEMICTREATMENTSYSTEMICTREATMENTT1orT2tumor1or2positivesentinellymphnodesBreastconservingtherapyWholebreastRTplannedNopreoperativechemotherapyT1orT2tumor1or2positivesentinellymphnodesBreastconservingtherapyWholebreastRTplannedNopreoperativechemotherapyT2FulfillscriteriaforbreastconservingtherapyexceptforsizeT2FulfillscriteriaforbreastconservingtherapyexceptforsizeT3FulfillscriteriaforbreastconservingtherapyexceptforsizeT3FulfillscriteriaforbreastconservingtherapyexceptforsizeTAC(docetaxel/doxorubicin/cyclophosphamide)TAC(docetaxel/doxorubicin/cyclophosphamide)TAC(docetaxel/doxorubicin/cyclophosphamide)TAC(docetaxel/doxorubicin/cyclophosphamide)Tamoxifenfor23yTamoxifenfor23yTamoxifenfor4.56yTamoxifenfor4.56yTamoxifenfor5yTamoxifenfor5yTamoxifenfor5yTamoxifenfor5yTamoxifenfor5yTamoxifenfor5yTamoxifenforanadditional5ytocomplete10yofendocrinetherapyTamoxifenforanadditional5ytocomplete10yofendocrinetherapyTamoxifenforanadditional5ytocomplete10yofendocrinetherapyTamoxifenforanadditional5ytocomplete10yofendocrinetherapyTamoxifenforanadditional5ytocomplete10yofendocrinetherapyTamoxifenforanadditional5ytocomplete10yofendocrinetherapyTamoxifenforupto10yTamoxifenforupto10yTamoxifentocomplete5yofendocrinetherapyTamoxifentocomplete5yofendocrinetherapyTC(docetaxelandcyclophosphamide)TC(docetaxelandcyclophosphamide)TC(docetaxelandcyclophosphamide)TC(docetaxelandcyclophosphamide)TCH(docetaxel/carboplatin/trastuzumab)±pertuzumabTCH(docetaxel/carboplatin/trastuzumab)±pertuzumabTCH(docetaxel/carboplatin/trastuzumab)±pertuzumabTCH(docetaxel/carboplatin/trastuzumab)±pertuzumabTestwithalternativeISHchromosome17probeTestwithalternativeISHchromosome17probeTotalmastectomyTotalmastectomyTotalmastectomyTotalmastectomyTotalmastectomyTotalmastectomyTotalmastectomywith surgicalaxillarystagingTotalmastectomywith surgicalaxillarystagingTotalmastectomywith surgicalaxillarystagingTotalmastectomywith surgicalaxillarystagingTransitiontopalliativecareTransitiontopalliativecareTrastuzumab+capecitabineTrastuzumab+capecitabineTrastuzumab+capecitabineTrastuzumab+capecitabineTrastuzumab+docetaxelTrastuzumab+docetaxelTrastuzumab+lapatinib(withoutcytotoxictherapy)Trastuzumab+lapatinib(withoutcytotoxictherapy)Trastuzumab+otheragentsTrastuzumab+otheragentsTrastuzumab+paclitaxelTrastuzumab+paclitaxelTrastuzumab+paclitaxel+carboplatinTrastuzumab+paclitaxel+carboplatinTrastuzumab+vinorelbineTrastuzumab+vinorelbineTrastuzumabfor1yearTrastuzumabfor1yearTrastuzumabcontainingchemoregimenTrastuzumabcontainingchemoregimenTrastuzumabcontainingchemoregimenTrastuzumabcontainingchemoregimenTrastuzumabcontainingchemoregimenTrastuzumabcontainingchemoregimenTrastuzumabcontainingchemoregimenTrastuzumabcontainingchemoregimenTrastuzumabcontainingchemoregimenTrastuzumabcontainingchemoregimenTrastuzumabcontainingchemoregimenTrastuzumabcontainingchemoregimenTrastuzumabexposeddiseaseTrastuzumabexposeddiseaseTrastuzumab/chemoTrastuzumab/chemoTreatasHRHER2TreatasHRHER2TREATMENTTREATMENTTREATMENTTREATMENTTREATMENTRESPONSETREATMENTRESPONSETreat asHRHER2+Treat asHRHER2+TubularTubularTubularTubularTumor0.61.0cmTumor0.61.0cmTumor0.61.0cmTumor0.61.0cmTumor0.61.0cmTumor0.61.0cmTumor>0.5cmTumor>0.5cmTumor>1cmTumor>1cmTumor>1cmTumor>1cmTumor>1cmTumor>1cmTumorisnottechnicallyresectableTumorisnottechnicallyresectableTumorisnottechnicallyresectableTumorisnottechnicallyresectableTumorisnottechnicallyresectableTumorisnottechnicallyresectableTumorisnottechnicallyresectableTumorisnottechnicallyresectableTumoristechnicallyresectableTumoristechnicallyresectableTumoristechnicallyresectableTumoristechnicallyresectableTumoristechnicallyresectableTumoristechnicallyresectableTumor≤0.5cmTumor≤0.5cmTumor≤0.5cmTumor≤0.5cmTumor≤0.5cmTumor≤0.5cmTumor≤0.5cmTumor≤0.5cmUltrasoundUltrasoundUltrasoundUltrasoundUltrasoundUltrasoundUpto5yofaromataseinhibitorUpto5yofaromataseinhibitorValidateddualprobeISHassayValidateddualprobeISHassayValidatedIHCassayValidatedIHCassayValidatedsingleprobeISHassayValidatedsingleprobeISHassayVinorelbineVinorelbineVisceralcrisisVisceralcrisisworkupWORKUPWORKUPWORKUPWORKUPWORKUPworkupWORKUPWORKUPWORKUPWORKUPWORKUPXraysofabnormalbonesXraysofabnormalbonesXraysofsymptomaticbonesXraysofsymptomaticbonesZoledronicacidZoledronicacid≥3cm≥3cm≥4positiveaxillarynodes≥4positiveaxillarynodes≥4positiveaxillarynodes≥4positiveaxillarynodes≥5yearsaftertreatment≥5yearsaftertreatment;12.9cm^^^12.9cm^^^13positiveaxillarynodes^^^13positiveaxillarynodes^^^13positiveaxillarynodes^^^13positiveaxillarynodes^^^21geneRTPCRassay^^^21geneRTPCRassay^^^<1cm^^^<1cm^^^AbdominalandpelvicdiagnosticCT^^^AbdominalandpelvicdiagnosticCT^^^AbdominalandpelvicdiagnosticCT^^^AbdominalandpelvicdiagnosticCT^^^AbdominalandpelvicdiagnosticCT^^^AbdominalandpelvicdiagnosticCT^^^AbdominalandpelvicdiagnosticCT^^^AbdominalandpelvicdiagnosticCT^^^AbdominalandpelvicdiagnosticMRI^^^AbdominalandpelvicdiagnosticMRI^^^AbdominalandpelvicdiagnosticMRI^^^AbdominalandpelvicdiagnosticMRI^^^AbdominalandpelvicdiagnosticMRI^^^AbdominalandpelvicdiagnosticMRI^^^AbdominalandpelvicdiagnosticMRI^^^AbdominalandpelvicdiagnosticMRI^^^AbdominalCT^^^AbdominalCT^^^AbdominalCT^^^AbdominalCT^^^AbdominalCT^^^AbdominalCT^^^AbdominalCT^^^AbdominalCT^^^AbdominalCT^^^AbdominalCT^^^AbdominalMRI^^^AbdominalMRI^^^AbdominalMRI^^^AbdominalMRI^^^AbdominalMRI^^^AbdominalMRI^^^AbdominalMRI^^^AbdominalMRI^^^AbdominalMRI^^^AbdominalMRI^^^AbdominalorpelvicdiagnosticCT^^^AbdominalorpelvicdiagnosticCT^^^AbdominalorpelvicdiagnosticMRI^^^AbdominalorpelvicdiagnosticMRI^^^Abdominalsymptoms^^^Abdominalsymptoms^^^Abnormalliverfunctiontests^^^Abnormalliverfunctiontests^^^Abnormallongandweightbearingbonesfound^^^Abnormallongandweightbearingbonesfound^^^Abnormalphysicalexaminationoftheabdomen^^^Abnormalphysicalexaminationoftheabdomen^^^Abnormalphysicalexaminationofthepelvis^^^Abnormalphysicalexaminationofthepelvis^^^AC(doxorubicin/cyclophosphamide)^^^AC(doxorubicin/cyclophosphamide)^^^AC(doxorubicin/cyclophosphamide)every3weeks^^^AC(doxorubicin/cyclophosphamide)every3weeks^^^AC(doxorubicin/cyclophosphamide)every3weeks^^^AC(doxorubicin/cyclophosphamide)every3weeks^^^ACfollowedbydocetaxel+trastuzumab±pertuzumab^^^ACfollowedbydocetaxel+trastuzumab±pertuzumab^^^ACfollowedbydocetaxel+trastuzumab±pertuzumab^^^ACfollowedbydocetaxel+trastuzumab±pertuzumab^^^ACfollowedbydocetaxelevery3weeks^^^ACfollowedbydocetaxelevery3weeks^^^ACfollowedbydocetaxelevery3weeks^^^ACfollowedbydocetaxelevery3weeks^^^ACfollowedbyT+trastuzumab±pertuzumab(doxorubicin/cyclophosphamidefollowedbypaclitaxelplustrastuzumab± pertuzumab,variousschedules)^^^ACfollowedbyT+trastuzumab±pertuzumab(doxorubicin/cyclophosphamidefollowedbypaclitaxelplustrastuzumab± pertuzumab,variousschedules)^^^ACfollowedbyT+trastuzumab±pertuzumab(doxorubicin/cyclophosphamidefollowedbypaclitaxelplustrastuzumab± pertuzumab,variousschedules)^^^ACfollowedbyT+trastuzumab±pertuzumab(doxorubicin/cyclophosphamidefollowedbypaclitaxelplustrastuzumab± pertuzumab,variousschedules)^^^ACfollowedbyweeklypaclitaxel^^^ACfollowedbyweeklypaclitaxel^^^ACfollowedbyweeklypaclitaxel^^^ACfollowedbyweeklypaclitaxel^^^AcuteLymphoblasticLeukemia^^^AcuteLymphoblasticLeukemia^^^AcuteLymphoblasticLeukemiatest^^^AcuteLymphoblasticLeukemiatest^^^Additionallineofendocrinetherapy^^^Additionallineofendocrinetherapy^^^Additionallineofendocrinetherapy^^^Additionallineofendocrinetherapy^^^Additionallineofendocrinetherapy^^^Additionallineofendocrinetherapy^^^Additionallineofendocrinetherapy^^^Additionallineofendocrinetherapy^^^AdditionalsystemicchemotherapyHER2+^^^AdditionalsystemicchemotherapyHER2+^^^AdditionalsystemicchemotherapyHER2negative^^^AdditionalsystemicchemotherapyHER2negative^^^ADDITIONALTESTING^^^ADDITIONALTESTING^^^adjuvantchemotherapy^^^Adjuvantchemotherapy^^^Adjuvantchemotherapy^^^Adjuvantchemotherapy^^^Adjuvantchemotherapy^^^Adjuvantchemotherapy^^^Adjuvantchemotherapy^^^adjuvantchemotherapy^^^Adjuvantchemotherapy^^^Adjuvantchemotherapy^^^Adjuvantchemotherapy^^^Adjuvantchemotherapy^^^Adjuvantchemotherapy^^^Adjuvantchemotherapy^^^AdjuvantEndocrineTherapy^^^Adjuvantendocrinetherapy^^^Adjuvantendocrinetherapy^^^Adjuvantendocrinetherapy^^^Adjuvantendocrinetherapy^^^Adjuvantendocrinetherapy^^^Adjuvantendocrinetherapy^^^Adjuvantendocrinetherapy^^^Adjuvantendocrinetherapy^^^Adjuvantendocrinetherapy^^^Adjuvantendocrinetherapy^^^Adjuvantendocrinetherapy^^^Adjuvantendocrinetherapy^^^Adjuvantendocrinetherapy^^^Adjuvantendocrinetherapy^^^Adjuvantendocrinetherapy^^^AdjuvantEndocrineTherapy^^^Adjuvantendocrinetherapy^^^Adjuvantendocrinetherapy^^^Adjuvantendocrinetherapy^^^Adjuvantendocrinetherapy^^^AdjuvantEndocrineTherapy^^^Adjuvantendocrinetherapy^^^Adjuvantendocrinetherapy^^^Adjuvantendocrinetherapy^^^Adjuvantendocrinetherapy^^^Adjuvantendocrinetherapy^^^Adjuvantendocrinetherapy^^^Adjuvantendocrinetherapy^^^Adjuvantendocrinetherapy^^^Adjuvantendocrinetherapy^^^Adjuvantendocrinetherapy^^^Adjuvantendocrinetherapy^^^Adjuvantendocrinetherapy^^^Adjuvantendocrinetherapy^^^Adjuvantendocrinetherapy^^^Adjuvantendocrinetherapy^^^AdjuvantEndocrineTherapy^^^Adjuvantendocrinetherapy^^^Adjuvantendocrinetherapy^^^Adjuvantendocrinetherapy^^^Adjuvantendocrinetherapy^^^Adjuvantendocrinetherapyforriskreduction^^^Adjuvantendocrinetherapyforriskreduction^^^AdjuvantEndocrineTherapy3.2014^^^AdjuvantEndocrineTherapy3.2014^^^Adjuvantsetting^^^Adjuvantsetting^^^AdjuvantsettingNodenegativeTumor≥1cm ^^^AdjuvantsettingNodenegativeTumor≥1cm ^^^AdjuvantsettingNodepositive^^^AdjuvantsettingNodepositive^^^ADJUVANTTREATMENT^^^ADJUVANTTREATMENT^^^ADJUVANTTREATMENT^^^ADJUVANTTREATMENT^^^ADJUVANTTREATMENT^^^ADJUVANTTREATMENT^^^ADJUVANTTREATMENT^^^ADJUVANTTREATMENT^^^ADJUVANTTREATMENT^^^ADJUVANTTREATMENT^^^ADJUVANTTREATMENT^^^ADJUVANTTREATMENT^^^ADJUVANTTREATMENT^^^ADJUVANTTREATMENT^^^ADJUVANTTREATMENT^^^ADJUVANTTREATMENT^^^ADJUVANTTREATMENT^^^ADJUVANTTREATMENT^^^ADJUVANTTREATMENT^^^ADJUVANTTREATMENT^^^Adjuvant chemotherapy^^^Adjuvant chemotherapy^^^Adotrastuzumabemtansine(TDM1)^^^Adotrastuzumabemtansine(TDM1)^^^Adotrastuzumabemtansine(TDM1)^^^Adotrastuzumabemtansine(TDM1)^^^Albuminboundpaclitaxel^^^Albuminboundpaclitaxel^^^Annualgynecologicassessmentevery12months^^^Annualgynecologicassessmentevery12months^^^Aromataseinhibitor^^^Aromataseinhibitor^^^Aromataseinhibitorfor23y^^^Aromataseinhibitorfor23y^^^Aromataseinhibitorfor5y^^^Aromataseinhibitorfor5y^^^Aromataseinhibitorfor5y^^^Aromataseinhibitorfor5y^^^Aromataseinhibitorfor5y^^^Aromataseinhibitorfor5y^^^Aromataseinhibitorfor5y^^^Aromataseinhibitorfor5y^^^Aromataseinhibitortocomplete5yofendocrinetherapy^^^Aromataseinhibitortocomplete5yofendocrinetherapy^^^ASSAY^^^ASSAY^^^Assaynotdone^^^Assaynotdone^^^Assessandencourageadherencetoadjuvantendocrinetherapy^^^Assessandencourageadherencetoadjuvantendocrinetherapy^^^Assessfordistress^^^Assessfordistress^^^Assessfordistress^^^Assessfordistress^^^Assessfordistress^^^Assessfordistress^^^Asymptomaticvisceral^^^Asymptomaticvisceral^^^Asymptomaticvisceral^^^Asymptomaticvisceral^^^AverageHER2copynumber<4.0signals/cell^^^AverageHER2copynumber<4.0signals/cell^^^AverageHER2copynumber<4.0signals/cell^^^AverageHER2copynumber<4.0signals/cell^^^AverageHER2copynumber<4.0signals/cell^^^AverageHER2copynumber<4.0signals/cell^^^AverageHER2copynumber≥4.0and<6.0signals/cell^^^AverageHER2copynumber≥4.0and<6.0signals/cell^^^AverageHER2copynumber≥4.0and<6.0signals/cell^^^AverageHER2copynumber≥4.0and<6.0signals/cell^^^AverageHER2copynumber≥4.0signals/cell^^^AverageHER2copynumber≥4.0signals/cell^^^AverageHER2copynumber≥6.0signals/cell^^^AverageHER2copynumber≥6.0signals/cell^^^AverageHER2copynumber≥6.0signals/cell^^^AverageHER2copynumber≥6.0signals/cell^^^AxillarydissectionlevelI/II^^^AxillarydissectionlevelI/II^^^AxillarydissectionlevelI/II^^^AxillarydissectionlevelI/II^^^Axillaryimagingwithultrasound^^^Axillaryimagingwithultrasound^^^Axillarylymphnodedissection^^^Axillarylymphnodedissection^^^Axillarylymphnodedissection^^^Axillarylymphnodedissection^^^Axillarylymphnodedissection^^^Axillarylymphnodedissection^^^Axillarylymphnodedissection^^^Axillarylymphnodedissection^^^Axillarylymphnodestaging^^^Axillarylymphnodestaging^^^Axillaryradiationforregionalcontrolofdisease^^^Axillaryradiationforregionalcontrolofdisease^^^Axillaryrecurrence^^^Axillaryrecurrence^^^Biopsyoffirstrecurrenceofdisease^^^Biopsyoffirstrecurrenceofdisease^^^Bonediseasenotpresent^^^Bonediseasenotpresent^^^Bonediseasepresent^^^Bonediseasepresent^^^Boneonly^^^Boneonly^^^Boneonly^^^Boneonly^^^Bonescan^^^Bonescan^^^Bonescan^^^Bonescan^^^Bonescan^^^Bonescan^^^Bonescan^^^Bonescan^^^Bonescan^^^Bonescan^^^Bonescan forsystemicstaging^^^Bonescan forsystemicstaging^^^Bonescan forsystemicstaging^^^Bonescan forsystemicstaging^^^BrainMRI^^^BrainMRI^^^BreastMRI^^^BreastMRI^^^BreastMRI^^^BreastMRI^^^BreastMRI^^^BreastMRI^^^Breastreconstruction^^^Breastreconstruction^^^CAF/FAC(cyclophosphamide/doxorubicin/fluorouracil)^^^CAF/FAC(cyclophosphamide/doxorubicin/fluorouracil)^^^Capecitabine^^^Capecitabine^^^Carboplatin^^^Carboplatin^^^CBC^^^CBC^^^CBC^^^CBC^^^CBC^^^CBC^^^CBC^^^CBC^^^CBC^^^CBC^^^Chemoindicated^^^Chemoindicated^^^Chemoindicated^^^Chemoindicated^^^Chemoindicated^^^Chemoindicated^^^Chemoindicated^^^Chemoindicated^^^Chemoindicated^^^Chemoindicated^^^Chemoindicated^^^Chemoindicated^^^Chemoindicated^^^Chemoindicated^^^ChemoindicatedPostmastectomyradiationtobedone^^^ChemoindicatedPostmastectomyradiationtobedone^^^Chemotherapy^^^Chemotherapy^^^ChemotherapyforRecurrentorMetastaticBreastCancer^^^ChemotherapyforRecurrentorMetastaticBreastCancer^^^ChemotherapyforRecurrentorMetastaticBreastCancer:HER2positive^^^ChemotherapyforRecurrentorMetastaticBreastCancer:HER2positive^^^Chemotherapyforrecurrent/metastaticdisease^^^Chemotherapyforrecurrent/metastaticdisease^^^Chemotherapy:Recurrent/Metastatic^^^Chemotherapy:Recurrent/Metastatic^^^Chemotherapy:Recurrent/Metastatic,HER2+^^^Chemotherapy:Recurrent/Metastatic,HER2+^^^Chemotherapy:Recurrent/Metastatic,HER2+3.2014^^^Chemotherapy:Recurrent/Metastatic,HER2+3.2014^^^Chemotherapy:Recurrent/Metastatic3.2014^^^Chemotherapy:Recurrent/Metastatic3.2014^^^ChestdiagnosticCT^^^ChestdiagnosticCT^^^ChestdiagnosticCT^^^ChestdiagnosticCT^^^ChestdiagnosticCT^^^ChestdiagnosticCT^^^Chest diagnosticCT^^^Chest diagnosticCT^^^Chest diagnosticCT^^^Chest diagnosticCT^^^Cisplatin^^^Cisplatin^^^CLINICALPRESENTATION^^^CLINICALPRESENTATION^^^CLINICALPRESENTATION^^^CLINICALPRESENTATION^^^CLINICALPRESENTATION^^^CLINICALPRESENTATION^^^CLINICALPRESENTATION^^^CLINICALPRESENTATION^^^CLINICALPRESENTATION^^^CLINICALPRESENTATION^^^CLINICALPRESENTATION^^^CLINICALPRESENTATION^^^CLINICALPRESENTATION^^^CLINICALPRESENTATION^^^CLINICALPRESENTATION^^^CLINICALPRESENTATION^^^CLINICALPRESENTATION^^^CLINICALPRESENTATION^^^CLINICALPRESENTATION^^^CLINICALPRESENTATION^^^CLINICALPRESENTATION^^^CLINICALPRESENTATION^^^CLINICALPRESENTATION^^^CLINICALPRESENTATION^^^CLINICALPRESENTATION^^^CLINICALPRESENTATION^^^ClinicalStageIIAT0,N1,M0T1,N1,M0T2,N0,M0^^^ClinicalStageIIAT0,N1,M0T1,N1,M0T2,N0,M0^^^ClinicalStageIIAT0,N1,M0T1,N1,M0T2,N0,M0^^^ClinicalStageIIAT0,N1,M0T1,N1,M0T2,N0,M0^^^ClinicalStageIIBT2,N1,M0T3,N0,M0^^^ClinicalStageIIBT2,N1,M0T3,N0,M0^^^ClinicalStageIIBT2,N1,M0T3,N0,M0^^^ClinicalStageIIBT2,N1,M0T3,N0,M0^^^ClinicalStageIIIAT3,N1,M0^^^ClinicalStageIIIAT3,N1,M0^^^ClinicalStageIIIAT3,N1,M0^^^ClinicalStageIIIAT3,N1,M0^^^ClinicalStageIT1,N0,M0^^^ClinicalStageIT1,N0,M0^^^ClinicalStageIT1,N0,M0^^^ClinicalStageIT1,N0,M0^^^ClinicallynegativeaxillaeUndergoingmastectomyRTisplanned^^^ClinicallynegativeaxillaeUndergoingmastectomyRTisplanned^^^Clinicallynegativeipsilateralaxillarylymphnode(s)^^^Clinicallynegativeipsilateralaxillarylymphnode(s)^^^Clinicallynegativeipsilateralaxillarylymphnodes(duringinitialworkup)andipsilaterialaxillarylymphnodeFNAorcorebiopsypositive(priortopreoperativesystemictherapy)^^^Clinicallynegativeipsilateralaxillarylymphnodes(duringinitialworkup)andipsilaterialaxillarylymphnodeFNAorcorebiopsypositive(priortopreoperativesystemictherapy)^^^Clinicallynegativeipsilateralaxillarylymphnodes(duringinitialworkup)andipsilaterialaxillarylymphnodeFNAorcorebiopsypositive (priortopreoperativesystemictherapy)^^^Clinicallynegativeipsilateralaxillarylymphnodes(duringinitialworkup)andipsilaterialaxillarylymphnodeFNAorcorebiopsypositive (priortopreoperativesystemictherapy)^^^Clinicallynodenegativeattimeofdiagnosis^^^Clinicallynodenegativeattimeofdiagnosis^^^Clinicallynodepositiveattimeofdiagnosis^^^Clinicallynodepositiveattimeofdiagnosis^^^Clinicallypositiveipsilateralaxillarylymphnode(s)^^^Clinicallypositiveipsilateralaxillarylymphnode(s)^^^Clinicallypositiveipsilateralaxillarylymphnodes(duringinitialworkup)andipsilaterialaxillarylymphnodeFNAorcorebiopsypositive (priortopreoperativesystemictherapy)^^^Clinicallypositiveipsilateralaxillarylymphnodes(duringinitialworkup)andipsilaterialaxillarylymphnodeFNAorcorebiopsypositive (priortopreoperativesystemictherapy)^^^Clinicallypositiveipsilateralaxillarylymphnodes(duringinitialworkup)andipsilaterialaxillarylymphnodeFNAorcorebiopsypositive (priortopreoperativesystemictherapy)^^^Clinicallypositiveipsilateralaxillarylymphnodes(duringinitialworkup)andipsilaterialaxillarylymphnodeFNAorcorebiopsypositive (priortopreoperativesystemictherapy)^^^CMF(cyclophosphamide/methotrexate/fluorouracil)^^^CMF(cyclophosphamide/methotrexate/fluorouracil)^^^CMF(cyclophosphamide/methotrexate/fluorouracil)^^^CMF(cyclophosphamide/methotrexate/fluorouracil)^^^CMF(cyclophosphamide/methotrexate/fluorouracil)^^^CMF(cyclophosphamide/methotrexate/fluorouracil)^^^Completeresponse^^^Completeresponse^^^Completeuptooneyearoftrastuzumabcontainingchemotherapy^^^Completeuptooneyearoftrastuzumabcontainingchemotherapy^^^Confirmedprogressivediseaseatanytime^^^Confirmedprogressivediseaseatanytime^^^Continueendocrinetherapyuntildevelopmentofunacceptabletoxicity^^^Continueendocrinetherapyuntildevelopmentofunacceptabletoxicity^^^Continueendocrinetherapyuntildiseaseprogressionorunacceptabletoxicity^^^Continueendocrinetherapyuntildiseaseprogressionorunacceptabletoxicity^^^Continueendocrinetherapyuntilprogression^^^Continueendocrinetherapyuntilprogression^^^ContinueHER2targetedtherapy^^^ContinueHER2targetedtherapy^^^Contraindicationtoaromataseinhibitors^^^Contraindicationtoaromataseinhibitors^^^Corebiopsyofbreastwithimagedetectablemarker(s)^^^Corebiopsyofbreastwithimagedetectablemarker(s)^^^Corebiopsyoflymphnodenegative^^^Corebiopsyoflymphnodenegative^^^Corebiopsyoflymphnodepositive^^^Corebiopsyoflymphnodepositive^^^Corebiopsyoflymphnodepositive^^^Corebiopsyoflymphnodepositive^^^Corebiospypositive^^^Corebiospypositive^^^Corebiospy negative^^^Corebiospy negative^^^Counselingforfertilityconcerns^^^Counselingforfertilityconcerns^^^Cyclophosphamide^^^Cyclophosphamide^^^DenovostageIV^^^DenovostageIV^^^Decline aromataseinhibitors^^^Decline aromataseinhibitors^^^Denosumab^^^Denosumab^^^DeterminationofER/PRstatus^^^DeterminationofER/PRstatus^^^DeterminationofER/PRstatus^^^DeterminationofER/PRstatus^^^DeterminationofER/PRstatusonmetastaticsite^^^DeterminationofER/PRstatusonmetastaticsite^^^DeterminationofHER2status^^^DeterminationofHER2status^^^DeterminationofHER2status^^^DeterminationofHER2status^^^DeterminationofHER2statusonmetastaticsite^^^DeterminationofHER2statusonmetastaticsite^^^DeterminationofHER2 status^^^DeterminationofHER2 status^^^Determinationoftumorestrogen/progesteronereceptor(ER/PR)status^^^Determinationoftumorestrogen/progesteronereceptor(ER/PR)status^^^Diagnosticbilateralmammogram^^^Diagnosticbilateralmammogram^^^Diagnosticbilateralmammogram^^^Diagnosticbilateralmammogram^^^Diagnosticbilateralmammogram^^^Diagnosticbilateralmammogram^^^DiagnosticCTforsystemicstaging^^^DiagnosticCTforsystemicstaging^^^DiagnosticCTforsystemicstaging^^^DiagnosticCTforsystemicstaging^^^Docetaxel^^^Docetaxel^^^Docetaxel+cyclophosphamide+trastuzumab^^^Docetaxel+cyclophosphamide+trastuzumab^^^Docetaxel+cyclophosphamide+trastuzumab^^^Docetaxel+cyclophosphamide+trastuzumab^^^Docetaxel/capecitabine^^^Docetaxel/capecitabine^^^DoesNOTmeetallofthefollowing:T1orT2tumor1or2positivesentinellymphnodesBreastconservingtherapyWholebreastRTplannedNopreoperativechemotherapy^^^DoesNOTmeetallofthefollowing:T1orT2tumor1or2positivesentinellymphnodesBreastconservingtherapyWholebreastRTplannedNopreoperativechemotherapy^^^DosedenseAC(doxorubicin/cyclophosphamide)^^^DosedenseAC(doxorubicin/cyclophosphamide)^^^DosedenseAC(doxorubicin/cyclophosphamide)^^^DosedenseAC(doxorubicin/cyclophosphamide)^^^DosedenseAC(doxorubicin/cyclophosphamide)followedby paclitaxelevery2weeks^^^DosedenseAC(doxorubicin/cyclophosphamide)followedby paclitaxelevery2weeks^^^DosedenseAC(doxorubicin/cyclophosphamide)followedby paclitaxelevery2weeks^^^DosedenseAC(doxorubicin/cyclophosphamide)followedby paclitaxelevery2weeks^^^DosedenseAC(doxorubicin/cyclophosphamide)followedby weeklypaclitaxel^^^DosedenseAC(doxorubicin/cyclophosphamide)followedby weeklypaclitaxel^^^DosedenseAC(doxorubicin/cyclophosphamide)followedby weeklypaclitaxel^^^DosedenseAC(doxorubicin/cyclophosphamide)followedby weeklypaclitaxel^^^Doxorubicin^^^Doxorubicin^^^Ductal^^^Ductal^^^Ductal^^^Ductal^^^Ductal^^^Ductal^^^Ductal^^^Ductal^^^Ductal^^^Ductal^^^EC(epirubicin/cyclophosphamide)^^^EC(epirubicin/cyclophosphamide)^^^EC(epirubicin/cyclophosphamide)^^^EC(epirubicin/cyclophosphamide)^^^EC(epirubicin/cyclophosphamide)^^^EC(epirubicin/cyclophosphamide)^^^ECOGperformancestatus≥3^^^ECOGperformancestatus≥3^^^Educate,monitor,andreferforlymphedemamanagement^^^Educate,monitor,andreferforlymphedemamanagement^^^Educationandcounselingregardinganactivelifestyle,healthydiet,limitedalcoholintake,andachievingandmaintinganidealbodyweight(2025BMI)^^^Educationandcounselingregardinganactivelifestyle,healthydiet,limitedalcoholintake,andachievingandmaintinganidealbodyweight(2025BMI)^^^Elevatedalkalinephosphatase^^^Elevatedalkalinephosphatase^^^Elevatedalkalinephosphatase^^^Elevatedalkalinephosphatase^^^Endocrinetherapy^^^Endocrinetherapy^^^Endocrinetherapyalone^^^Endocrinetherapyalone^^^Endocrinetherapyalone^^^Endocrinetherapyalone^^^Endocrinetherapyalone^^^Endocrinetherapyalone^^^Endocrinetherapyalone^^^Endocrinetherapyalone^^^Endocrinetherapyasforpostmenopausal^^^Endocrinetherapyasforpostmenopausal^^^Endocrinetherapyasforpostmenopausal^^^Endocrinetherapyasforpostmenopausal^^^Endocrinetreatment^^^Endocrinetreatment^^^Epirubicin^^^Epirubicin^^^Equivocalresult^^^Equivocalresult^^^Equivocalresult^^^Equivocalresult^^^Equivocalresult^^^Equivocalresult^^^ERnegativePRnegative^^^ERnegativePRnegative^^^ERpositive^^^ERpositive^^^ERnegativePRnegative^^^ERnegativePRnegative^^^ERnegativePRnegative^^^ERnegativePRnegative^^^ERpositive^^^ERpositive^^^ERpositive^^^ERpositive^^^Eribulin^^^Eribulin^^^FACfollowedbyT (fluorouracil/doxorubicin/cyclophosphamidefollowedbyweeklypaclitaxel)^^^FACfollowedbyT (fluorouracil/doxorubicin/cyclophosphamidefollowedbyweeklypaclitaxel)^^^FACfollowedbyT (fluorouracil/doxorubicin/cyclophosphamidefollowedbyweeklypaclitaxel)^^^FACfollowedbyT (fluorouracil/doxorubicin/cyclophosphamidefollowedbyweeklypaclitaxel)^^^FDGPET/CT^^^FDGPET/CT^^^FDGPET/CT^^^FDGPET/CT^^^FDGPET/CT^^^FDGPET/CT^^^FDGPET/CT^^^FDGPET/CT^^^FDGPET/CT^^^FDGPET/CT^^^FDGPET/CT^^^FDGPET/CT^^^FEC(fluorouracil/epirubicin/cyclophosphamide)^^^FEC(fluorouracil/epirubicin/cyclophosphamide)^^^FECfollowedbydocetaxel+trastuzumab+pertuzumab^^^FECfollowedbydocetaxel+trastuzumab+pertuzumab^^^FECfollowedbydocetaxel+trastuzumab+pertuzumab^^^FECfollowedbydocetaxel+trastuzumab+pertuzumab^^^FECfollowedbypaclitaxel+trastuzumab+pertuzumab^^^FECfollowedbypaclitaxel+trastuzumab+pertuzumab^^^FECfollowedbypaclitaxel+trastuzumab+pertuzumab^^^FECfollowedbypaclitaxel+trastuzumab+pertuzumab^^^FEC/CEFfollowedbyT(fluorouracil/epirubicin/cyclophosphamidefollowedbydocetaxel)^^^FEC/CEFfollowedbyT(fluorouracil/epirubicin/cyclophosphamidefollowedbydocetaxel)^^^FEC/CEFfollowedbyT(fluorouracil/epirubicin/cyclophosphamidefollowedbydocetaxel)^^^FEC/CEFfollowedbyT(fluorouracil/epirubicin/cyclophosphamidefollowedbydocetaxel)^^^FEC/CEFfollowedbyT(fluorouracil/epirubicin/cyclophosphamidefollowedbyweeklypaclitaxel)^^^FEC/CEFfollowedbyT(fluorouracil/epirubicin/cyclophosphamidefollowedbyweeklypaclitaxel)^^^FEC/CEFfollowedbyT(fluorouracil/epirubicin/cyclophosphamidefollowedbyweeklypaclitaxel)^^^FEC/CEFfollowedbyT(fluorouracil/epirubicin/cyclophosphamidefollowedbyweeklypaclitaxel)^^^Fertilitycounseling^^^Fertilitycounseling^^^Fertilitycounseling^^^Fertilitycounseling^^^FINDINGS^^^FINDINGS^^^FINDINGS^^^FINDINGS^^^Finish^^^Finish^^^Finish^^^Finish^^^Finish^^^Finish^^^Finish^^^Finish^^^Finish^^^Finish^^^Finish^^^Finish^^^Finish^^^Finish^^^Finish^^^Finish^^^Finish^^^Finish^^^Finish^^^Finish^^^Finish^^^Finish^^^Finish^^^Finish^^^Finish^^^Finish^^^Finish^^^Finish^^^Finish^^^Finish^^^Finish^^^Finish^^^Finish^^^Finish^^^Finish^^^Finish^^^Finish^^^Finish^^^Finish^^^Finish^^^Finish^^^Finish^^^First5yearsaftertreatment^^^First5yearsaftertreatment^^^FNAnegative^^^FNAnegative^^^FNApositive^^^FNApositive^^^Fulfillscriteriaforbreastconservingsurgeryexceptfortumorsize^^^Fulfillscriteriaforbreastconservingsurgeryexceptfortumorsize^^^Gemcitabine^^^Gemcitabine^^^Gemcitabine/carboplatin^^^Gemcitabine/carboplatin^^^Geneticcounseling^^^Geneticcounseling^^^Geneticcounseling^^^Geneticcounseling^^^Geneticcounseling^^^Geneticcounseling^^^Geneticcounseling^^^Geneticcounseling^^^GT(gemcitabine/paclitaxel)^^^GT(gemcitabine/paclitaxel)^^^H&P^^^H&P^^^H&P^^^H&P^^^H&P^^^H&P^^^H&P14timesperyearasclinicallyappropriate^^^H&P14timesperyearasclinicallyappropriate^^^H&P annually^^^H&P annually^^^HER2negative^^^HER2negative^^^HER2negativeadjuvant chemotherapy^^^HER2negativeadjuvant chemotherapy^^^HER2negativeadjuvant chemotherapy^^^HER2negativeadjuvant chemotherapy^^^HER2negativepreoperativechemotherapy^^^HER2negativepreoperativechemotherapy^^^HER2negativepreoperativechemotherapy^^^HER2negativepreoperativechemotherapy^^^HER2negativepreoperativechemotherapy^^^HER2negativepreoperativechemotherapy^^^HER2negativepreoperativechemotherapy^^^HER2negativepreoperativechemotherapy^^^HER2negativepreoperativechemotherapy^^^HER2negativepreoperativechemotherapy^^^HER2negativepreoperativechemotherapy^^^HER2negativepreoperativechemotherapy^^^HER2negativepreoperativechemotherapy^^^HER2negativepreoperativechemotherapy^^^HER2negativepreoperativechemotherapy^^^HER2negativepreoperativechemotherapy^^^HER2negativepreoperativechemotherapy^^^HER2negativepreoperativechemotherapy^^^HER2negativepreoperativechemotherapy^^^HER2negativepreoperativechemotherapy^^^HER2positive^^^HER2positive^^^HER2positiveadjuvant chemotherapy^^^HER2positiveadjuvant chemotherapy^^^HER2positivepreoperativechemowithtrastuzumab^^^HER2positivepreoperativechemowithtrastuzumab^^^HER2positivepreoperativechemotherapy^^^HER2positivepreoperativechemotherapy^^^HER2positivepreoperativechemotherapy^^^HER2positivepreoperativechemotherapy^^^HER2positivepreoperativechemotherapy^^^HER2positivepreoperativechemotherapy^^^HER2positivepreoperativechemotherapy^^^HER2positivepreoperativechemotherapy^^^HER2positivepreoperativechemotherapy^^^HER2positivepreoperativechemotherapy^^^HER2positivepreoperativechemotherapy^^^HER2positivepreoperativechemotherapy^^^HER2positivepreoperativechemotherapy^^^HER2positivepreoperativechemotherapy^^^HER2positivepreoperativechemotherapy^^^HER2positivepreoperativechemotherapy^^^HER2positivepreoperativechemotherapywithtrastuzumab^^^HER2positivepreoperativechemotherapywithtrastuzumab^^^HER2testing^^^HER2testing^^^HER2testing3.2014^^^HER2testing3.2014^^^HER2+^^^HER2+^^^HER2+^^^HER2+^^^HER2^^^HER2^^^HER2negative^^^HER2negative^^^HER2negative^^^HER2negative^^^HER2negativedisease^^^HER2negativedisease^^^HER2positive^^^HER2positive^^^HER2positive^^^HER2positive^^^HER2positive^^^HER2positive^^^HER2positivedisease^^^HER2positivedisease^^^HER2targetedchemotherapy^^^HER2targetedchemotherapy^^^HER2/CEP17ratio<2.0^^^HER2/CEP17ratio<2.0^^^HER2/CEP17ratio≥2.0^^^HER2/CEP17ratio≥2.0^^^Highrecurrencescore(≥31)^^^Highrecurrencescore(≥31)^^^HISTOLOGY^^^HISTOLOGY^^^HISTOLOGY^^^HISTOLOGY^^^HISTOLOGY^^^HISTOLOGY^^^HISTOLOGY^^^HISTOLOGY^^^HISTOLOGY^^^HISTOLOGY^^^History&physical^^^History&physical^^^HRnegativeHER2negative^^^HRnegativeHER2negative^^^HRnegativeHER2negative^^^HRnegativeHER2negative^^^HRnegativeHER2positive^^^HRnegativeHER2positive^^^HRpositive^^^HRpositive^^^HRpositive,endocrinerefractoryHER2negative^^^HRpositive,endocrinerefractoryHER2negative^^^HRpositive,endocrinerefractoryHER2negative^^^HRpositive,endocrinerefractoryHER2negative^^^HRpositive,endocrinerefractoryHER2positive^^^HRpositive,endocrinerefractoryHER2positive^^^HRpositive,endocrinerefractoryHER2positive^^^HRpositive,endocrinerefractoryHER2positive^^^HRpositive,HER2negative^^^HRpositive,HER2negative^^^HRpositive,HER2+^^^HRpositive,HER2+^^^HRpositiveHER2negative^^^HRpositiveHER2negative^^^HRpositiveHER2positive^^^HRpositiveHER2positive^^^IHC0,1+^^^IHC0,1+^^^IHC2+^^^IHC2+^^^IHC3+^^^IHC3+^^^Imagingstudiesformetastasesscreening^^^Imagingstudiesformetastasesscreening^^^Indicationsforradiationtherapy^^^Indicationsforradiationtherapy^^^Indicationsforradiationtherapy^^^Indicationsforradiationtherapy^^^Individualizedtreatment^^^Individualizedtreatment^^^InitialtreatmentwithlumpectomyRadiationtherapy^^^InitialtreatmentwithlumpectomyRadiationtherapy^^^InitialtreatmentwithmastectomyLevelI/IIaxillarydissectionPriorradiationtherapy^^^InitialtreatmentwithmastectomyLevelI/IIaxillarydissectionPriorradiationtherapy^^^Initialtreatmentwith mastectomyNopriorradiationtherapy^^^Initialtreatmentwith mastectomyNopriorradiationtherapy^^^Inoperable/LocallyAdvanced(StageIII)^^^Inoperable/LocallyAdvanced(StageIII)^^^Inoperable/LocallyAdvanced(StageIII)3.2014^^^Inoperable/LocallyAdvanced(StageIII)3.2014^^^Intermediaterecurrencescore(1830)^^^Intermediaterecurrencescore(1830)^^^Internalmammarynoderecurrence^^^Internalmammarynoderecurrence^^^Intolerantofaromataseinhibitors^^^Intolerantofaromataseinhibitors^^^InvasiveBreastCancer^^^InvasiveBreastCancer^^^InvasiveBreastCancer2.2016^^^InvasiveBreastCancer2.2016^^^IpsilateralaxillarylymphnodeFNAnegative^^^IpsilateralaxillarylymphnodeFNAnegative^^^IpsilateralaxillarylymphnodeFNApositive^^^IpsilateralaxillarylymphnodeFNApositive^^^IpsilateralaxillarylymphnodeFNApositive^^^IpsilateralaxillarylymphnodeFNApositive^^^ISHnegative^^^ISHnegative^^^ISHnegative^^^ISHnegative^^^ISHpositive^^^ISHpositive^^^ISHpositive^^^ISHpositive^^^ISHpositive^^^ISHpositive^^^ISHpositive^^^ISHpositive^^^Ixabepilone^^^Ixabepilone^^^Laboratorystudiesformetastasesscreening^^^Laboratorystudiesformetastasesscreening^^^Lapatinib+capecitabine^^^Lapatinib+capecitabine^^^LevelI/IIaxillarydissection^^^LevelI/IIaxillarydissection^^^LevelI/IIaxillarydissection^^^LevelI/IIaxillarydissection^^^LevelI/IIaxillarydissection^^^LevelI/IIaxillarydissection^^^LevelI/IIaxillarydissectionnotpreviouslydone^^^LevelI/IIaxillarydissectionnotpreviouslydone^^^Liverfunctiontests,alkalinephosphatase^^^Liverfunctiontests,alkalinephosphatase^^^Liverfunctiontests,alkalinephosphatase^^^Liverfunctiontests,alkalinephosphatase^^^Liverfunctiontests,alkalinephosphatase^^^Liverfunctiontests,alkalinephosphatase^^^Liverfunctiontests,alkalinephosphatase^^^Liverfunctiontests,alkalinephosphatase^^^Liverfunctiontests,alkalinephosphatase^^^Liverfunctiontests,alkalinephosphatase^^^Lobular^^^Lobular^^^Lobular^^^Lobular^^^Lobular^^^Lobular^^^Lobular^^^Lobular^^^Lobular^^^Lobular^^^Localandregionalrecurrence^^^Localandregionalrecurrence^^^Localonlyrecurrence^^^Localonlyrecurrence^^^Localizedbonepain^^^Localizedbonepain^^^LOCOREGIONALTREATMENT^^^LOCOREGIONALTREATMENT^^^LocoregionalTreatment:I,IIA,IIB,IIIA(T3,N1,M0only)^^^LocoregionalTreatment:I,IIA,IIB,IIIA(T3,N1,M0only)^^^LocoregionalTreatment:I,IIA,IIB,IIIA(T3,N1,M0only)3.2014^^^LocoregionalTreatment:I,IIA,IIB,IIIA(T3,N1,M0only)3.2014^^^Lowrecurrencescore(<18)^^^Lowrecurrencescore(<18)^^^LowriskstageI^^^LowriskstageI^^^LowriskstageI^^^LowriskstageI^^^Lumpectomy^^^Lumpectomy^^^Lumpectomy^^^Lumpectomy^^^Lumpectomy^^^Lumpectomy^^^Lumpectomy(omitaxillarystaging)^^^Lumpectomy(omitaxillarystaging)^^^Lumpectomywithsurgicalaxillarystaging^^^Lumpectomywithsurgicalaxillarystaging^^^Lymphnodestatusattimeofdiagnosis^^^Lymphnodestatusattimeofdiagnosis^^^Mammographyevery12months^^^Mammographyevery12months^^^Marginspositive^^^Marginspositive^^^Mastectomy(omitaxillarystaging)+/reconstruction^^^Mastectomy(omitaxillarystaging)+/reconstruction^^^Mastectomy+/reconstruction^^^Mastectomy+/reconstruction^^^Mastectomy+/reconstruction^^^Mastectomy+/reconstruction^^^Metaplastic^^^Metaplastic^^^Metaplastic^^^Metaplastic^^^Metaplastic^^^Metaplastic^^^Metaplastic^^^Metaplastic^^^Metaplastic^^^Metaplastic^^^Metastaticbreastcancer^^^Metastaticbreastcancer^^^Metastatic HER2positivedisease^^^Metastatic HER2positivedisease^^^Microinvasive^^^Microinvasive^^^Microinvasive^^^Microinvasive^^^Microinvasive^^^Microinvasive^^^Microinvasive^^^Microinvasive^^^Mixed^^^Mixed^^^Mixed^^^Mixed^^^Mixed^^^Mixed^^^Mixed^^^Mixed^^^Mixed^^^Mixed^^^Monitoringofbonehealthwithabonemineraldensitydeterminationatbaselineandperiodicallythereafter^^^Monitoringofbonehealthwithabonemineraldensitydeterminationatbaselineandperiodicallythereafter^^^Mucinous^^^Mucinous^^^Mucinous^^^Mucinous^^^Negative axillarynodes^^^Negative axillarynodes^^^Negative axillarynodesTumor>5cm^^^Negative axillarynodesTumor>5cm^^^Negative axillarynodesTumor≤5cmMargins≥1mm^^^Negative axillarynodesTumor≤5cmMargins≥1mm^^^Negative axillarynodesTumor≤5cmNegativemarginsbut<1mm^^^Negative axillarynodesTumor≤5cmNegativemarginsbut<1mm^^^Newspecimenavailable^^^Newspecimenavailable^^^Newspecimenavailable^^^Newspecimenavailable^^^Newspecimenavailable^^^Newspecimenavailable^^^Noadjuvanttherapy^^^Noadjuvanttherapy^^^Nobenefitafter3sequentiallinesofchemotherapy^^^Nobenefitafter3sequentiallinesofchemotherapy^^^Noclinicalbenefitafter3sequentialendocrinetherapies^^^Noclinicalbenefitafter3sequentialendocrinetherapies^^^Noclinicalsignsorsymptomssuggestiveofrecurrentdisease^^^Noclinicalsignsorsymptomssuggestiveofrecurrentdisease^^^Nofurtheraxillarysurgery^^^Nofurtheraxillarysurgery^^^Nofurtheraxillarysurgery^^^Nofurtheraxillarysurgery^^^Nofurthercytotoxictherapy^^^Nofurthercytotoxictherapy^^^Nofurtherendocrinetherapy^^^Nofurtherendocrinetherapy^^^Nopriorendocrinetherapywithin1year^^^Nopriorendocrinetherapywithin1year^^^Noradiationtherapy^^^Noradiationtherapy^^^Noresponse^^^Noresponse^^^Noresponse^^^Noresponse^^^Nosymptomaticvisceraldisease^^^Nosymptomaticvisceraldisease^^^Nosymptomaticvisceraldisease^^^Nosymptomaticvisceraldisease^^^Nodepositive(oneormoremetastases>2mmtooneormoreipsilateralaxillarylymphnodes)^^^Nodepositive(oneormoremetastases>2mmtooneormoreipsilateralaxillarylymphnodes)^^^Nodepositive(oneormoremetastases>2mmtooneormoreipsilateralaxillarylymphnodes)^^^Nodepositive(oneormoremetastases>2mmtooneormoreipsilateralaxillarylymphnodes)^^^Nodepositive(oneormoremetastases>2mmtooneormoreipsilateralaxillarylymphnodes)^^^Nodepositive(oneormoremetastases>2mmtooneormoreipsilateralaxillarylymphnodes)^^^Nodepositive(oneormoremetastases>2mmtooneormoreipsilateralaxillarylymphnodes)^^^Nodepositive(oneormoremetastases>2mmtooneormoreipsilateralaxillarylymphnodes)^^^Nodepositive(oneormoremetastases>2mmtooneormoreipsilateralaxillarylymphnodes)^^^Nodepositive(oneormoremetastases>2mmtooneormoreipsilateralaxillarylymphnodes)^^^Notcompletedpreoperatively^^^Notcompletedpreoperatively^^^Noteligibleforotherstandardadjuvantregimensduetocomorbidities^^^Noteligibleforotherstandardadjuvantregimensduetocomorbidities^^^Noteligibleforotherstandardadjuvantregimensduetocomorbidities^^^Noteligibleforotherstandardadjuvantregimensduetocomorbidities^^^Notendocrinerefractory^^^Notendocrinerefractory^^^Notendocrinerefractory^^^Notendocrinerefractory^^^OrdernewtestwithIHC^^^OrdernewtestwithIHC^^^OrdernewtestwithIHC^^^OrdernewtestwithIHC^^^OrdernewtestwithIHC^^^OrdernewtestwithIHC^^^OrdernewtestwithISH^^^OrdernewtestwithISH^^^OrdernewtestwithISH^^^OrdernewtestwithISH^^^OrdernewtestwithISH^^^OrdernewtestwithISH^^^Ovarianablation^^^Ovarianablation^^^Ovarianablation^^^Ovarianablation^^^Ovarianfailuresecondarytotreatment^^^Ovarianfailuresecondarytotreatment^^^Ovariansuppressionorablation^^^Ovariansuppressionorablation^^^Ovariansuppressionorablation^^^Ovariansuppressionorablation^^^Ovarian suppression^^^Ovarian suppression^^^Ovarian suppression^^^Ovarian suppression^^^Paclitaxel^^^Paclitaxel^^^Paclitaxel+trastuzumab^^^Paclitaxel+trastuzumab^^^Paclitaxel+trastuzumab^^^Paclitaxel+trastuzumab^^^Paclitaxel/bevacizumab^^^Paclitaxel/bevacizumab^^^Pamidronate^^^Pamidronate^^^Partialbreastirradiationinselectedpatients^^^Partialbreastirradiationinselectedpatients^^^PartialresponseLumpectomynotpossible^^^PartialresponseLumpectomynotpossible^^^PartialresponseLumpectomypossible^^^PartialresponseLumpectomypossible^^^Pathologyreview^^^Pathologyreview^^^Pathologyreview^^^Pathologyreview^^^Pathologyreview^^^Pathologyreview^^^Patientdoesnothavemultiplehighriskrecurrencefactors^^^Patientdoesnothavemultiplehighriskrecurrencefactors^^^Patienthasmultiplehighriskrecurrencefactors^^^Patienthasmultiplehighriskrecurrencefactors^^^Patientishighriskforhereditarybreastcancer^^^Patientishighriskforhereditarybreastcancer^^^Patientishighriskforhereditarybreastcancer^^^Patientishighriskforhereditarybreastcancer^^^Patientishighriskforhereditarybreastcancer^^^Patientishighriskforhereditarybreastcancer^^^Patientishighriskforhereditarybreastcancer^^^Patientishighriskforhereditarybreastcancer^^^PatientisontamoxifenUterusispresent^^^PatientisontamoxifenUterusispresent^^^Patienttakingaromataseinhibitor^^^Patienttakingaromataseinhibitor^^^Pegylatedliposomaldoxorubicin^^^Pegylatedliposomaldoxorubicin^^^Periodicscreeningforchangesinfamilyhistory^^^Periodicscreeningforchangesinfamilyhistory^^^Pertuzumab+trastuzumab+docetaxel^^^Pertuzumab+trastuzumab+docetaxel^^^Pertuzumab+trastuzumab+docetaxelfollowedbyFEC^^^Pertuzumab+trastuzumab+docetaxelfollowedbyFEC^^^Pertuzumab+trastuzumab+docetaxelfollowedbyFEC^^^Pertuzumab+trastuzumab+docetaxelfollowedbyFEC^^^Pertuzumab+trastuzumab+paclitaxel^^^Pertuzumab+trastuzumab+paclitaxel^^^Pertuzumab+trastuzumab+paclitaxelfollowedbyFEC^^^Pertuzumab+trastuzumab+paclitaxelfollowedbyFEC^^^Pertuzumab+trastuzumab+paclitaxelfollowedbyFEC^^^Pertuzumab+trastuzumab+paclitaxelfollowedbyFEC^^^Pertuzumab/trastuzumab/taxane^^^Pertuzumab/trastuzumab/taxane^^^Plannedadjuvantsystemictherapy basedonhormoneandHER2receptorstatus^^^Plannedadjuvantsystemictherapy basedonhormoneandHER2receptorstatus^^^Plannedadjuvantsystemictherapy basedonhormoneandHER2receptorstatus^^^Plannedadjuvantsystemictherapy basedonhormoneandHER2receptorstatus^^^pN0^^^pN0^^^pN0^^^pN0^^^pN0^^^pN0^^^pN0^^^pN0^^^pN1mi^^^pN1mi^^^pN1mi^^^pN1mi^^^pN1mi^^^pN1mi^^^pN1mi^^^pN1mi^^^Postmastectomyradiationtherapy^^^Postmastectomyradiationtherapy^^^Postmenopausal^^^Postmenopausal^^^Postmenopausal^^^Postmenopausal^^^Postmenopausal^^^Postmenopausal^^^Postmenopausalatdiagnosis^^^Postmenopausalatdiagnosis^^^PRpositive^^^PRpositive^^^PRpositive^^^PRpositive^^^PRpositive^^^PRpositive^^^Premenopausal^^^Premenopausal^^^Premenopausal^^^Premenopausal^^^Premenopausal^^^Premenopausal^^^Premenopausal^^^Premenopausal^^^Premenopausal^^^Premenopausal^^^Premenopausal^^^Premenopausal^^^Premenopausalatdiagnosis^^^Premenopausalatdiagnosis^^^PreoperativeAxillaryEvaluation/SystemicTherapy^^^PreoperativeAxillaryEvaluation/SystemicTherapy^^^PreoperativeAxillaryEvaluation/SystemicTherapy3.2014^^^PreoperativeAxillaryEvaluation/SystemicTherapy3.2014^^^Preoperativeradiation^^^Preoperativeradiation^^^Preoperativesetting^^^Preoperativesetting^^^PreoperativeSystemicTherapy^^^PREOPERATIVESYSTEMICTHERAPY^^^PreoperativeSystemicTherapy^^^PREOPERATIVESYSTEMICTHERAPY^^^PreoperativesystemictherapybasedonhormoneandHER2receptorstatus^^^PreoperativesystemictherapybasedonhormoneandHER2receptorstatus^^^PreoperativesystemictherapybasedonhormoneandHER2receptorstatus^^^PreoperativesystemictherapybasedonhormoneandHER2receptorstatus^^^Preoperativesystemictherapynotcompletedpreoperatively^^^Preoperativesystemictherapynotcompletedpreoperatively^^^PreoperativeWorkup^^^PreoperativeWorkup^^^PreoperativeWorkup3.2014^^^PreoperativeWorkup3.2014^^^Preoperative/AdjuvantChemotherapy:HER2negative^^^Preoperative/AdjuvantChemotherapy:HER2negative^^^Preoperative/AdjuvantChemotherapy:HER2positive^^^Preoperative/AdjuvantChemotherapy:HER2positive^^^Preoperative/AdjuvantChemotherapy:HER2positive^^^Preoperative/AdjuvantChemotherapy:HER2positive^^^Preoperative/AdjuvantChemotherapy:HER2positive3.2014^^^Preoperative/AdjuvantChemotherapy:HER2positive3.2014^^^Preoperative/AdjuvantChemotherapy:HER2negative^^^Preoperative/AdjuvantChemotherapy:HER2negative^^^Preoperative/AdjuvantChemotherapy:HER2negative3.2014^^^Preoperative/AdjuvantChemotherapy:HER2negative3.2014^^^PRIMARYTREATMENT^^^PRIMARYTREATMENT^^^PRIMARYTREATMENT^^^PRIMARYTREATMENT^^^PRIMARYTREATMENT^^^PRIMARYTREATMENT^^^PRIMARYTREATMENT^^^PRIMARYTREATMENT^^^PRIMARYTREATMENT^^^PRIMARYTREATMENT^^^PRIMARYTREATMENT^^^PRIMARYTREATMENT^^^PRIMARYTREATMENT^^^PRIMARYTREATMENT^^^Priorendocrinetherapywithin1year^^^Priorendocrinetherapywithin1year^^^pT1,pT2,orpT3andpN0orpN1mi(≤2mmaxillarynodemetastasis)^^^pT1,pT2,orpT3andpN0orpN1mi(≤2mmaxillarynodemetastasis)^^^pT1,pT2,orpT3andpN0orpN1mi(≤2mmaxillarynodemetastasis)^^^pT1,pT2,orpT3andpN0orpN1mi(≤2mmaxillarynodemetastasis)^^^pT1,pT2,orpT3andpN0orpN1mi(≤2mmaxillarynodemetastasis)^^^pT1,pT2,orpT3andpN0orpN1mi(≤2mmaxillarynodemetastasis)^^^pT1,pT2,orpT3andpN0orpN1mi(≤2mmaxillarynodemetastasis)^^^pT1,pT2,orpT3andpN0orpN1mi(≤2mmaxillarynodemetastasis)^^^pT1,pT2,orpT3andpN0orpN1mi(≤2mmaxillarynodemetastasis)^^^pT1,pT2,orpT3andpN0orpN1mi(≤2mmaxillarynodemetastasis)^^^Pulmonary symptomspresent^^^Pulmonary symptomspresent^^^Radiation^^^Radiation^^^Radiation^^^Radiation^^^Radiation^^^Radiation^^^Radiation^^^Radiation^^^Radiation^^^Radiation^^^Radiation^^^Radiation^^^Radiationindicatedandnotpreviouslyadministered^^^Radiationindicatedandnotpreviouslyadministered^^^Radiationindicatedandnotpreviouslyadministered^^^Radiationindicatedandnotpreviouslyadministered^^^Radiationindicatedandnotpreviouslyadministered^^^Radiationindicatedandnotpreviouslyadministered^^^Radiationindicatedandnotpreviouslyadministered^^^Radiationindicatedandnotpreviouslyadministered^^^Radiationindicatedandnotpreviouslyadministered^^^Radiationindicatedandnotpreviouslyadministered^^^Radiationpreviouslydoneornotindicated^^^Radiationpreviouslydoneornotindicated^^^Radiationpreviouslydoneornotindicated^^^Radiationpreviouslydoneornotindicated^^^Radiationpreviouslydoneornotindicated^^^Radiationpreviouslydoneornotindicated^^^Radiationpreviouslydoneornotindicated^^^Radiationpreviouslydoneornotindicated^^^Radiationpreviouslydoneornotindicated^^^Radiationpreviouslydoneornotindicated^^^Radiationtherapy^^^Radiationtherapy^^^Radiationtherapy^^^Radiationtherapy^^^Radiationtherapy^^^Radiationtherapy^^^Radiationtherapybasedontumorsizeandaxillarylymphnodestatusatdiagnosis^^^Radiationtherapybasedontumorsizeandaxillarylymphnodestatusatdiagnosis^^^Radiationtherapytochestwall^^^Radiationtherapytochestwall^^^Radiationtherapytochestwall±infraclavicularregion±supraclaviculararea±internalmammarynodesandanypartoftheaxillarybedatrisk^^^Radiationtherapytochestwall±infraclavicularregion±supraclaviculararea±internalmammarynodesandanypartoftheaxillarybedatrisk^^^Radiationtherapytochestwall,infraclavicularregion,supraclaviculararea,internalmammarynodes,andanypartoftheaxillarybedatrisk^^^Radiationtherapytochestwall,infraclavicularregion,supraclaviculararea,internalmammarynodes,andanypartoftheaxillarybedatrisk^^^Radiationtherapytochestwall,infraclavicularregion,supraclaviculararea,internalmammarynodes,andanypartoftheaxillarybedatrisk^^^Radiationtherapytochestwall,infraclavicularregion,supraclaviculararea,internalmammarynodes,andanypartoftheaxillarybedatrisk^^^Radiationtherapytochestwall,infraclavicularregion,supraclaviculararea,internalmammarynodes,andanypartoftheaxillarybedatrisk^^^Radiationtherapytochestwall,infraclavicularregion,supraclaviculararea,internalmammarynodes,andanypartoftheaxillarybedatrisk^^^Radiationtherapytochestwall,infraclavicularregion,supraclaviculararea,internalmammarynodes,andanypartoftheaxillarybedatrisk^^^Radiationtherapytochestwall,infraclavicularregion,supraclaviculararea,internalmammarynodes,andanypartoftheaxillarybedatrisk^^^Radiationtherapytochestwall,infraclavicularregion,supraclaviculararea,internalmammarynodes,andanypartoftheaxillarybedatrisk^^^Radiationtherapytochestwall,infraclavicularregion,supraclaviculararea,internalmammarynodes,andanypartoftheaxillarybedatrisk^^^Radiationtherapytoinfraclavicularregion,supraclaviculararea,internalmammarynodes,andanypartoftheaxillarybedatrisk^^^Radiationtherapytoinfraclavicularregion,supraclaviculararea,internalmammarynodes,andanypartoftheaxillarybedatrisk^^^Radiationtherapytoinfraclavicularregion,supraclaviculararea,internalmammarynodes,andanypartoftheaxillarybedatrisk^^^Radiationtherapytoinfraclavicularregion,supraclaviculararea,internalmammarynodes,andanypartoftheaxillarybedatrisk^^^Radiationtherapytowholebreastwithboosttotumorbed^^^Radiationtherapytowholebreastwithboosttotumorbed^^^Radiationtherapytowholebreastwithboosttotumorbed^^^Radiationtherapytowholebreastwithboosttotumorbed^^^Radiationtherapytowholebreastwithboosttotumorbed+ infraclavicularregion,supraclaviculararea,internalmammarynodes,andanypartoftheaxillarybedatrisk^^^Radiationtherapytowholebreastwithboosttotumorbed+ infraclavicularregion,supraclaviculararea,internalmammarynodes,andanypartoftheaxillarybedatrisk^^^Radiationtherapytowholebreastwithoutboosttotumorbed^^^Radiationtherapytowholebreastwithoutboosttotumorbed^^^Radiationtherapytowholebreastwithoutboosttotumorbed^^^Radiationtherapytowholebreastwithoutboosttotumorbed^^^Radiationtherapytowholebreastwithoutboosttotumorbed+ infraclavicularregion,supraclaviculararea,internalmammarynodes,andanypartoftheaxillarybedatrisk^^^Radiationtherapytowholebreastwithoutboosttotumorbed+ infraclavicularregion,supraclaviculararea,internalmammarynodes,andanypartoftheaxillarybedatrisk^^^Reconstruction^^^Reconstruction^^^Recurrence/StageIV:InitialTreatment^^^Recurrence/StageIV:InitialTreatment^^^Recurrence/StageIV:InitialTreatment3.2014^^^Recurrence/StageIV:InitialTreatment3.2014^^^Recurrence/StageIV:SystemicTreatment^^^Recurrence/StageIV:SystemicTreatment^^^Recurrence/StageIV:SystemicTreatment3.2014^^^Recurrence/StageIV:SystemicTreatment3.2014^^^Recurrentbreastcancer^^^Recurrentbreastcancer^^^Recurrentdisease^^^Recurrentdisease^^^RecurrentHER2positivedisease^^^RecurrentHER2positivedisease^^^Referraltogeneticcounseling^^^Referraltogeneticcounseling^^^ReflextestwithdualprobeISH^^^ReflextestwithdualprobeISH^^^ReflextestwithIHC^^^ReflextestwithIHC^^^ReflextestwithIHC^^^ReflextestwithIHC^^^ReflextestwithISH^^^ReflextestwithISH^^^Regionalonly^^^Regionalonly^^^RepeatdeterminationofER/PRstatus^^^RepeatdeterminationofER/PRstatus^^^Response^^^Response^^^Response^^^Response^^^ReviewHRandHER2receptorstatus^^^ReviewHRandHER2receptorstatus^^^Routineimagingofreconstructedbreast^^^Routineimagingofreconstructedbreast^^^Samespecimen^^^Samespecimen^^^Samespecimen^^^Samespecimen^^^Samespecimen^^^Samespecimen^^^Samplebycorebiopsyoflymphnodepriortopreoperativesystemictherapy^^^Samplebycorebiopsyoflymphnodepriortopreoperativesystemictherapy^^^Samplebycorebiopsyoflymphnodepriortopreoperativesystemictherapy^^^Samplebycorebiopsyoflymphnodepriortopreoperativesystemictherapy^^^SamplebyFNApriortopreoperativesystemictherapy^^^SamplebyFNApriortopreoperativesystemictherapy^^^SamplebyFNApriortopreoperativesystemictherapy^^^SamplebyFNApriortopreoperativesystemictherapy^^^Seeappropriatepathway^^^Seeappropriatepathway^^^SeeASCO/CAPHER2GuidelineDataSupplement2Eformoreinformationontheserarescenarios^^^SeeASCO/CAPHER2GuidelineDataSupplement2Eformoreinformationontheserarescenarios^^^SeeFollowup^^^SeeFollowup^^^SeeFollowup^^^SeeFollowup^^^SeeFollowup^^^SeeFollowup^^^SeeFollowup^^^SeeFollowup^^^SeeFollowup^^^SeeFollowup^^^SeeLocoregionalTreatment^^^SeeLocoregionalTreatment^^^SeeNCCNGuidelinesforDistressManagement^^^SeeNCCNGuidelinesforDistressManagement^^^SeeNCCNGuidelinesforGenetic/FamilialHighRiskAssessment:BreastandOvarian^^^SeeNCCNGuidelinesforGenetic/FamilialHighRiskAssessment:BreastandOvarian^^^SeeNCCNGuidelinesforGenetic/FamilialHighRiskAssessment:BreastandOvarian^^^SeeNCCNGuidelinesforGenetic/FamilialHighRiskAssessment:BreastandOvarian^^^SeeNCCNGuidelinesforGenetic/FamilialHighRiskAssessment:BreastandOvarian^^^SeeNCCNGuidelinesforGenetic/FamilialHighRiskAssessment:BreastandOvarian^^^SeeNCCNGuidelinesforGenetic/FamilialHighRiskAssessment:BreastandOvarian^^^SeeNCCNGuidelinesforGenetic/FamilialHighRiskAssessment:BreastandOvarian^^^SeeNCCNGuidelinesforPalliative Care^^^SeeNCCNGuidelinesforPalliative Care^^^SeeNCCNGuidelinesforSupportiveCare^^^SeeNCCNGuidelinesforSupportiveCare^^^SeeNCCNGuidelinesforSurvivorship^^^SeeNCCNGuidelinesforSurvivorship^^^SeeNCCNGuidelinesfor DistressManagement^^^SeeNCCNGuidelinesfor DistressManagement^^^SeeNCCNGuidelinesfor DistressManagement^^^SeeNCCNGuidelinesfor DistressManagement^^^SeePreoperativeSystemicTherapy^^^SeePreoperativeSystemicTherapy^^^SeeRecurrentDisease^^^SeeRecurrentDisease^^^SeeSurveillance/Followup^^^SeeSurveillance/Followup^^^SeeSystemicAdjuvantTreatment:HR+,HER2+^^^SeeSystemicAdjuvantTreatment:HR+,HER2+^^^SeeSystemicAdjuvantTreatment:HR+,HER2^^^SeeSystemicAdjuvantTreatment:HR+,HER2^^^SeeSystemicAdjuvantTreatment:HR,HER2+^^^SeeSystemicAdjuvantTreatment:HR,HER2+^^^SeeSystemicAdjuvantTreatment:HR,HER2^^^SeeSystemicAdjuvantTreatment:HR,HER2^^^SeeSystemicAdjuvantTreatment: FavorableHistologies^^^SeeSystemicAdjuvantTreatment: FavorableHistologies^^^Seesystemictreatmentfor recurrent/metastaticdisease^^^Seesystemictreatmentfor recurrent/metastaticdisease^^^Seesystemictreatmentfor recurrent/metastaticdisease,HER2+^^^Seesystemictreatmentfor recurrent/metastaticdisease,HER2+^^^SeeSystemictreatment,HRnegative,orHR+andendocrinerefractoryHER2negative^^^SeeSystemictreatment,HRnegative,orHR+andendocrinerefractoryHER2negative^^^SeeSystemictreatment,HRnegative,orHR+andendocrinerefractoryHER2+^^^SeeSystemictreatment,HRnegative,orHR+andendocrinerefractoryHER2+^^^SeeSystemictreatment, HR+HER2negativeorpositive^^^SeeSystemictreatment, HR+HER2negativeorpositive^^^SelectiveERmodulators^^^SelectiveERmodulators^^^SelectiveERmodulators^^^SelectiveERmodulators^^^SelectiveER downregulator^^^SelectiveER downregulator^^^Sentinellymphnodebiopsy^^^Sentinellymphnodebiopsy^^^Sentinellymphnodebiopsy^^^Sentinellymphnodebiopsy^^^Sentinelnodemappingandexcision^^^Sentinelnodemappingandexcision^^^Sentinelnodenegative^^^Sentinelnodenegative^^^Sentinelnodenotidentified^^^Sentinelnodenotidentified^^^Sentinelnodepositive^^^Sentinelnodepositive^^^Signsandsymptomspresent^^^Signsandsymptomspresent^^^SLNBperformedduringaxillaryevaluationandnegativefindings^^^SLNBperformedduringaxillaryevaluationandnegativefindings^^^SLNBperformedduringaxillaryevaluationandnegativefindings^^^SLNBperformedduringaxillaryevaluationandnegativefindings^^^SodiumFluoridePET/CT^^^SodiumfluoridePET/CT^^^SodiumfluoridePET/CT^^^SodiumfluoridePET/CT^^^SodiumFluoridePET/CT^^^SodiumfluoridePET/CT^^^SodiumfluoridePET/CT^^^SodiumfluoridePET/CT^^^Softtissueonly^^^Softtissueonly^^^Softtissueonly^^^Softtissueonly^^^Someclinicalbenefitswithin3sequentialendocrinetherapies^^^Someclinicalbenefitswithin3sequentialendocrinetherapies^^^StageI^^^StageI^^^StageIIA^^^StageIIA^^^StageIIA(T2,N0,M0)Fulfillscriteriaforbreastconservingsurgeryexceptfortumorsize)^^^StageIIA(T2,N0,M0)Fulfillscriteriaforbreastconservingsurgeryexceptfortumorsize)^^^StageIIAT2,N0,M0^^^StageIIAT2,N0,M0^^^StageIIB^^^StageIIB^^^StageIIB(T2,N1,M0)Fulfillscriteriaforbreastconservingsurgeryexceptfortumorsize)^^^StageIIB(T2,N1,M0)Fulfillscriteriaforbreastconservingsurgeryexceptfortumorsize)^^^StageIIB(T3,N0,M0)Fulfillscriteriaforbreastconservingsurgeryexceptfortumorsize)^^^StageIIB(T3,N0,M0)Fulfillscriteriaforbreastconservingsurgeryexceptfortumorsize)^^^StageIIBT2,N1,M0T3,N0,M0^^^StageIIBT2,N1,M0T3,N0,M0^^^StageIIIA(T3,N1,M0)^^^StageIIIA(T3,N1,M0)^^^StageIIIA(T3,N1,M0)^^^StageIIIA(T3,N1,M0)^^^StageIIIA(T3,N1,M0)Fulfillscriteriaforbreastconservingsurgeryexceptfortumorsize)^^^StageIIIA(T3,N1,M0)Fulfillscriteriaforbreastconservingsurgeryexceptfortumorsize)^^^StageIIIAT0,N2,M0T1,N2,M0T2,N2,M0T3,N2,M0^^^StageIIIAT0,N2,M0T1,N2,M0T2,N2,M0T3,N2,M0^^^StageIIIAT2,N1,M0^^^StageIIIAT2,N1,M0^^^StageIIIBT4,N0,M0T4,N1,M0T4,N2,M0^^^StageIIIBT4,N0,M0T4,N1,M0T4,N2,M0^^^StageIIICAnyTN3,M0^^^StageIIICAnyTN3,M0^^^StageIVdisease^^^StageIVdisease^^^STAGING^^^STAGING^^^Start^^^Start^^^Start^^^Start^^^Start^^^Start^^^Start^^^Start^^^Start^^^Start^^^Start^^^Start^^^Start^^^Start^^^Start^^^Start^^^Start^^^Start^^^Start^^^Start^^^Start^^^Start^^^Start^^^Start^^^Start^^^Start^^^Start^^^Start^^^Start^^^Start^^^Start^^^Start^^^Start^^^Start^^^Start^^^Start^^^Start^^^Start^^^Start^^^Start^^^Start^^^Start^^^Start^^^Start^^^StartfromRecurrence/StageIV:InitialTreatment3.2014^^^StartfromRecurrence/StageIV:InitialTreatment3.2014^^^StartfromRecurrence/StageIV:InitialTreatment3.2014(2)^^^StartfromRecurrence/StageIV:InitialTreatment3.2014(2)^^^StartfromRecurrence/StageIV:InitialTreatment3.2014(3)^^^StartfromRecurrence/StageIV:InitialTreatment3.2014(3)^^^StartfromSystemicAdjTherapy:FavorableHistologies3.2014^^^StartfromSystemicAdjTherapy:FavorableHistologies3.2014^^^StartfromSystemicAdjTherapy:HR+,HER2+3.2014^^^StartfromSystemicAdjTherapy:HR+,HER2+3.2014^^^StartfromSystemicAdjTherapy:HR+,HER23.2014^^^StartfromSystemicAdjTherapy:HR+,HER23.2014^^^StartfromSystemicAdjTherapy:HR,HER2+3.2014^^^StartfromSystemicAdjTherapy:HR,HER2+3.2014^^^StartfromSystemicAdjTherapy:HR,HER23.2014^^^StartfromSystemicAdjTherapy:HR,HER23.2014^^^Supraclavicularrecurrence^^^Supraclavicularrecurrence^^^SurgicalAxillaryStaging^^^SurgicalAxillaryStaging^^^SurgicalAxillaryStaging3.2014^^^SurgicalAxillaryStaging3.2014^^^Surgicalresection^^^Surgicalresection^^^Surgicalresection^^^Surgicalresection^^^Surgicalresection^^^Surgicalresection^^^SURGICALTREATMENT^^^SURGICALTREATMENT^^^SURGICALTREATMENT^^^SURGICALTREATMENT^^^Surgicaltreatment+/surgicalaxillarystaging+/reconstruction^^^Surgicaltreatment+/surgicalaxillarystaging+/reconstruction^^^Surgical/AdjuvantTreatment^^^Surgical/AdjuvantTreatment^^^Surgical/AdjuvantTreatment3.2014^^^Surgical/AdjuvantTreatment3.2014^^^Surveillance^^^SURVEILLANCE^^^Surveillance^^^Surveillance^^^SURVEILLANCE^^^Surveillance^^^Surveillance3.2014^^^Surveillance3.2014^^^Surveillance/Followup^^^Surveillance/Followup^^^SuspiciousCNSsymptoms^^^SuspiciousCNSsymptoms^^^Suspiciousnodes^^^Suspiciousnodes^^^Symptomaticvisceral^^^Symptomaticvisceral^^^Symptomaticvisceral^^^Symptomaticvisceral^^^Symptomaticvisceral^^^Symptomaticvisceral^^^Symptomaticvisceraldisease^^^Symptomaticvisceraldisease^^^SystemicAdjTherapy:FavorableHistologies^^^SystemicAdjTherapy:FavorableHistologies^^^SystemicAdjTherapy:FavorableHistologies3.2014^^^SystemicAdjTherapy:FavorableHistologies3.2014^^^SystemicAdjTherapy:HR+,HER2+^^^SystemicAdjTherapy:HR+,HER2+^^^SystemicAdjTherapy:HR+,HER2+3.2014^^^SystemicAdjTherapy:HR+,HER2+3.2014^^^SystemicAdjTherapy:HR+,HER2^^^SystemicAdjTherapy:HR+,HER2^^^SystemicAdjTherapy:HR+,HER23.2014^^^SystemicAdjTherapy:HR+,HER23.2014^^^SystemicAdjTherapy:HR,HER2+^^^SystemicAdjTherapy:HR,HER2+^^^SystemicAdjTherapy:HR,HER2+3.2014^^^SystemicAdjTherapy:HR,HER2+3.2014^^^SystemicAdjTherapy:HR,HER2^^^SystemicAdjTherapy:HR,HER2^^^SystemicAdjTherapy:HR,HER23.2014^^^SystemicAdjTherapy:HR,HER23.2014^^^Systemicdisease^^^Systemicdisease^^^Systemictherapy^^^Systemictherapy^^^SystemictherapytobestresponseHER2negative^^^SystemictherapytobestresponseHER2negative^^^SystemictherapytobestresponseHER2negative^^^SystemictherapytobestresponseHER2negative^^^SystemictherapytobestresponseHER2positive^^^SystemictherapytobestresponseHER2positive^^^SystemictherapytobestresponseHER2positive^^^SystemictherapytobestresponseHER2positive^^^SYSTEMICTREATMENT^^^SYSTEMICTREATMENT^^^T1orT2tumor1or2positivesentinellymphnodesBreastconservingtherapyWholebreastRTplannedNopreoperativechemotherapy^^^T1orT2tumor1or2positivesentinellymphnodesBreastconservingtherapyWholebreastRTplannedNopreoperativechemotherapy^^^T2Fulfillscriteriaforbreastconservingtherapyexceptforsize^^^T2Fulfillscriteriaforbreastconservingtherapyexceptforsize^^^T3Fulfillscriteriaforbreastconservingtherapyexceptforsize^^^T3Fulfillscriteriaforbreastconservingtherapyexceptforsize^^^TAC(docetaxel/doxorubicin/cyclophosphamide)^^^TAC(docetaxel/doxorubicin/cyclophosphamide)^^^TAC(docetaxel/doxorubicin/cyclophosphamide)^^^TAC(docetaxel/doxorubicin/cyclophosphamide)^^^Tamoxifenfor23y^^^Tamoxifenfor23y^^^Tamoxifenfor4.56y^^^Tamoxifenfor4.56y^^^Tamoxifenfor5y^^^Tamoxifenfor5y^^^Tamoxifenfor5y^^^Tamoxifenfor5y^^^Tamoxifenfor5y^^^Tamoxifenfor5y^^^Tamoxifenforanadditional5ytocomplete10yofendocrinetherapy^^^Tamoxifenforanadditional5ytocomplete10yofendocrinetherapy^^^Tamoxifenforanadditional5ytocomplete10yofendocrinetherapy^^^Tamoxifenforanadditional5ytocomplete10yofendocrinetherapy^^^Tamoxifenforanadditional5ytocomplete10yofendocrinetherapy^^^Tamoxifenforanadditional5ytocomplete10yofendocrinetherapy^^^Tamoxifenforupto10y^^^Tamoxifenforupto10y^^^Tamoxifentocomplete5yofendocrinetherapy^^^Tamoxifentocomplete5yofendocrinetherapy^^^TC(docetaxelandcyclophosphamide)^^^TC(docetaxelandcyclophosphamide)^^^TC(docetaxelandcyclophosphamide)^^^TC(docetaxelandcyclophosphamide)^^^TCH(docetaxel/carboplatin/trastuzumab)±pertuzumab^^^TCH(docetaxel/carboplatin/trastuzumab)±pertuzumab^^^TCH(docetaxel/carboplatin/trastuzumab)±pertuzumab^^^TCH(docetaxel/carboplatin/trastuzumab)±pertuzumab^^^TestwithalternativeISHchromosome17probe^^^TestwithalternativeISHchromosome17probe^^^Totalmastectomy^^^Totalmastectomy^^^Totalmastectomy^^^Totalmastectomy^^^Totalmastectomy^^^Totalmastectomy^^^Totalmastectomywith surgicalaxillarystaging^^^Totalmastectomywith surgicalaxillarystaging^^^Totalmastectomywith surgicalaxillarystaging^^^Totalmastectomywith surgicalaxillarystaging^^^Transitiontopalliativecare^^^Transitiontopalliativecare^^^Trastuzumab+capecitabine^^^Trastuzumab+capecitabine^^^Trastuzumab+capecitabine^^^Trastuzumab+capecitabine^^^Trastuzumab+docetaxel^^^Trastuzumab+docetaxel^^^Trastuzumab+lapatinib(withoutcytotoxictherapy)^^^Trastuzumab+lapatinib(withoutcytotoxictherapy)^^^Trastuzumab+otheragents^^^Trastuzumab+otheragents^^^Trastuzumab+paclitaxel^^^Trastuzumab+paclitaxel^^^Trastuzumab+paclitaxel+carboplatin^^^Trastuzumab+paclitaxel+carboplatin^^^Trastuzumab+vinorelbine^^^Trastuzumab+vinorelbine^^^Trastuzumabfor1year^^^Trastuzumabfor1year^^^Trastuzumabcontainingchemoregimen^^^Trastuzumabcontainingchemoregimen^^^Trastuzumabcontainingchemoregimen^^^Trastuzumabcontainingchemoregimen^^^Trastuzumabcontainingchemoregimen^^^Trastuzumabcontainingchemoregimen^^^Trastuzumabcontainingchemoregimen^^^Trastuzumabcontainingchemoregimen^^^Trastuzumabcontainingchemoregimen^^^Trastuzumabcontainingchemoregimen^^^Trastuzumabcontainingchemoregimen^^^Trastuzumabcontainingchemoregimen^^^Trastuzumabexposeddisease^^^Trastuzumabexposeddisease^^^Trastuzumab/chemo^^^Trastuzumab/chemo^^^TreatasHR,HER2^^^TreatasHR,HER2^^^TREATMENT^^^TREATMENT^^^TREATMENT^^^TREATMENT^^^TREATMENTRESPONSE^^^TREATMENTRESPONSE^^^Treat asHR,HER2+^^^Treat asHR,HER2+^^^Tubular^^^Tubular^^^Tubular^^^Tubular^^^Tumor0.61.0cm^^^Tumor0.61.0cm^^^Tumor0.61.0cm^^^Tumor0.61.0cm^^^Tumor0.61.0cm^^^Tumor0.61.0cm^^^Tumor>0.5cm^^^Tumor>0.5cm^^^Tumor>1cm^^^Tumor>1cm^^^Tumor>1cm^^^Tumor>1cm^^^Tumor>1cm^^^Tumor>1cm^^^Tumorisnottechnicallyresectable^^^Tumorisnottechnicallyresectable^^^Tumorisnottechnicallyresectable^^^Tumorisnottechnicallyresectable^^^Tumorisnottechnicallyresectable^^^Tumorisnottechnicallyresectable^^^Tumorisnottechnicallyresectable^^^Tumorisnottechnicallyresectable^^^Tumoristechnicallyresectable^^^Tumoristechnicallyresectable^^^Tumoristechnicallyresectable^^^Tumoristechnicallyresectable^^^Tumoristechnicallyresectable^^^Tumoristechnicallyresectable^^^Tumor≤0.5cm^^^Tumor≤0.5cm^^^Tumor≤0.5cm^^^Tumor≤0.5cm^^^Tumor≤0.5cm^^^Tumor≤0.5cm^^^Tumor≤0.5cm^^^Tumor≤0.5cm^^^Ultrasound^^^Ultrasound^^^Ultrasound^^^Ultrasound^^^Ultrasound^^^Ultrasound^^^Upto5yofaromataseinhibitor^^^Upto5yofaromataseinhibitor^^^ValidateddualprobeISHassay^^^ValidateddualprobeISHassay^^^ValidatedIHCassay^^^ValidatedIHCassay^^^ValidatedsingleprobeISHassay^^^ValidatedsingleprobeISHassay^^^Vinorelbine^^^Vinorelbine^^^Visceralcrisis^^^Visceralcrisis^^^workup^^^WORKUP^^^WORKUP^^^WORKUP^^^WORKUP^^^WORKUP^^^workup^^^WORKUP^^^WORKUP^^^WORKUP^^^WORKUP^^^WORKUP^^^Xraysofabnormalbones^^^Xraysofabnormalbones^^^Xraysofsymptomaticbones^^^Xraysofsymptomaticbones^^^Zoledronicacid^^^Zoledronicacid^^^≥3cm^^^≥3cm^^^≥4positiveaxillarynodes^^^≥4positiveaxillarynodes^^^≥4positiveaxillarynodes^^^≥4positiveaxillarynodes^^^≥5yearsaftertreatment^^^≥5yearsaftertreatment;12.9cm12.9cm13positiveaxillarynodes13positiveaxillarynodes13positiveaxillarynodes13positiveaxillarynodes21geneRTPCRassay21geneRTPCRassay<1cm<1cmAbdominalandpelvicdiagnosticCTAbdominalandpelvicdiagnosticCTAbdominalandpelvicdiagnosticCTAbdominalandpelvicdiagnosticCTAbdominalandpelvicdiagnosticCTAbdominalandpelvicdiagnosticCTAbdominalandpelvicdiagnosticCTAbdominalandpelvicdiagnosticCTAbdominalandpelvicdiagnosticMRIAbdominalandpelvicdiagnosticMRIAbdominalandpelvicdiagnosticMRIAbdominalandpelvicdiagnosticMRIAbdominalandpelvicdiagnosticMRIAbdominalandpelvicdiagnosticMRIAbdominalandpelvicdiagnosticMRIAbdominalandpelvicdiagnosticMRIAbdominalCTAbdominalCTAbdominalCTAbdominalCTAbdominalCTAbdominalCTAbdominalCTAbdominalCTAbdominalCTAbdominalCTAbdominalMRIAbdominalMRIAbdominalMRIAbdominalMRIAbdominalMRIAbdominalMRIAbdominalMRIAbdominalMRIAbdominalMRIAbdominalMRIAbdominalorpelvicdiagnosticCTAbdominalorpelvicdiagnosticCTAbdominalorpelvicdiagnosticMRIAbdominalorpelvicdiagnosticMRIAbdominalsymptomsAbdominalsymptomsAbnormalliverfunctiontestsAbnormalliverfunctiontestsAbnormallongandweightbearingbonesfoundAbnormallongandweightbearingbonesfoundAbnormalphysicalexaminationoftheabdomenAbnormalphysicalexaminationoftheabdomenAbnormalphysicalexaminationofthepelvisAbnormalphysicalexaminationofthepelvisAC(doxorubicin/cyclophosphamide)AC(doxorubicin/cyclophosphamide)AC(doxorubicin/cyclophosphamide)every3weeksAC(doxorubicin/cyclophosphamide)every3weeksAC(doxorubicin/cyclophosphamide)every3weeksAC(doxorubicin/cyclophosphamide)every3weeksACfollowedbydocetaxel+trastuzumab±pertuzumabACfollowedbydocetaxel+trastuzumab±pertuzumabACfollowedbydocetaxel+trastuzumab±pertuzumabACfollowedbydocetaxel+trastuzumab±pertuzumabACfollowedbydocetaxelevery3weeksACfollowedbydocetaxelevery3weeksACfollowedbydocetaxelevery3weeksACfollowedbydocetaxelevery3weeksACfollowedbyT+trastuzumab±pertuzumab(doxorubicin/cyclophosphamidefollowedbypaclitaxelplustrastuzumab± pertuzumabvariousschedules)ACfollowedbyT+trastuzumab±pertuzumab(doxorubicin/cyclophosphamidefollowedbypaclitaxelplustrastuzumab± pertuzumabvariousschedules)ACfollowedbyT+trastuzumab±pertuzumab(doxorubicin/cyclophosphamidefollowedbypaclitaxelplustrastuzumab± pertuzumabvariousschedules)ACfollowedbyT+trastuzumab±pertuzumab(doxorubicin/cyclophosphamidefollowedbypaclitaxelplustrastuzumab± pertuzumabvariousschedules)ACfollowedbyweeklypaclitaxelACfollowedbyweeklypaclitaxelACfollowedbyweeklypaclitaxelACfollowedbyweeklypaclitaxelAcuteLymphoblasticLeukemiaAcuteLymphoblasticLeukemiaAcuteLymphoblasticLeukemiatestAcuteLymphoblasticLeukemiatestAdditionallineofendocrinetherapyAdditionallineofendocrinetherapyAdditionallineofendocrinetherapyAdditionallineofendocrinetherapyAdditionallineofendocrinetherapyAdditionallineofendocrinetherapyAdditionallineofendocrinetherapyAdditionallineofendocrinetherapyAdditionalsystemicchemotherapyHER2+AdditionalsystemicchemotherapyHER2+AdditionalsystemicchemotherapyHER2negativeAdditionalsystemicchemotherapyHER2negativeADDITIONALTESTINGADDITIONALTESTINGadjuvantchemotherapyAdjuvantchemotherapyAdjuvantchemotherapyAdjuvantchemotherapyAdjuvantchemotherapyAdjuvantchemotherapyAdjuvantchemotherapyadjuvantchemotherapyAdjuvantchemotherapyAdjuvantchemotherapyAdjuvantchemotherapyAdjuvantchemotherapyAdjuvantchemotherapyAdjuvantchemotherapyAdjuvantEndocrineTherapyAdjuvantendocrinetherapyAdjuvantendocrinetherapyAdjuvantendocrinetherapyAdjuvantendocrinetherapyAdjuvantendocrinetherapyAdjuvantendocrinetherapyAdjuvantendocrinetherapyAdjuvantendocrinetherapyAdjuvantendocrinetherapyAdjuvantendocrinetherapyAdjuvantendocrinetherapyAdjuvantendocrinetherapyAdjuvantendocrinetherapyAdjuvantendocrinetherapyAdjuvantendocrinetherapyAdjuvantEndocrineTherapyAdjuvantendocrinetherapyAdjuvantendocrinetherapyAdjuvantendocrinetherapyAdjuvantendocrinetherapyAdjuvantEndocrineTherapyAdjuvantendocrinetherapyAdjuvantendocrinetherapyAdjuvantendocrinetherapyAdjuvantendocrinetherapyAdjuvantendocrinetherapyAdjuvantendocrinetherapyAdjuvantendocrinetherapyAdjuvantendocrinetherapyAdjuvantendocrinetherapyAdjuvantendocrinetherapyAdjuvantendocrinetherapyAdjuvantendocrinetherapyAdjuvantendocrinetherapyAdjuvantendocrinetherapyAdjuvantendocrinetherapyAdjuvantEndocrineTherapyAdjuvantendocrinetherapyAdjuvantendocrinetherapyAdjuvantendocrinetherapyAdjuvantendocrinetherapyAdjuvantendocrinetherapyforriskreductionAdjuvantendocrinetherapyforriskreductionAdjuvantEndocrineTherapy3.2014AdjuvantEndocrineTherapy3.2014AdjuvantsettingAdjuvantsettingAdjuvantsettingNodenegativeTumor≥1cm AdjuvantsettingNodenegativeTumor≥1cm AdjuvantsettingNodepositiveAdjuvantsettingNodepositiveADJUVANTTREATMENTADJUVANTTREATMENTADJUVANTTREATMENTADJUVANTTREATMENTADJUVANTTREATMENTADJUVANTTREATMENTADJUVANTTREATMENTADJUVANTTREATMENTADJUVANTTREATMENTADJUVANTTREATMENTADJUVANTTREATMENTADJUVANTTREATMENTADJUVANTTREATMENTADJUVANTTREATMENTADJUVANTTREATMENTADJUVANTTREATMENTADJUVANTTREATMENTADJUVANTTREATMENTADJUVANTTREATMENTADJUVANTTREATMENTAdjuvant chemotherapyAdjuvant chemotherapyAdotrastuzumabemtansine(TDM1)Adotrastuzumabemtansine(TDM1)Adotrastuzumabemtansine(TDM1)Adotrastuzumabemtansine(TDM1)AlbuminboundpaclitaxelAlbuminboundpaclitaxelAnnualgynecologicassessmentevery12monthsAnnualgynecologicassessmentevery12monthsAromataseinhibitorAromataseinhibitorAromataseinhibitorfor23yAromataseinhibitorfor23yAromataseinhibitorfor5yAromataseinhibitorfor5yAromataseinhibitorfor5yAromataseinhibitorfor5yAromataseinhibitorfor5yAromataseinhibitorfor5yAromataseinhibitorfor5yAromataseinhibitorfor5yAromataseinhibitortocomplete5yofendocrinetherapyAromataseinhibitortocomplete5yofendocrinetherapyASSAYASSAYAssaynotdoneAssaynotdoneAssessandencourageadherencetoadjuvantendocrinetherapyAssessandencourageadherencetoadjuvantendocrinetherapyAssessfordistressAssessfordistressAssessfordistressAssessfordistressAssessfordistressAssessfordistressAsymptomaticvisceralAsymptomaticvisceralAsymptomaticvisceralAsymptomaticvisceralAverageHER2copynumber<4.0signals/cellAverageHER2copynumber<4.0signals/cellAverageHER2copynumber<4.0signals/cellAverageHER2copynumber<4.0signals/cellAverageHER2copynumber<4.0signals/cellAverageHER2copynumber<4.0signals/cellAverageHER2copynumber≥4.0and<6.0signals/cellAverageHER2copynumber≥4.0and<6.0signals/cellAverageHER2copynumber≥4.0and<6.0signals/cellAverageHER2copynumber≥4.0and<6.0signals/cellAverageHER2copynumber≥4.0signals/cellAverageHER2copynumber≥4.0signals/cellAverageHER2copynumber≥6.0signals/cellAverageHER2copynumber≥6.0signals/cellAverageHER2copynumber≥6.0signals/cellAverageHER2copynumber≥6.0signals/cellAxillarydissectionlevelI/IIAxillarydissectionlevelI/IIAxillarydissectionlevelI/IIAxillarydissectionlevelI/IIAxillaryimagingwithultrasoundAxillaryimagingwithultrasoundAxillarylymphnodedissectionAxillarylymphnodedissectionAxillarylymphnodedissectionAxillarylymphnodedissectionAxillarylymphnodedissectionAxillarylymphnodedissectionAxillarylymphnodedissectionAxillarylymphnodedissectionAxillarylymphnodestagingAxillarylymphnodestagingAxillaryradiationforregionalcontrolofdiseaseAxillaryradiationforregionalcontrolofdiseaseAxillaryrecurrenceAxillaryrecurrenceBiopsyoffirstrecurrenceofdiseaseBiopsyoffirstrecurrenceofdiseaseBonediseasenotpresentBonediseasenotpresentBonediseasepresentBonediseasepresentBoneonlyBoneonlyBoneonlyBoneonlyBonescanBonescanBonescanBonescanBonescanBonescanBonescanBonescanBonescanBonescanBonescan forsystemicstagingBonescan forsystemicstagingBonescan forsystemicstagingBonescan forsystemicstagingBrainMRIBrainMRIBreastMRIBreastMRIBreastMRIBreastMRIBreastMRIBreastMRIBreastreconstructionBreastreconstructionCAF/FAC(cyclophosphamide/doxorubicin/fluorouracil)CAF/FAC(cyclophosphamide/doxorubicin/fluorouracil)CapecitabineCapecitabineCarboplatinCarboplatinCBCCBCCBCCBCCBCCBCCBCCBCCBCCBCChemoindicatedChemoindicatedChemoindicatedChemoindicatedChemoindicatedChemoindicatedChemoindicatedChemoindicatedChemoindicatedChemoindicatedChemoindicatedChemoindicatedChemoindicatedChemoindicatedChemoindicatedPostmastectomyradiationtobedoneChemoindicatedPostmastectomyradiationtobedoneChemotherapyChemotherapyChemotherapyforRecurrentorMetastaticBreastCancerChemotherapyforRecurrentorMetastaticBreastCancerChemotherapyforRecurrentorMetastaticBreastCancer:HER2positiveChemotherapyforRecurrentorMetastaticBreastCancer:HER2positiveChemotherapyforrecurrent/metastaticdiseaseChemotherapyforrecurrent/metastaticdiseaseChemotherapy:Recurrent/MetastaticChemotherapy:Recurrent/MetastaticChemotherapy:Recurrent/MetastaticHER2+Chemotherapy:Recurrent/MetastaticHER2+Chemotherapy:Recurrent/MetastaticHER2+3.2014Chemotherapy:Recurrent/MetastaticHER2+3.2014Chemotherapy:Recurrent/Metastatic3.2014Chemotherapy:Recurrent/Metastatic3.2014ChestdiagnosticCTChestdiagnosticCTChestdiagnosticCTChestdiagnosticCTChestdiagnosticCTChestdiagnosticCTChest diagnosticCTChest diagnosticCTChest diagnosticCTChest diagnosticCTCisplatinCisplatinCLINICALPRESENTATIONCLINICALPRESENTATIONCLINICALPRESENTATIONCLINICALPRESENTATIONCLINICALPRESENTATIONCLINICALPRESENTATIONCLINICALPRESENTATIONCLINICALPRESENTATIONCLINICALPRESENTATIONCLINICALPRESENTATIONCLINICALPRESENTATIONCLINICALPRESENTATIONCLINICALPRESENTATIONCLINICALPRESENTATIONCLINICALPRESENTATIONCLINICALPRESENTATIONCLINICALPRESENTATIONCLINICALPRESENTATIONCLINICALPRESENTATIONCLINICALPRESENTATIONCLINICALPRESENTATIONCLINICALPRESENTATIONCLINICALPRESENTATIONCLINICALPRESENTATIONCLINICALPRESENTATIONCLINICALPRESENTATIONClinicalStageIIAT0N1M0T1N1M0T2N0M0ClinicalStageIIAT0N1M0T1N1M0T2N0M0ClinicalStageIIAT0N1M0T1N1M0T2N0M0ClinicalStageIIAT0N1M0T1N1M0T2N0M0ClinicalStageIIBT2N1M0T3N0M0ClinicalStageIIBT2N1M0T3N0M0ClinicalStageIIBT2N1M0T3N0M0ClinicalStageIIBT2N1M0T3N0M0ClinicalStageIIIAT3N1M0ClinicalStageIIIAT3N1M0ClinicalStageIIIAT3N1M0ClinicalStageIIIAT3N1M0ClinicalStageIT1N0M0ClinicalStageIT1N0M0ClinicalStageIT1N0M0ClinicalStageIT1N0M0ClinicallynegativeaxillaeUndergoingmastectomyRTisplannedClinicallynegativeaxillaeUndergoingmastectomyRTisplannedClinicallynegativeipsilateralaxillarylymphnode(s)Clinicallynegativeipsilateralaxillarylymphnode(s)Clinicallynegativeipsilateralaxillarylymphnodes(duringinitialworkup)andipsilaterialaxillarylymphnodeFNAorcorebiopsypositive(priortopreoperativesystemictherapy)Clinicallynegativeipsilateralaxillarylymphnodes(duringinitialworkup)andipsilaterialaxillarylymphnodeFNAorcorebiopsypositive(priortopreoperativesystemictherapy)Clinicallynegativeipsilateralaxillarylymphnodes(duringinitialworkup)andipsilaterialaxillarylymphnodeFNAorcorebiopsypositive (priortopreoperativesystemictherapy)Clinicallynegativeipsilateralaxillarylymphnodes(duringinitialworkup)andipsilaterialaxillarylymphnodeFNAorcorebiopsypositive (priortopreoperativesystemictherapy)ClinicallynodenegativeattimeofdiagnosisClinicallynodenegativeattimeofdiagnosisClinicallynodepositiveattimeofdiagnosisClinicallynodepositiveattimeofdiagnosisClinicallypositiveipsilateralaxillarylymphnode(s)Clinicallypositiveipsilateralaxillarylymphnode(s)Clinicallypositiveipsilateralaxillarylymphnodes(duringinitialworkup)andipsilaterialaxillarylymphnodeFNAorcorebiopsypositive (priortopreoperativesystemictherapy)Clinicallypositiveipsilateralaxillarylymphnodes(duringinitialworkup)andipsilaterialaxillarylymphnodeFNAorcorebiopsypositive (priortopreoperativesystemictherapy)Clinicallypositiveipsilateralaxillarylymphnodes(duringinitialworkup)andipsilaterialaxillarylymphnodeFNAorcorebiopsypositive (priortopreoperativesystemictherapy)Clinicallypositiveipsilateralaxillarylymphnodes(duringinitialworkup)andipsilaterialaxillarylymphnodeFNAorcorebiopsypositive (priortopreoperativesystemictherapy)CMF(cyclophosphamide/methotrexate/fluorouracil)CMF(cyclophosphamide/methotrexate/fluorouracil)CMF(cyclophosphamide/methotrexate/fluorouracil)CMF(cyclophosphamide/methotrexate/fluorouracil)CMF(cyclophosphamide/methotrexate/fluorouracil)CMF(cyclophosphamide/methotrexate/fluorouracil)CompleteresponseCompleteresponseCompleteuptooneyearoftrastuzumabcontainingchemotherapyCompleteuptooneyearoftrastuzumabcontainingchemotherapyConfirmedprogressivediseaseatanytimeConfirmedprogressivediseaseatanytimeContinueendocrinetherapyuntildevelopmentofunacceptabletoxicityContinueendocrinetherapyuntildevelopmentofunacceptabletoxicityContinueendocrinetherapyuntildiseaseprogressionorunacceptabletoxicityContinueendocrinetherapyuntildiseaseprogressionorunacceptabletoxicityContinueendocrinetherapyuntilprogressionContinueendocrinetherapyuntilprogressionContinueHER2targetedtherapyContinueHER2targetedtherapyContraindicationtoaromataseinhibitorsContraindicationtoaromataseinhibitorsCorebiopsyofbreastwithimagedetectablemarker(s)Corebiopsyofbreastwithimagedetectablemarker(s)CorebiopsyoflymphnodenegativeCorebiopsyoflymphnodenegativeCorebiopsyoflymphnodepositiveCorebiopsyoflymphnodepositiveCorebiopsyoflymphnodepositiveCorebiopsyoflymphnodepositiveCorebiospypositiveCorebiospypositiveCorebiospy negativeCorebiospy negativeCounselingforfertilityconcernsCounselingforfertilityconcernsCyclophosphamideCyclophosphamideDenovostageIVDenovostageIVDecline aromataseinhibitorsDecline aromataseinhibitorsDenosumabDenosumabDeterminationofER/PRstatusDeterminationofER/PRstatusDeterminationofER/PRstatusDeterminationofER/PRstatusDeterminationofER/PRstatusonmetastaticsiteDeterminationofER/PRstatusonmetastaticsiteDeterminationofHER2statusDeterminationofHER2statusDeterminationofHER2statusDeterminationofHER2statusDeterminationofHER2statusonmetastaticsiteDeterminationofHER2statusonmetastaticsiteDeterminationofHER2 statusDeterminationofHER2 statusDeterminationoftumorestrogen/progesteronereceptor(ER/PR)statusDeterminationoftumorestrogen/progesteronereceptor(ER/PR)statusDiagnosticbilateralmammogramDiagnosticbilateralmammogramDiagnosticbilateralmammogramDiagnosticbilateralmammogramDiagnosticbilateralmammogramDiagnosticbilateralmammogramDiagnosticCTforsystemicstagingDiagnosticCTforsystemicstagingDiagnosticCTforsystemicstagingDiagnosticCTforsystemicstagingDocetaxelDocetaxelDocetaxel+cyclophosphamide+trastuzumabDocetaxel+cyclophosphamide+trastuzumabDocetaxel+cyclophosphamide+trastuzumabDocetaxel+cyclophosphamide+trastuzumabDocetaxel/capecitabineDocetaxel/capecitabineDoesNOTmeetallofthefollowing:T1orT2tumor1or2positivesentinellymphnodesBreastconservingtherapyWholebreastRTplannedNopreoperativechemotherapyDoesNOTmeetallofthefollowing:T1orT2tumor1or2positivesentinellymphnodesBreastconservingtherapyWholebreastRTplannedNopreoperativechemotherapyDosedenseAC(doxorubicin/cyclophosphamide)DosedenseAC(doxorubicin/cyclophosphamide)DosedenseAC(doxorubicin/cyclophosphamide)DosedenseAC(doxorubicin/cyclophosphamide)DosedenseAC(doxorubicin/cyclophosphamide)followedby paclitaxelevery2weeksDosedenseAC(doxorubicin/cyclophosphamide)followedby paclitaxelevery2weeksDosedenseAC(doxorubicin/cyclophosphamide)followedby paclitaxelevery2weeksDosedenseAC(doxorubicin/cyclophosphamide)followedby paclitaxelevery2weeksDosedenseAC(doxorubicin/cyclophosphamide)followedby weeklypaclitaxelDosedenseAC(doxorubicin/cyclophosphamide)followedby weeklypaclitaxelDosedenseAC(doxorubicin/cyclophosphamide)followedby weeklypaclitaxelDosedenseAC(doxorubicin/cyclophosphamide)followedby weeklypaclitaxelDoxorubicinDoxorubicinDuctalDuctalDuctalDuctalDuctalDuctalDuctalDuctalDuctalDuctalEC(epirubicin/cyclophosphamide)EC(epirubicin/cyclophosphamide)EC(epirubicin/cyclophosphamide)EC(epirubicin/cyclophosphamide)EC(epirubicin/cyclophosphamide)EC(epirubicin/cyclophosphamide)ECOGperformancestatus≥3ECOGperformancestatus≥3EducatemonitorandreferforlymphedemamanagementEducatemonitorandreferforlymphedemamanagementEducationandcounselingregardinganactivelifestylehealthydietlimitedalcoholintakeandachievingandmaintinganidealbodyweight(2025BMI)Educationandcounselingregardinganactivelifestylehealthydietlimitedalcoholintakeandachievingandmaintinganidealbodyweight(2025BMI)ElevatedalkalinephosphataseElevatedalkalinephosphataseElevatedalkalinephosphataseElevatedalkalinephosphataseEndocrinetherapyEndocrinetherapyEndocrinetherapyaloneEndocrinetherapyaloneEndocrinetherapyaloneEndocrinetherapyaloneEndocrinetherapyaloneEndocrinetherapyaloneEndocrinetherapyaloneEndocrinetherapyaloneEndocrinetherapyasforpostmenopausalEndocrinetherapyasforpostmenopausalEndocrinetherapyasforpostmenopausalEndocrinetherapyasforpostmenopausalEndocrinetreatmentEndocrinetreatmentEpirubicinEpirubicinEquivocalresultEquivocalresultEquivocalresultEquivocalresultEquivocalresultEquivocalresultERnegativePRnegativeERnegativePRnegativeERpositiveERpositiveERnegativePRnegativeERnegativePRnegativeERnegativePRnegativeERnegativePRnegativeERpositiveERpositiveERpositiveERpositiveEribulinEribulinFACfollowedbyT (fluorouracil/doxorubicin/cyclophosphamidefollowedbyweeklypaclitaxel)FACfollowedbyT (fluorouracil/doxorubicin/cyclophosphamidefollowedbyweeklypaclitaxel)FACfollowedbyT (fluorouracil/doxorubicin/cyclophosphamidefollowedbyweeklypaclitaxel)FACfollowedbyT (fluorouracil/doxorubicin/cyclophosphamidefollowedbyweeklypaclitaxel)FDGPET/CTFDGPET/CTFDGPET/CTFDGPET/CTFDGPET/CTFDGPET/CTFDGPET/CTFDGPET/CTFDGPET/CTFDGPET/CTFDGPET/CTFDGPET/CTFEC(fluorouracil/epirubicin/cyclophosphamide)FEC(fluorouracil/epirubicin/cyclophosphamide)FECfollowedbydocetaxel+trastuzumab+pertuzumabFECfollowedbydocetaxel+trastuzumab+pertuzumabFECfollowedbydocetaxel+trastuzumab+pertuzumabFECfollowedbydocetaxel+trastuzumab+pertuzumabFECfollowedbypaclitaxel+trastuzumab+pertuzumabFECfollowedbypaclitaxel+trastuzumab+pertuzumabFECfollowedbypaclitaxel+trastuzumab+pertuzumabFECfollowedbypaclitaxel+trastuzumab+pertuzumabFEC/CEFfollowedbyT(fluorouracil/epirubicin/cyclophosphamidefollowedbydocetaxel)FEC/CEFfollowedbyT(fluorouracil/epirubicin/cyclophosphamidefollowedbydocetaxel)FEC/CEFfollowedbyT(fluorouracil/epirubicin/cyclophosphamidefollowedbydocetaxel)FEC/CEFfollowedbyT(fluorouracil/epirubicin/cyclophosphamidefollowedbydocetaxel)FEC/CEFfollowedbyT(fluorouracil/epirubicin/cyclophosphamidefollowedbyweeklypaclitaxel)FEC/CEFfollowedbyT(fluorouracil/epirubicin/cyclophosphamidefollowedbyweeklypaclitaxel)FEC/CEFfollowedbyT(fluorouracil/epirubicin/cyclophosphamidefollowedbyweeklypaclitaxel)FEC/CEFfollowedbyT(fluorouracil/epirubicin/cyclophosphamidefollowedbyweeklypaclitaxel)FertilitycounselingFertilitycounselingFertilitycounselingFertilitycounselingFINDINGSFINDINGSFINDINGSFINDINGSFinishFinishFinishFinishFinishFinishFinishFinishFinishFinishFinishFinishFinishFinishFinishFinishFinishFinishFinishFinishFinishFinishFinishFinishFinishFinishFinishFinishFinishFinishFinishFinishFinishFinishFinishFinishFinishFinishFinishFinishFinishFinishFirst5yearsaftertreatmentFirst5yearsaftertreatmentFNAnegativeFNAnegativeFNApositiveFNApositiveFulfillscriteriaforbreastconservingsurgeryexceptfortumorsizeFulfillscriteriaforbreastconservingsurgeryexceptfortumorsizeGemcitabineGemcitabineGemcitabine/carboplatinGemcitabine/carboplatinGeneticcounselingGeneticcounselingGeneticcounselingGeneticcounselingGeneticcounselingGeneticcounselingGeneticcounselingGeneticcounselingGT(gemcitabine/paclitaxel)GT(gemcitabine/paclitaxel)H&PH&PH&PH&PH&PH&PH&P14timesperyearasclinicallyappropriateH&P14timesperyearasclinicallyappropriateH&P annuallyH&P annuallyHER2negativeHER2negativeHER2negativeadjuvant chemotherapyHER2negativeadjuvant chemotherapyHER2negativeadjuvant chemotherapyHER2negativeadjuvant chemotherapyHER2negativepreoperativechemotherapyHER2negativepreoperativechemotherapyHER2negativepreoperativechemotherapyHER2negativepreoperativechemotherapyHER2negativepreoperativechemotherapyHER2negativepreoperativechemotherapyHER2negativepreoperativechemotherapyHER2negativepreoperativechemotherapyHER2negativepreoperativechemotherapyHER2negativepreoperativechemotherapyHER2negativepreoperativechemotherapyHER2negativepreoperativechemotherapyHER2negativepreoperativechemotherapyHER2negativepreoperativechemotherapyHER2negativepreoperativechemotherapyHER2negativepreoperativechemotherapyHER2negativepreoperativechemotherapyHER2negativepreoperativechemotherapyHER2negativepreoperativechemotherapyHER2negativepreoperativechemotherapyHER2positiveHER2positiveHER2positiveadjuvant chemotherapyHER2positiveadjuvant chemotherapyHER2positivepreoperativechemowithtrastuzumabHER2positivepreoperativechemowithtrastuzumabHER2positivepreoperativechemotherapyHER2positivepreoperativechemotherapyHER2positivepreoperativechemotherapyHER2positivepreoperativechemotherapyHER2positivepreoperativechemotherapyHER2positivepreoperativechemotherapyHER2positivepreoperativechemotherapyHER2positivepreoperativechemotherapyHER2positivepreoperativechemotherapyHER2positivepreoperativechemotherapyHER2positivepreoperativechemotherapyHER2positivepreoperativechemotherapyHER2positivepreoperativechemotherapyHER2positivepreoperativechemotherapyHER2positivepreoperativechemotherapyHER2positivepreoperativechemotherapyHER2positivepreoperativechemotherapywithtrastuzumabHER2positivepreoperativechemotherapywithtrastuzumabHER2testingHER2testingHER2testing3.2014HER2testing3.2014HER2+HER2+HER2+HER2+HER2HER2HER2negativeHER2negativeHER2negativeHER2negativeHER2negativediseaseHER2negativediseaseHER2positiveHER2positiveHER2positiveHER2positiveHER2positiveHER2positiveHER2positivediseaseHER2positivediseaseHER2targetedchemotherapyHER2targetedchemotherapyHER2/CEP17ratio<2.0HER2/CEP17ratio<2.0HER2/CEP17ratio≥2.0HER2/CEP17ratio≥2.0Highrecurrencescore(≥31)Highrecurrencescore(≥31)HISTOLOGYHISTOLOGYHISTOLOGYHISTOLOGYHISTOLOGYHISTOLOGYHISTOLOGYHISTOLOGYHISTOLOGYHISTOLOGYHistory&physicalHistory&physicalHRnegativeHER2negativeHRnegativeHER2negativeHRnegativeHER2negativeHRnegativeHER2negativeHRnegativeHER2positiveHRnegativeHER2positiveHRpositiveHRpositiveHRpositiveendocrinerefractoryHER2negativeHRpositiveendocrinerefractoryHER2negativeHRpositiveendocrinerefractoryHER2negativeHRpositiveendocrinerefractoryHER2negativeHRpositiveendocrinerefractoryHER2positiveHRpositiveendocrinerefractoryHER2positiveHRpositiveendocrinerefractoryHER2positiveHRpositiveendocrinerefractoryHER2positiveHRpositiveHER2negativeHRpositiveHER2negativeHRpositiveHER2+HRpositiveHER2+HRpositiveHER2negativeHRpositiveHER2negativeHRpositiveHER2positiveHRpositiveHER2positiveIHC01+IHC01+IHC2+IHC2+IHC3+IHC3+ImagingstudiesformetastasesscreeningImagingstudiesformetastasesscreeningIndicationsforradiationtherapyIndicationsforradiationtherapyIndicationsforradiationtherapyIndicationsforradiationtherapyIndividualizedtreatmentIndividualizedtreatmentInitialtreatmentwithlumpectomyRadiationtherapyInitialtreatmentwithlumpectomyRadiationtherapyInitialtreatmentwithmastectomyLevelI/IIaxillarydissectionPriorradiationtherapyInitialtreatmentwithmastectomyLevelI/IIaxillarydissectionPriorradiationtherapyInitialtreatmentwith mastectomyNopriorradiationtherapyInitialtreatmentwith mastectomyNopriorradiationtherapyInoperable/LocallyAdvanced(StageIII)Inoperable/LocallyAdvanced(StageIII)Inoperable/LocallyAdvanced(StageIII)3.2014Inoperable/LocallyAdvanced(StageIII)3.2014Intermediaterecurrencescore(1830)Intermediaterecurrencescore(1830)InternalmammarynoderecurrenceInternalmammarynoderecurrenceIntolerantofaromataseinhibitorsIntolerantofaromataseinhibitorsInvasiveBreastCancerInvasiveBreastCancerInvasiveBreastCancer2.2016InvasiveBreastCancer2.2016IpsilateralaxillarylymphnodeFNAnegativeIpsilateralaxillarylymphnodeFNAnegativeIpsilateralaxillarylymphnodeFNApositiveIpsilateralaxillarylymphnodeFNApositiveIpsilateralaxillarylymphnodeFNApositiveIpsilateralaxillarylymphnodeFNApositiveISHnegativeISHnegativeISHnegativeISHnegativeISHpositiveISHpositiveISHpositiveISHpositiveISHpositiveISHpositiveISHpositiveISHpositiveIxabepiloneIxabepiloneLaboratorystudiesformetastasesscreeningLaboratorystudiesformetastasesscreeningLapatinib+capecitabineLapatinib+capecitabineLevelI/IIaxillarydissectionLevelI/IIaxillarydissectionLevelI/IIaxillarydissectionLevelI/IIaxillarydissectionLevelI/IIaxillarydissectionLevelI/IIaxillarydissectionLevelI/IIaxillarydissectionnotpreviouslydoneLevelI/IIaxillarydissectionnotpreviouslydoneLiverfunctiontestsalkalinephosphataseLiverfunctiontestsalkalinephosphataseLiverfunctiontestsalkalinephosphataseLiverfunctiontestsalkalinephosphataseLiverfunctiontestsalkalinephosphataseLiverfunctiontestsalkalinephosphataseLiverfunctiontestsalkalinephosphataseLiverfunctiontestsalkalinephosphataseLiverfunctiontestsalkalinephosphataseLiverfunctiontestsalkalinephosphataseLobularLobularLobularLobularLobularLobularLobularLobularLobularLobularLocalandregionalrecurrenceLocalandregionalrecurrenceLocalonlyrecurrenceLocalonlyrecurrenceLocalizedbonepainLocalizedbonepainLOCOREGIONALTREATMENTLOCOREGIONALTREATMENTLocoregionalTreatment:IIIAIIBIIIA(T3N1M0only)LocoregionalTreatment:IIIAIIBIIIA(T3N1M0only)LocoregionalTreatment:IIIAIIBIIIA(T3N1M0only)3.2014LocoregionalTreatment:IIIAIIBIIIA(T3N1M0only)3.2014Lowrecurrencescore(<18)Lowrecurrencescore(<18)LowriskstageILowriskstageILowriskstageILowriskstageILumpectomyLumpectomyLumpectomyLumpectomyLumpectomyLumpectomyLumpectomy(omitaxillarystaging)Lumpectomy(omitaxillarystaging)LumpectomywithsurgicalaxillarystagingLumpectomywithsurgicalaxillarystagingLymphnodestatusattimeofdiagnosisLymphnodestatusattimeofdiagnosisMammographyevery12monthsMammographyevery12monthsMarginspositiveMarginspositiveMastectomy(omitaxillarystaging)+/reconstructionMastectomy(omitaxillarystaging)+/reconstructionMastectomy+/reconstructionMastectomy+/reconstructionMastectomy+/reconstructionMastectomy+/reconstructionMetaplasticMetaplasticMetaplasticMetaplasticMetaplasticMetaplasticMetaplasticMetaplasticMetaplasticMetaplasticMetastaticbreastcancerMetastaticbreastcancerMetastatic HER2positivediseaseMetastatic HER2positivediseaseMicroinvasiveMicroinvasiveMicroinvasiveMicroinvasiveMicroinvasiveMicroinvasiveMicroinvasiveMicroinvasiveMixedMixedMixedMixedMixedMixedMixedMixedMixedMixedMonitoringofbonehealthwithabonemineraldensitydeterminationatbaselineandperiodicallythereafterMonitoringofbonehealthwithabonemineraldensitydeterminationatbaselineandperiodicallythereafterMucinousMucinousMucinousMucinousNegative axillarynodesNegative axillarynodesNegative axillarynodesTumor>5cmNegative axillarynodesTumor>5cmNegative axillarynodesTumor≤5cmMargins≥1mmNegative axillarynodesTumor≤5cmMargins≥1mmNegative axillarynodesTumor≤5cmNegativemarginsbut<1mmNegative axillarynodesTumor≤5cmNegativemarginsbut<1mmNewspecimenavailableNewspecimenavailableNewspecimenavailableNewspecimenavailableNewspecimenavailableNewspecimenavailableNoadjuvanttherapyNoadjuvanttherapyNobenefitafter3sequentiallinesofchemotherapyNobenefitafter3sequentiallinesofchemotherapyNoclinicalbenefitafter3sequentialendocrinetherapiesNoclinicalbenefitafter3sequentialendocrinetherapiesNoclinicalsignsorsymptomssuggestiveofrecurrentdiseaseNoclinicalsignsorsymptomssuggestiveofrecurrentdiseaseNofurtheraxillarysurgeryNofurtheraxillarysurgeryNofurtheraxillarysurgeryNofurtheraxillarysurgeryNofurthercytotoxictherapyNofurthercytotoxictherapyNofurtherendocrinetherapyNofurtherendocrinetherapyNopriorendocrinetherapywithin1yearNopriorendocrinetherapywithin1yearNoradiationtherapyNoradiationtherapyNoresponseNoresponseNoresponseNoresponseNosymptomaticvisceraldiseaseNosymptomaticvisceraldiseaseNosymptomaticvisceraldiseaseNosymptomaticvisceraldiseaseNodepositive(oneormoremetastases>2mmtooneormoreipsilateralaxillarylymphnodes)Nodepositive(oneormoremetastases>2mmtooneormoreipsilateralaxillarylymphnodes)Nodepositive(oneormoremetastases>2mmtooneormoreipsilateralaxillarylymphnodes)Nodepositive(oneormoremetastases>2mmtooneormoreipsilateralaxillarylymphnodes)Nodepositive(oneormoremetastases>2mmtooneormoreipsilateralaxillarylymphnodes)Nodepositive(oneormoremetastases>2mmtooneormoreipsilateralaxillarylymphnodes)Nodepositive(oneormoremetastases>2mmtooneormoreipsilateralaxillarylymphnodes)Nodepositive(oneormoremetastases>2mmtooneormoreipsilateralaxillarylymphnodes)Nodepositive(oneormoremetastases>2mmtooneormoreipsilateralaxillarylymphnodes)Nodepositive(oneormoremetastases>2mmtooneormoreipsilateralaxillarylymphnodes)NotcompletedpreoperativelyNotcompletedpreoperativelyNoteligibleforotherstandardadjuvantregimensduetocomorbiditiesNoteligibleforotherstandardadjuvantregimensduetocomorbiditiesNoteligibleforotherstandardadjuvantregimensduetocomorbiditiesNoteligibleforotherstandardadjuvantregimensduetocomorbiditiesNotendocrinerefractoryNotendocrinerefractoryNotendocrinerefractoryNotendocrinerefractoryOrdernewtestwithIHCOrdernewtestwithIHCOrdernewtestwithIHCOrdernewtestwithIHCOrdernewtestwithIHCOrdernewtestwithIHCOrdernewtestwithISHOrdernewtestwithISHOrdernewtestwithISHOrdernewtestwithISHOrdernewtestwithISHOrdernewtestwithISHOvarianablationOvarianablationOvarianablationOvarianablationOvarianfailuresecondarytotreatmentOvarianfailuresecondarytotreatmentOvariansuppressionorablationOvariansuppressionorablationOvariansuppressionorablationOvariansuppressionorablationOvarian suppressionOvarian suppressionOvarian suppressionOvarian suppressionPaclitaxelPaclitaxelPaclitaxel+trastuzumabPaclitaxel+trastuzumabPaclitaxel+trastuzumabPaclitaxel+trastuzumabPaclitaxel/bevacizumabPaclitaxel/bevacizumabPamidronatePamidronatePartialbreastirradiationinselectedpatientsPartialbreastirradiationinselectedpatientsPartialresponseLumpectomynotpossiblePartialresponseLumpectomynotpossiblePartialresponseLumpectomypossiblePartialresponseLumpectomypossiblePathologyreviewPathologyreviewPathologyreviewPathologyreviewPathologyreviewPathologyreviewPatientdoesnothavemultiplehighriskrecurrencefactorsPatientdoesnothavemultiplehighriskrecurrencefactorsPatienthasmultiplehighriskrecurrencefactorsPatienthasmultiplehighriskrecurrencefactorsPatientishighriskforhereditarybreastcancerPatientishighriskforhereditarybreastcancerPatientishighriskforhereditarybreastcancerPatientishighriskforhereditarybreastcancerPatientishighriskforhereditarybreastcancerPatientishighriskforhereditarybreastcancerPatientishighriskforhereditarybreastcancerPatientishighriskforhereditarybreastcancerPatientisontamoxifenUterusispresentPatientisontamoxifenUterusispresentPatienttakingaromataseinhibitorPatienttakingaromataseinhibitorPegylatedliposomaldoxorubicinPegylatedliposomaldoxorubicinPeriodicscreeningforchangesinfamilyhistoryPeriodicscreeningforchangesinfamilyhistoryPertuzumab+trastuzumab+docetaxelPertuzumab+trastuzumab+docetaxelPertuzumab+trastuzumab+docetaxelfollowedbyFECPertuzumab+trastuzumab+docetaxelfollowedbyFECPertuzumab+trastuzumab+docetaxelfollowedbyFECPertuzumab+trastuzumab+docetaxelfollowedbyFECPertuzumab+trastuzumab+paclitaxelPertuzumab+trastuzumab+paclitaxelPertuzumab+trastuzumab+paclitaxelfollowedbyFECPertuzumab+trastuzumab+paclitaxelfollowedbyFECPertuzumab+trastuzumab+paclitaxelfollowedbyFECPertuzumab+trastuzumab+paclitaxelfollowedbyFECPertuzumab/trastuzumab/taxanePertuzumab/trastuzumab/taxanePlannedadjuvantsystemictherapy basedonhormoneandHER2receptorstatusPlannedadjuvantsystemictherapy basedonhormoneandHER2receptorstatusPlannedadjuvantsystemictherapy basedonhormoneandHER2receptorstatusPlannedadjuvantsystemictherapy basedonhormoneandHER2receptorstatuspN0pN0pN0pN0pN0pN0pN0pN0pN1mipN1mipN1mipN1mipN1mipN1mipN1mipN1miPostmastectomyradiationtherapyPostmastectomyradiationtherapyPostmenopausalPostmenopausalPostmenopausalPostmenopausalPostmenopausalPostmenopausalPostmenopausalatdiagnosisPostmenopausalatdiagnosisPRpositivePRpositivePRpositivePRpositivePRpositivePRpositivePremenopausalPremenopausalPremenopausalPremenopausalPremenopausalPremenopausalPremenopausalPremenopausalPremenopausalPremenopausalPremenopausalPremenopausalPremenopausalatdiagnosisPremenopausalatdiagnosisPreoperativeAxillaryEvaluation/SystemicTherapyPreoperativeAxillaryEvaluation/SystemicTherapyPreoperativeAxillaryEvaluation/SystemicTherapy3.2014PreoperativeAxillaryEvaluation/SystemicTherapy3.2014PreoperativeradiationPreoperativeradiationPreoperativesettingPreoperativesettingPreoperativeSystemicTherapyPREOPERATIVESYSTEMICTHERAPYPreoperativeSystemicTherapyPREOPERATIVESYSTEMICTHERAPYPreoperativesystemictherapybasedonhormoneandHER2receptorstatusPreoperativesystemictherapybasedonhormoneandHER2receptorstatusPreoperativesystemictherapybasedonhormoneandHER2receptorstatusPreoperativesystemictherapybasedonhormoneandHER2receptorstatusPreoperativesystemictherapynotcompletedpreoperativelyPreoperativesystemictherapynotcompletedpreoperativelyPreoperativeWorkupPreoperativeWorkupPreoperativeWorkup3.2014PreoperativeWorkup3.2014Preoperative/AdjuvantChemotherapy:HER2negativePreoperative/AdjuvantChemotherapy:HER2negativePreoperative/AdjuvantChemotherapy:HER2positivePreoperative/AdjuvantChemotherapy:HER2positivePreoperative/AdjuvantChemotherapy:HER2positivePreoperative/AdjuvantChemotherapy:HER2positivePreoperative/AdjuvantChemotherapy:HER2positive3.2014Preoperative/AdjuvantChemotherapy:HER2positive3.2014Preoperative/AdjuvantChemotherapy:HER2negativePreoperative/AdjuvantChemotherapy:HER2negativePreoperative/AdjuvantChemotherapy:HER2negative3.2014Preoperative/AdjuvantChemotherapy:HER2negative3.2014PRIMARYTREATMENTPRIMARYTREATMENTPRIMARYTREATMENTPRIMARYTREATMENTPRIMARYTREATMENTPRIMARYTREATMENTPRIMARYTREATMENTPRIMARYTREATMENTPRIMARYTREATMENTPRIMARYTREATMENTPRIMARYTREATMENTPRIMARYTREATMENTPRIMARYTREATMENTPRIMARYTREATMENTPriorendocrinetherapywithin1yearPriorendocrinetherapywithin1yearpT1pT2orpT3andpN0orpN1mi(≤2mmaxillarynodemetastasis)pT1pT2orpT3andpN0orpN1mi(≤2mmaxillarynodemetastasis)pT1pT2orpT3andpN0orpN1mi(≤2mmaxillarynodemetastasis)pT1pT2orpT3andpN0orpN1mi(≤2mmaxillarynodemetastasis)pT1pT2orpT3andpN0orpN1mi(≤2mmaxillarynodemetastasis)pT1pT2orpT3andpN0orpN1mi(≤2mmaxillarynodemetastasis)pT1pT2orpT3andpN0orpN1mi(≤2mmaxillarynodemetastasis)pT1pT2orpT3andpN0orpN1mi(≤2mmaxillarynodemetastasis)pT1pT2orpT3andpN0orpN1mi(≤2mmaxillarynodemetastasis)pT1pT2orpT3andpN0orpN1mi(≤2mmaxillarynodemetastasis)Pulmonary symptomspresentPulmonary symptomspresentRadiationRadiationRadiationRadiationRadiationRadiationRadiationRadiationRadiationRadiationRadiationRadiationRadiationindicatedandnotpreviouslyadministeredRadiationindicatedandnotpreviouslyadministeredRadiationindicatedandnotpreviouslyadministeredRadiationindicatedandnotpreviouslyadministeredRadiationindicatedandnotpreviouslyadministeredRadiationindicatedandnotpreviouslyadministeredRadiationindicatedandnotpreviouslyadministeredRadiationindicatedandnotpreviouslyadministeredRadiationindicatedandnotpreviouslyadministeredRadiationindicatedandnotpreviouslyadministeredRadiationpreviouslydoneornotindicatedRadiationpreviouslydoneornotindicatedRadiationpreviouslydoneornotindicatedRadiationpreviouslydoneornotindicatedRadiationpreviouslydoneornotindicatedRadiationpreviouslydoneornotindicatedRadiationpreviouslydoneornotindicatedRadiationpreviouslydoneornotindicatedRadiationpreviouslydoneornotindicatedRadiationpreviouslydoneornotindicatedRadiationtherapyRadiationtherapyRadiationtherapyRadiationtherapyRadiationtherapyRadiationtherapyRadiationtherapybasedontumorsizeandaxillarylymphnodestatusatdiagnosisRadiationtherapybasedontumorsizeandaxillarylymphnodestatusatdiagnosisRadiationtherapytochestwallRadiationtherapytochestwallRadiationtherapytochestwall±infraclavicularregion±supraclaviculararea±internalmammarynodesandanypartoftheaxillarybedatriskRadiationtherapytochestwall±infraclavicularregion±supraclaviculararea±internalmammarynodesandanypartoftheaxillarybedatriskRadiationtherapytochestwallinfraclavicularregionsupraclavicularareainternalmammarynodesandanypartoftheaxillarybedatriskRadiationtherapytochestwallinfraclavicularregionsupraclavicularareainternalmammarynodesandanypartoftheaxillarybedatriskRadiationtherapytochestwallinfraclavicularregionsupraclavicularareainternalmammarynodesandanypartoftheaxillarybedatriskRadiationtherapytochestwallinfraclavicularregionsupraclavicularareainternalmammarynodesandanypartoftheaxillarybedatriskRadiationtherapytochestwallinfraclavicularregionsupraclavicularareainternalmammarynodesandanypartoftheaxillarybedatriskRadiationtherapytochestwallinfraclavicularregionsupraclavicularareainternalmammarynodesandanypartoftheaxillarybedatriskRadiationtherapytochestwallinfraclavicularregionsupraclavicularareainternalmammarynodesandanypartoftheaxillarybedatriskRadiationtherapytochestwallinfraclavicularregionsupraclavicularareainternalmammarynodesandanypartoftheaxillarybedatriskRadiationtherapytochestwallinfraclavicularregionsupraclavicularareainternalmammarynodesandanypartoftheaxillarybedatriskRadiationtherapytochestwallinfraclavicularregionsupraclavicularareainternalmammarynodesandanypartoftheaxillarybedatriskRadiationtherapytoinfraclavicularregionsupraclavicularareainternalmammarynodesandanypartoftheaxillarybedatriskRadiationtherapytoinfraclavicularregionsupraclavicularareainternalmammarynodesandanypartoftheaxillarybedatriskRadiationtherapytoinfraclavicularregionsupraclavicularareainternalmammarynodesandanypartoftheaxillarybedatriskRadiationtherapytoinfraclavicularregionsupraclavicularareainternalmammarynodesandanypartoftheaxillarybedatriskRadiationtherapytowholebreastwithboosttotumorbedRadiationtherapytowholebreastwithboosttotumorbedRadiationtherapytowholebreastwithboosttotumorbedRadiationtherapytowholebreastwithboosttotumorbedRadiationtherapytowholebreastwithboosttotumorbed+ infraclavicularregionsupraclavicularareainternalmammarynodesandanypartoftheaxillarybedatriskRadiationtherapytowholebreastwithboosttotumorbed+ infraclavicularregionsupraclavicularareainternalmammarynodesandanypartoftheaxillarybedatriskRadiationtherapytowholebreastwithoutboosttotumorbedRadiationtherapytowholebreastwithoutboosttotumorbedRadiationtherapytowholebreastwithoutboosttotumorbedRadiationtherapytowholebreastwithoutboosttotumorbedRadiationtherapytowholebreastwithoutboosttotumorbed+ infraclavicularregionsupraclavicularareainternalmammarynodesandanypartoftheaxillarybedatriskRadiationtherapytowholebreastwithoutboosttotumorbed+ infraclavicularregionsupraclavicularareainternalmammarynodesandanypartoftheaxillarybedatriskReconstructionReconstructionRecurrence/StageIV:InitialTreatmentRecurrence/StageIV:InitialTreatmentRecurrence/StageIV:InitialTreatment3.2014Recurrence/StageIV:InitialTreatment3.2014Recurrence/StageIV:SystemicTreatmentRecurrence/StageIV:SystemicTreatmentRecurrence/StageIV:SystemicTreatment3.2014Recurrence/StageIV:SystemicTreatment3.2014RecurrentbreastcancerRecurrentbreastcancerRecurrentdiseaseRecurrentdiseaseRecurrentHER2positivediseaseRecurrentHER2positivediseaseReferraltogeneticcounselingReferraltogeneticcounselingReflextestwithdualprobeISHReflextestwithdualprobeISHReflextestwithIHCReflextestwithIHCReflextestwithIHCReflextestwithIHCReflextestwithISHReflextestwithISHRegionalonlyRegionalonlyRepeatdeterminationofER/PRstatusRepeatdeterminationofER/PRstatusResponseResponseResponseResponseReviewHRandHER2receptorstatusReviewHRandHER2receptorstatusRoutineimagingofreconstructedbreastRoutineimagingofreconstructedbreastSamespecimenSamespecimenSamespecimenSamespecimenSamespecimenSamespecimenSamplebycorebiopsyoflymphnodepriortopreoperativesystemictherapySamplebycorebiopsyoflymphnodepriortopreoperativesystemictherapySamplebycorebiopsyoflymphnodepriortopreoperativesystemictherapySamplebycorebiopsyoflymphnodepriortopreoperativesystemictherapySamplebyFNApriortopreoperativesystemictherapySamplebyFNApriortopreoperativesystemictherapySamplebyFNApriortopreoperativesystemictherapySamplebyFNApriortopreoperativesystemictherapySeeappropriatepathwaySeeappropriatepathwaySeeASCO/CAPHER2GuidelineDataSupplement2EformoreinformationontheserarescenariosSeeASCO/CAPHER2GuidelineDataSupplement2EformoreinformationontheserarescenariosSeeFollowupSeeFollowupSeeFollowupSeeFollowupSeeFollowupSeeFollowupSeeFollowupSeeFollowupSeeFollowupSeeFollowupSeeLocoregionalTreatmentSeeLocoregionalTreatmentSeeNCCNGuidelinesforDistressManagementSeeNCCNGuidelinesforDistressManagementSeeNCCNGuidelinesforGenetic/FamilialHighRiskAssessment:BreastandOvarianSeeNCCNGuidelinesforGenetic/FamilialHighRiskAssessment:BreastandOvarianSeeNCCNGuidelinesforGenetic/FamilialHighRiskAssessment:BreastandOvarianSeeNCCNGuidelinesforGenetic/FamilialHighRiskAssessment:BreastandOvarianSeeNCCNGuidelinesforGenetic/FamilialHighRiskAssessment:BreastandOvarianSeeNCCNGuidelinesforGenetic/FamilialHighRiskAssessment:BreastandOvarianSeeNCCNGuidelinesforGenetic/FamilialHighRiskAssessment:BreastandOvarianSeeNCCNGuidelinesforGenetic/FamilialHighRiskAssessment:BreastandOvarianSeeNCCNGuidelinesforPalliative CareSeeNCCNGuidelinesforPalliative CareSeeNCCNGuidelinesforSupportiveCareSeeNCCNGuidelinesforSupportiveCareSeeNCCNGuidelinesforSurvivorshipSeeNCCNGuidelinesforSurvivorshipSeeNCCNGuidelinesfor DistressManagementSeeNCCNGuidelinesfor DistressManagementSeeNCCNGuidelinesfor DistressManagementSeeNCCNGuidelinesfor DistressManagementSeePreoperativeSystemicTherapySeePreoperativeSystemicTherapySeeRecurrentDiseaseSeeRecurrentDiseaseSeeSurveillance/FollowupSeeSurveillance/FollowupSeeSystemicAdjuvantTreatment:HR+HER2+SeeSystemicAdjuvantTreatment:HR+HER2+SeeSystemicAdjuvantTreatment:HR+HER2SeeSystemicAdjuvantTreatment:HR+HER2SeeSystemicAdjuvantTreatment:HRHER2+SeeSystemicAdjuvantTreatment:HRHER2+SeeSystemicAdjuvantTreatment:HRHER2SeeSystemicAdjuvantTreatment:HRHER2SeeSystemicAdjuvantTreatment: FavorableHistologiesSeeSystemicAdjuvantTreatment: FavorableHistologiesSeesystemictreatmentfor recurrent/metastaticdiseaseSeesystemictreatmentfor recurrent/metastaticdiseaseSeesystemictreatmentfor recurrent/metastaticdiseaseHER2+Seesystemictreatmentfor recurrent/metastaticdiseaseHER2+SeeSystemictreatmentHRnegativeorHR+andendocrinerefractoryHER2negativeSeeSystemictreatmentHRnegativeorHR+andendocrinerefractoryHER2negativeSeeSystemictreatmentHRnegativeorHR+andendocrinerefractoryHER2+SeeSystemictreatmentHRnegativeorHR+andendocrinerefractoryHER2+SeeSystemictreatment HR+HER2negativeorpositiveSeeSystemictreatment HR+HER2negativeorpositiveSelectiveERmodulatorsSelectiveERmodulatorsSelectiveERmodulatorsSelectiveERmodulatorsSelectiveER downregulatorSelectiveER downregulatorSentinellymphnodebiopsySentinellymphnodebiopsySentinellymphnodebiopsySentinellymphnodebiopsySentinelnodemappingandexcisionSentinelnodemappingandexcisionSentinelnodenegativeSentinelnodenegativeSentinelnodenotidentifiedSentinelnodenotidentifiedSentinelnodepositiveSentinelnodepositiveSignsandsymptomspresentSignsandsymptomspresentSLNBperformedduringaxillaryevaluationandnegativefindingsSLNBperformedduringaxillaryevaluationandnegativefindingsSLNBperformedduringaxillaryevaluationandnegativefindingsSLNBperformedduringaxillaryevaluationandnegativefindingsSodiumFluoridePET/CTSodiumfluoridePET/CTSodiumfluoridePET/CTSodiumfluoridePET/CTSodiumFluoridePET/CTSodiumfluoridePET/CTSodiumfluoridePET/CTSodiumfluoridePET/CTSofttissueonlySofttissueonlySofttissueonlySofttissueonlySomeclinicalbenefitswithin3sequentialendocrinetherapiesSomeclinicalbenefitswithin3sequentialendocrinetherapiesStageIStageIStageIIAStageIIAStageIIA(T2N0M0)Fulfillscriteriaforbreastconservingsurgeryexceptfortumorsize)StageIIA(T2N0M0)Fulfillscriteriaforbreastconservingsurgeryexceptfortumorsize)StageIIAT2N0M0StageIIAT2N0M0StageIIBStageIIBStageIIB(T2N1M0)Fulfillscriteriaforbreastconservingsurgeryexceptfortumorsize)StageIIB(T2N1M0)Fulfillscriteriaforbreastconservingsurgeryexceptfortumorsize)StageIIB(T3N0M0)Fulfillscriteriaforbreastconservingsurgeryexceptfortumorsize)StageIIB(T3N0M0)Fulfillscriteriaforbreastconservingsurgeryexceptfortumorsize)StageIIBT2N1M0T3N0M0StageIIBT2N1M0T3N0M0StageIIIA(T3N1M0)StageIIIA(T3N1M0)StageIIIA(T3N1M0)StageIIIA(T3N1M0)StageIIIA(T3N1M0)Fulfillscriteriaforbreastconservingsurgeryexceptfortumorsize)StageIIIA(T3N1M0)Fulfillscriteriaforbreastconservingsurgeryexceptfortumorsize)StageIIIAT0N2M0T1N2M0T2N2M0T3N2M0StageIIIAT0N2M0T1N2M0T2N2M0T3N2M0StageIIIAT2N1M0StageIIIAT2N1M0StageIIIBT4N0M0T4N1M0T4N2M0StageIIIBT4N0M0T4N1M0T4N2M0StageIIICAnyTN3M0StageIIICAnyTN3M0StageIVdiseaseStageIVdiseaseSTAGINGSTAGINGStartStartStartStartStartStartStartStartStartStartStartStartStartStartStartStartStartStartStartStartStartStartStartStartStartStartStartStartStartStartStartStartStartStartStartStartStartStartStartStartStartStartStartStartStartfromRecurrence/StageIV:InitialTreatment3.2014StartfromRecurrence/StageIV:InitialTreatment3.2014StartfromRecurrence/StageIV:InitialTreatment3.2014(2)StartfromRecurrence/StageIV:InitialTreatment3.2014(2)StartfromRecurrence/StageIV:InitialTreatment3.2014(3)StartfromRecurrence/StageIV:InitialTreatment3.2014(3)StartfromSystemicAdjTherapy:FavorableHistologies3.2014StartfromSystemicAdjTherapy:FavorableHistologies3.2014StartfromSystemicAdjTherapy:HR+HER2+3.2014StartfromSystemicAdjTherapy:HR+HER2+3.2014StartfromSystemicAdjTherapy:HR+HER23.2014StartfromSystemicAdjTherapy:HR+HER23.2014StartfromSystemicAdjTherapy:HRHER2+3.2014StartfromSystemicAdjTherapy:HRHER2+3.2014StartfromSystemicAdjTherapy:HRHER23.2014StartfromSystemicAdjTherapy:HRHER23.2014SupraclavicularrecurrenceSupraclavicularrecurrenceSurgicalAxillaryStagingSurgicalAxillaryStagingSurgicalAxillaryStaging3.2014SurgicalAxillaryStaging3.2014SurgicalresectionSurgicalresectionSurgicalresectionSurgicalresectionSurgicalresectionSurgicalresectionSURGICALTREATMENTSURGICALTREATMENTSURGICALTREATMENTSURGICALTREATMENTSurgicaltreatment+/surgicalaxillarystaging+/reconstructionSurgicaltreatment+/surgicalaxillarystaging+/reconstructionSurgical/AdjuvantTreatmentSurgical/AdjuvantTreatmentSurgical/AdjuvantTreatment3.2014Surgical/AdjuvantTreatment3.2014SurveillanceSURVEILLANCESurveillanceSurveillanceSURVEILLANCESurveillanceSurveillance3.2014Surveillance3.2014Surveillance/FollowupSurveillance/FollowupSuspiciousCNSsymptomsSuspiciousCNSsymptomsSuspiciousnodesSuspiciousnodesSymptomaticvisceralSymptomaticvisceralSymptomaticvisceralSymptomaticvisceralSymptomaticvisceralSymptomaticvisceralSymptomaticvisceraldiseaseSymptomaticvisceraldiseaseSystemicAdjTherapy:FavorableHistologiesSystemicAdjTherapy:FavorableHistologiesSystemicAdjTherapy:FavorableHistologies3.2014SystemicAdjTherapy:FavorableHistologies3.2014SystemicAdjTherapy:HR+HER2+SystemicAdjTherapy:HR+HER2+SystemicAdjTherapy:HR+HER2+3.2014SystemicAdjTherapy:HR+HER2+3.2014SystemicAdjTherapy:HR+HER2SystemicAdjTherapy:HR+HER2SystemicAdjTherapy:HR+HER23.2014SystemicAdjTherapy:HR+HER23.2014SystemicAdjTherapy:HRHER2+SystemicAdjTherapy:HRHER2+SystemicAdjTherapy:HRHER2+3.2014SystemicAdjTherapy:HRHER2+3.2014SystemicAdjTherapy:HRHER2SystemicAdjTherapy:HRHER2SystemicAdjTherapy:HRHER23.2014SystemicAdjTherapy:HRHER23.2014SystemicdiseaseSystemicdiseaseSystemictherapySystemictherapySystemictherapytobestresponseHER2negativeSystemictherapytobestresponseHER2negativeSystemictherapytobestresponseHER2negativeSystemictherapytobestresponseHER2negativeSystemictherapytobestresponseHER2positiveSystemictherapytobestresponseHER2positiveSystemictherapytobestresponseHER2positiveSystemictherapytobestresponseHER2positiveSYSTEMICTREATMENTSYSTEMICTREATMENTT1orT2tumor1or2positivesentinellymphnodesBreastconservingtherapyWholebreastRTplannedNopreoperativechemotherapyT1orT2tumor1or2positivesentinellymphnodesBreastconservingtherapyWholebreastRTplannedNopreoperativechemotherapyT2FulfillscriteriaforbreastconservingtherapyexceptforsizeT2FulfillscriteriaforbreastconservingtherapyexceptforsizeT3FulfillscriteriaforbreastconservingtherapyexceptforsizeT3FulfillscriteriaforbreastconservingtherapyexceptforsizeTAC(docetaxel/doxorubicin/cyclophosphamide)TAC(docetaxel/doxorubicin/cyclophosphamide)TAC(docetaxel/doxorubicin/cyclophosphamide)TAC(docetaxel/doxorubicin/cyclophosphamide)Tamoxifenfor23yTamoxifenfor23yTamoxifenfor4.56yTamoxifenfor4.56yTamoxifenfor5yTamoxifenfor5yTamoxifenfor5yTamoxifenfor5yTamoxifenfor5yTamoxifenfor5yTamoxifenforanadditional5ytocomplete10yofendocrinetherapyTamoxifenforanadditional5ytocomplete10yofendocrinetherapyTamoxifenforanadditional5ytocomplete10yofendocrinetherapyTamoxifenforanadditional5ytocomplete10yofendocrinetherapyTamoxifenforanadditional5ytocomplete10yofendocrinetherapyTamoxifenforanadditional5ytocomplete10yofendocrinetherapyTamoxifenforupto10yTamoxifenforupto10yTamoxifentocomplete5yofendocrinetherapyTamoxifentocomplete5yofendocrinetherapyTC(docetaxelandcyclophosphamide)TC(docetaxelandcyclophosphamide)TC(docetaxelandcyclophosphamide)TC(docetaxelandcyclophosphamide)TCH(docetaxel/carboplatin/trastuzumab)±pertuzumabTCH(docetaxel/carboplatin/trastuzumab)±pertuzumabTCH(docetaxel/carboplatin/trastuzumab)±pertuzumabTCH(docetaxel/carboplatin/trastuzumab)±pertuzumabTestwithalternativeISHchromosome17probeTestwithalternativeISHchromosome17probeTotalmastectomyTotalmastectomyTotalmastectomyTotalmastectomyTotalmastectomyTotalmastectomyTotalmastectomywith surgicalaxillarystagingTotalmastectomywith surgicalaxillarystagingTotalmastectomywith surgicalaxillarystagingTotalmastectomywith surgicalaxillarystagingTransitiontopalliativecareTransitiontopalliativecareTrastuzumab+capecitabineTrastuzumab+capecitabineTrastuzumab+capecitabineTrastuzumab+capecitabineTrastuzumab+docetaxelTrastuzumab+docetaxelTrastuzumab+lapatinib(withoutcytotoxictherapy)Trastuzumab+lapatinib(withoutcytotoxictherapy)Trastuzumab+otheragentsTrastuzumab+otheragentsTrastuzumab+paclitaxelTrastuzumab+paclitaxelTrastuzumab+paclitaxel+carboplatinTrastuzumab+paclitaxel+carboplatinTrastuzumab+vinorelbineTrastuzumab+vinorelbineTrastuzumabfor1yearTrastuzumabfor1yearTrastuzumabcontainingchemoregimenTrastuzumabcontainingchemoregimenTrastuzumabcontainingchemoregimenTrastuzumabcontainingchemoregimenTrastuzumabcontainingchemoregimenTrastuzumabcontainingchemoregimenTrastuzumabcontainingchemoregimenTrastuzumabcontainingchemoregimenTrastuzumabcontainingchemoregimenTrastuzumabcontainingchemoregimenTrastuzumabcontainingchemoregimenTrastuzumabcontainingchemoregimenTrastuzumabexposeddiseaseTrastuzumabexposeddiseaseTrastuzumab/chemoTrastuzumab/chemoTreatasHRHER2TreatasHRHER2TREATMENTTREATMENTTREATMENTTREATMENTTREATMENTRESPONSETREATMENTRESPONSETreat asHRHER2+Treat asHRHER2+TubularTubularTubularTubularTumor0.61.0cmTumor0.61.0cmTumor0.61.0cmTumor0.61.0cmTumor0.61.0cmTumor0.61.0cmTumor>0.5cmTumor>0.5cmTumor>1cmTumor>1cmTumor>1cmTumor>1cmTumor>1cmTumor>1cmTumorisnottechnicallyresectableTumorisnottechnicallyresectableTumorisnottechnicallyresectableTumorisnottechnicallyresectableTumorisnottechnicallyresectableTumorisnottechnicallyresectableTumorisnottechnicallyresectableTumorisnottechnicallyresectableTumoristechnicallyresectableTumoristechnicallyresectableTumoristechnicallyresectableTumoristechnicallyresectableTumoristechnicallyresectableTumoristechnicallyresectableTumor≤0.5cmTumor≤0.5cmTumor≤0.5cmTumor≤0.5cmTumor≤0.5cmTumor≤0.5cmTumor≤0.5cmTumor≤0.5cmUltrasoundUltrasoundUltrasoundUltrasoundUltrasoundUltrasoundUpto5yofaromataseinhibitorUpto5yofaromataseinhibitorValidateddualprobeISHassayValidateddualprobeISHassayValidatedIHCassayValidatedIHCassayValidatedsingleprobeISHassayValidatedsingleprobeISHassayVinorelbineVinorelbineVisceralcrisisVisceralcrisisworkupWORKUPWORKUPWORKUPWORKUPWORKUPworkupWORKUPWORKUPWORKUPWORKUPWORKUPXraysofabnormalbonesXraysofabnormalbonesXraysofsymptomaticbonesXraysofsymptomaticbonesZoledronicacidZoledronicacid≥3cm≥3cm≥4positiveaxillarynodes≥4positiveaxillarynodes≥4positiveaxillarynodes≥4positiveaxillarynodes≥5yearsaftertreatment≥5yearsaftertreatment;903;28622;31.0;26.0;26.0
